GeneIdx, PercentGeneCovered, AberageKMerDepth
>1000|F60S|ARO:3003074|Staphylococcus aureus cls conferring resistance to daptomycin|MEG_1730|Drugs|Lipopeptides|Daptomycin-resistant_mutant|CLS|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000571549.1|60|cls_F60S|LIPOPEPTIDE|DAPTOMYCIN|Staphylococcus_aureus_daptomycin_resistant_Cls|wt_coherence=TRUE,8.64198%,0.823045
>1002|V213I|ARO:3003901|Staphylococcus aureus GlpT with mutation conferring resistance to fosfomycin|MEG_3143|Drugs|Fosfomycin|Fosfomycin_target_mutation|GLPT|RequiresSNPConfirmation|Staphylococcus_aureus|WP_001010116.1|213|glpT_V213I|FOSFOMYCIN|FOSFOMYCIN|Staphylococcus_aureus_fosfomycin_resistant_GlpT|wt_coherence=TRUE,9.45946%,0.691441
>1003|W137R|ARO:3003901|Staphylococcus aureus GlpT with mutation conferring resistance to fosfomycin|MEG_3143|Drugs|Fosfomycin|Fosfomycin_target_mutation|GLPT|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.45946%,1.52252
>1005|L27F|ARO:3003901|Staphylococcus aureus GlpT with mutation conferring resistance to fosfomycin|MEG_3143|Drugs|Fosfomycin|Fosfomycin_target_mutation|GLPT|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.45946%,1.51802
>1006|A100V|ARO:3003901|Staphylococcus aureus GlpT with mutation conferring resistance to fosfomycin|MEG_3143|Drugs|Fosfomycin|Fosfomycin_target_mutation|GLPT|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.45946%,0.93018
>1007|G352D|ARO:3003901|Staphylococcus aureus GlpT with mutation conferring resistance to fosfomycin|MEG_3143|Drugs|Fosfomycin|Fosfomycin_target_mutation|GLPT|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.45946%,1.12613
>1008|S85P|ARO:3003296|Staphylococcus aureus gyrA conferring resistance to fluoroquinolones|MEG_3186|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.27531%,0.069397
>1009|E88K|ARO:3003296|Staphylococcus aureus gyrA conferring resistance to fluoroquinolones|MEG_3186|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.07167%,0.0432309
>100|K59T|ARO:3003092|Enterococcus faecium cls conferring resistance to daptomycin|MEG_1732|Drugs|Lipopeptides|Daptomycin-resistant_mutant|CLS|RequiresSNPConfirmation|Enterococcus_faecium|WP_002289473.1|59|cls_K59T|LIPOPEPTIDE|DAPTOMYCIN|Enterococcus_faecium_daptomycin_resistant_Cls|wt_coherence=TRUE,8.84211%,0.701053
>1010|S84L|ARO:3003296|Staphylococcus aureus gyrA conferring resistance to fluoroquinolones|MEG_3186|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.04778%,0.036405
>1011|E88A|ARO:3003296|Staphylococcus aureus gyrA conferring resistance to fluoroquinolones|MEG_3186|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.27531%,0.0227531
>1012|R143S|ARO:3003301|Staphylococcus aureus gyrB conferring resistance to aminocoumarin|MEG_3245|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|GYRBA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_010956585.1|143|gyrB_R143S|AMINOCOUMARIN|AMINOCOUMARIN|Staphylococcus_aureus_aminocoumarin_resistant_GyrB|wt_coherence=TRUE,6.61417%,0.551181
>1013|I55S|ARO:3003301|Staphylococcus aureus gyrB conferring resistance to aminocoumarin|MEG_3245|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|GYRBA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_010956585.1|55|gyrB_I55S|AMINOCOUMARIN|AMINOCOUMARIN|Staphylococcus_aureus_aminocoumarin_resistant_GyrB|wt_coherence=TRUE,6.61417%,0.508661
>1014|T172A|ARO:3003301|Staphylococcus aureus gyrB conferring resistance to aminocoumarin|MEG_3245|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|GYRBA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_010956585.1|172|gyrB_T172A|AMINOCOUMARIN|AMINOCOUMARIN|Staphylococcus_aureus_aminocoumarin_resistant_GyrB|wt_coherence=TRUE,6.61417%,0.535433
>1015|I101S|ARO:3003301|Staphylococcus aureus gyrB conferring resistance to aminocoumarin|MEG_3245|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|GYRBA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_010956585.1|101|gyrB_I101S|AMINOCOUMARIN|AMINOCOUMARIN|Staphylococcus_aureus_aminocoumarin_resistant_GyrB|wt_coherence=TRUE,6.61417%,0.631496
>1016|S128L|ARO:3003301|Staphylococcus aureus gyrB conferring resistance to aminocoumarin|MEG_3245|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|GYRBA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.61417%,0.44252
>1017|G84S|ARO:3003301|Staphylococcus aureus gyrB conferring resistance to aminocoumarin|MEG_3245|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|GYRBA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_010956585.1|84|gyrB_G84S|AMINOCOUMARIN|AMINOCOUMARIN|Staphylococcus_aureus_aminocoumarin_resistant_GyrB|wt_coherence=TRUE,6.61417%,0.392126
>1018|R143I|ARO:3003301|Staphylococcus aureus gyrB conferring resistance to aminocoumarin|MEG_3245|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|GYRBA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_010956585.1|143|gyrB_R143I|AMINOCOUMARIN|AMINOCOUMARIN|Staphylococcus_aureus_aminocoumarin_resistant_GyrB|wt_coherence=TRUE,6.61417%,0.420472
>1019|V588F|ARO:3003729|Staphylococcus aureus ileS with mutation conferring resistance to mupirocin|MEG_3296|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|ILES|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000384706.1|588|ileS_V588F|MUPIROCIN|MUPIROCIN|Staphylococcus_aureus_mupirocin_resistant_IleS|wt_coherence=TRUE,4.62046%,0.413641
>101|H215R|ARO:3003092|Enterococcus faecium cls conferring resistance to daptomycin|MEG_1732|Drugs|Lipopeptides|Daptomycin-resistant_mutant|CLS|RequiresSNPConfirmation|Enterococcus_faecium|WP_002289473.1|215|cls_H215R|LIPOPEPTIDE|DAPTOMYCIN|Enterococcus_faecium_daptomycin_resistant_Cls|wt_coherence=TRUE,1.89474%,0.168421
>1020|V631F|ARO:3003729|Staphylococcus aureus ileS with mutation conferring resistance to mupirocin|MEG_3296|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|ILES|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000384706.1|631|ileS_V631F|MUPIROCIN|MUPIROCIN|Staphylococcus_aureus_mupirocin_resistant_IleS|wt_coherence=TRUE,4.62046%,0.356436
>1021|G33D|ARO:3003917|Staphylococcus aureus menA with mutation conferring resistance to lysocin|MEG_3831|Drugs|Lipopeptides|Lysocin-resistant_mutant|MENA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,13.8158%,1.15461
>1022|T345K|ARO:3003319|Staphylococcus aureus mprF with mutation conferring resistance to daptomycin|MEG_4057|Drugs|Lipopeptides|Daptomycin-resistant_mutant|MPRFD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.07246%,0.528986
>1023|T472K|ARO:3003319|Staphylococcus aureus mprF with mutation conferring resistance to daptomycin|MEG_4057|Drugs|Lipopeptides|Daptomycin-resistant_mutant|MPRFD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.07246%,0.5
>1024|M347R|ARO:3003319|Staphylococcus aureus mprF with mutation conferring resistance to daptomycin|MEG_4057|Drugs|Lipopeptides|Daptomycin-resistant_mutant|MPRFD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.07246%,0.560386
>1025|I420N|ARO:3003319|Staphylococcus aureus mprF with mutation conferring resistance to daptomycin|MEG_4057|Drugs|Lipopeptides|Daptomycin-resistant_mutant|MPRFD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.07246%,0.450483
>1027|P314L|ARO:3003319|Staphylococcus aureus mprF with mutation conferring resistance to daptomycin|MEG_4057|Drugs|Lipopeptides|Daptomycin-resistant_mutant|MPRFD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.07246%,0.751208
>1028|I418N|ARO:3003319|Staphylococcus aureus mprF with mutation conferring resistance to daptomycin|MEG_4057|Drugs|Lipopeptides|Daptomycin-resistant_mutant|MPRFD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.07246%,0.339372
>1029|S295L|ARO:3003319|Staphylococcus aureus mprF with mutation conferring resistance to daptomycin|MEG_4057|Drugs|Lipopeptides|Daptomycin-resistant_mutant|MPRFD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.07246%,0.799517
>1030|G61V|ARO:3003319|Staphylococcus aureus mprF with mutation conferring resistance to daptomycin|MEG_4057|Drugs|Lipopeptides|Daptomycin-resistant_mutant|MPRFD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.07246%,0.842995
>1031|L341S|ARO:3003319|Staphylococcus aureus mprF with mutation conferring resistance to daptomycin|MEG_4057|Drugs|Lipopeptides|Daptomycin-resistant_mutant|MPRFD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.07246%,0.398551
>1032|S337L|ARO:3003319|Staphylococcus aureus mprF with mutation conferring resistance to daptomycin|MEG_4057|Drugs|Lipopeptides|Daptomycin-resistant_mutant|MPRFD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.4686%,0.306763
>1033|T345A|ARO:3003319|Staphylococcus aureus mprF with mutation conferring resistance to daptomycin|MEG_4057|Drugs|Lipopeptides|Daptomycin-resistant_mutant|MPRFD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.07246%,0.535024
>1034|F57S|ARO:3003319|Staphylococcus aureus mprF with mutation conferring resistance to daptomycin|MEG_4057|Drugs|Lipopeptides|Daptomycin-resistant_mutant|MPRFD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.07246%,0.400966
>1035|T345I|ARO:3003319|Staphylococcus aureus mprF with mutation conferring resistance to daptomycin|MEG_4057|Drugs|Lipopeptides|Daptomycin-resistant_mutant|MPRFD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.07246%,0.141304
>1036|V351E|ARO:3003319|Staphylococcus aureus mprF with mutation conferring resistance to daptomycin|MEG_4057|Drugs|Lipopeptides|Daptomycin-resistant_mutant|MPRFD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.07246%,0.460145
>1037|G257D|ARO:3003776|Staphylococcus aureus murA with mutation conferring resistance to fosfomycin|MEG_4094|Drugs|Fosfomycin|Fosfomycin_target_mutation|MURA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.1695%,1.36562
>1038|E291D|ARO:3003776|Staphylococcus aureus murA with mutation conferring resistance to fosfomycin|MEG_4094|Drugs|Fosfomycin|Fosfomycin_target_mutation|MURA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000358006.1|291|murA_E291D|FOSFOMYCIN|FOSFOMYCIN|Staphylococcus_aureus_fosfomycin_resistant_MurA|wt_coherence=TRUE,10.1695%,1.15496
>1040|D278E|ARO:3003776|Staphylococcus aureus murA with mutation conferring resistance to fosfomycin|MEG_4094|Drugs|Fosfomycin|Fosfomycin_target_mutation|MURA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000358006.1|278|murA_D278E|FOSFOMYCIN|FOSFOMYCIN|Staphylococcus_aureus_fosfomycin_resistant_MurA|wt_coherence=TRUE,12.5908%,0.842615
>1041|T396N|ARO:3003776|Staphylococcus aureus murA with mutation conferring resistance to fosfomycin|MEG_4094|Drugs|Fosfomycin|Fosfomycin_target_mutation|MURA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.1695%,1.74334
>1042|V65L|ARO:3003776|Staphylococcus aureus murA with mutation conferring resistance to fosfomycin|MEG_4094|Drugs|Fosfomycin|Fosfomycin_target_mutation|MURA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.1695%,0.719128
>1044|E84G|ARO:3003312|Staphylococcus aureus parC conferring resistance to fluoroquinolones|MEG_5329|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.40909%,0.193182
>1045|S80F|ARO:3003312|Staphylococcus aureus parC conferring resistance to fluoroquinolones|MEG_5329|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.30303%,0.949495
>1046|G78S|ARO:3003314|Staphylococcus aureus parE conferring resistance to aminocoumarin|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.41221%,0.818321
>1047|R136G|ARO:3003314|Staphylococcus aureus parE conferring resistance to aminocoumarin|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.41221%,1.00305
>1048|D434H|ARO:3003315|Staphylococcus aureus parE conferring resistance to fluoroquinolones|MEG_5395|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PAREF|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.87062%,0.133942
>1049|P587S|ARO:3003315|Staphylococcus aureus parE conferring resistance to fluoroquinolones|MEG_5395|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PAREF|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.39269%,0.828006
>1050|D434N|ARO:3003315|Staphylococcus aureus parE conferring resistance to fluoroquinolones|MEG_5395|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PAREF|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.456621%,0.0136986
>1052|A64V|ARO:3003323|Staphylococcus aureus pgsA mutations conferring resistance to daptomycin|MEG_5780|Drugs|Lipopeptides|Daptomycin-resistant_mutant|PGSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_001025093.1|64|pgsA_A64V|LIPOPEPTIDE|DAPTOMYCIN|Staphylococcus_aureus_daptomycin_resistant_PgsA|wt_coherence=TRUE,22.8261%,2.2337
>1053|K66R|ARO:3003323|Staphylococcus aureus pgsA mutations conferring resistance to daptomycin|MEG_5780|Drugs|Lipopeptides|Daptomycin-resistant_mutant|PGSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_001025093.1|66|pgsA_K66R|LIPOPEPTIDE|DAPTOMYCIN|Staphylococcus_aureus_daptomycin_resistant_PgsA|wt_coherence=TRUE,22.8261%,1.47826
>1054|V59N|ARO:3003323|Staphylococcus aureus pgsA mutations conferring resistance to daptomycin|MEG_5780|Drugs|Lipopeptides|Daptomycin-resistant_mutant|PGSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_001025093.1|59|pgsA_V59N|LIPOPEPTIDE|DAPTOMYCIN|Staphylococcus_aureus_daptomycin_resistant_PgsA|wt_coherence=TRUE,22.8261%,1.67391
>1055|A621E|ARO:3003287|Staphylococcus aureus rpoB mutants conferring resistance to daptomycin|MEG_6137|Drugs|Lipopeptides|Daptomycin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOBL|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000918664.1|621|rpoB_A621E|LIPOPEPTIDE|DAPTOMYCIN|Staphylococcus_aureus_daptomycin_resistant_RpoB|wt_coherence=TRUE,3.57447%,0.157447
>1056|I953S|ARO:3003287|Staphylococcus aureus rpoB mutants conferring resistance to daptomycin|MEG_6137|Drugs|Lipopeptides|Daptomycin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOBL|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000918664.1|953|rpoB_I953S|LIPOPEPTIDE|DAPTOMYCIN|Staphylococcus_aureus_daptomycin_resistant_RpoB|wt_coherence=TRUE,3.57447%,0.268085
>1057|A1085V|ARO:3003287|Staphylococcus aureus rpoB mutants conferring resistance to daptomycin|MEG_6137|Drugs|Lipopeptides|Daptomycin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOBL|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000918664.1|1085|rpoB_A1085V|LIPOPEPTIDE|DAPTOMYCIN|Staphylococcus_aureus_daptomycin_resistant_RpoB|wt_coherence=TRUE,3.57447%,0.298723
>1058|H481N|ARO:3003285|Staphylococcus aureus rpoB mutants conferring resistance to rifampicin|MEG_6136|Drugs|Lipopeptides|Daptomycin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOBL|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000918664.1|481|rpoB_H481N|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,1.78723%,0.0706383
>1059|Q468K|ARO:3003285|Staphylococcus aureus rpoB mutants conferring resistance to rifampicin|MEG_6136|Drugs|Lipopeptides|Daptomycin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOBL|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000918664.1|468|rpoB_Q468K|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,3.91489%,0.285106
>105|D27N|ARO:3003092|Enterococcus faecium cls conferring resistance to daptomycin|MEG_1732|Drugs|Lipopeptides|Daptomycin-resistant_mutant|CLS|RequiresSNPConfirmation|Enterococcus_faecium|WP_002289473.1|27|cls_D27N|LIPOPEPTIDE|DAPTOMYCIN|Enterococcus_faecium_daptomycin_resistant_Cls|wt_coherence=TRUE,8.84211%,0.637895
>1060|A473T|ARO:3003285|Staphylococcus aureus rpoB mutants conferring resistance to rifampicin|MEG_6136|Drugs|Lipopeptides|Daptomycin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOBL|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000918664.1|473|rpoB_A473T|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,3.57447%,1.26894
>1061|Q465R|ARO:3003285|Staphylococcus aureus rpoB mutants conferring resistance to rifampicin|MEG_6136|Drugs|Lipopeptides|Daptomycin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOBL|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000918664.1|465|rpoB_Q465R|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,4.08511%,0.137021
>1062|L466S|ARO:3003285|Staphylococcus aureus rpoB mutants conferring resistance to rifampicin|MEG_6136|Drugs|Lipopeptides|Daptomycin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOBL|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000918664.1|466|rpoB_L466S|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,3.57447%,0.389787
>1063|A477T|ARO:3003285|Staphylococcus aureus rpoB mutants conferring resistance to rifampicin|MEG_6136|Drugs|Lipopeptides|Daptomycin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOBL|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000918664.1|477|rpoB_A477T|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,1.2766%,0.0144681
>1064|Q961K|ARO:3003291|Staphylococcus aureus rpoC conferring resistance to daptomycin|MEG_6139|Drugs|Lipopeptides|Daptomycin-resistant_beta-subunit_of_RNA_polymerase_RpoC|RPOCL|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000567963.1|961|rpoC_Q961K|LIPOPEPTIDE|DAPTOMYCIN|Staphylococcus_aureus_daptomycin_resistant_RpoC|wt_coherence=TRUE,3.50292%,0.301084
>1065|F632S|ARO:3003291|Staphylococcus aureus rpoC conferring resistance to daptomycin|MEG_6139|Drugs|Lipopeptides|Daptomycin-resistant_beta-subunit_of_RNA_polymerase_RpoC|RPOCL|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000567963.1|632|rpoC_F632S|LIPOPEPTIDE|DAPTOMYCIN|Staphylococcus_aureus_daptomycin_resistant_RpoC|wt_coherence=TRUE,3.50292%,0.267723
>1066|G358V|ARO:3003902|Staphylococcus aureus UhpT with mutation conferring resistance to fosfomycin|MEG_7329|Drugs|Fosfomycin|Fosfomycin_target_mutation|UHPT|RequiresSNPConfirmation|Staphylococcus_aureus|WP_001008722.1|358|uhpT_G358V|FOSFOMYCIN|FOSFOMYCIN|Staphylococcus_aureus_fosfomycin_resistant_UhpT|wt_coherence=TRUE,9.31264%,0.920177
>1067|W425R|ARO:3003902|Staphylococcus aureus UhpT with mutation conferring resistance to fosfomycin|MEG_7329|Drugs|Fosfomycin|Fosfomycin_target_mutation|UHPT|RequiresSNPConfirmation|Staphylococcus_aureus|WP_001008722.1|425|uhpT_W425R|FOSFOMYCIN|FOSFOMYCIN|Staphylococcus_aureus_fosfomycin_resistant_UhpT|wt_coherence=TRUE,9.31264%,0.727273
>1068|G112E|ARO:3003902|Staphylococcus aureus UhpT with mutation conferring resistance to fosfomycin|MEG_7329|Drugs|Fosfomycin|Fosfomycin_target_mutation|UHPT|RequiresSNPConfirmation|Staphylococcus_aureus|WP_001008722.1|112|uhpT_G112E|FOSFOMYCIN|FOSFOMYCIN|Staphylococcus_aureus_fosfomycin_resistant_UhpT|wt_coherence=TRUE,9.31264%,0.578714
>1069|S221P|ARO:3003794|Staphylococcus aureus walK with mutation conferring resistance to daptomycin|MEG_7806|Drugs|Lipopeptides|Daptomycin-resistant_mutant|WALK|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000871610.1|221|walK_S221P|LIPOPEPTIDE|DAPTOMYCIN|Staphylococcus_aureus_daptomycin_resistant_WalK|wt_coherence=TRUE,7%,0.663333
>106|G178T|ARO:3003092|Enterococcus faecium cls conferring resistance to daptomycin|MEG_1732|Drugs|Lipopeptides|Daptomycin-resistant_mutant|CLS|RequiresSNPConfirmation|Enterococcus_faecium|WP_002289473.1|178|cls_G178T|LIPOPEPTIDE|DAPTOMYCIN|Enterococcus_faecium_daptomycin_resistant_Cls|wt_coherence=TRUE,8.84211%,0.911579
>1070|R263C|ARO:3003794|Staphylococcus aureus walK with mutation conferring resistance to daptomycin|MEG_7806|Drugs|Lipopeptides|Daptomycin-resistant_mutant|WALK|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000871610.1|263|walK_R263C|LIPOPEPTIDE|DAPTOMYCIN|Staphylococcus_aureus_daptomycin_resistant_WalK|wt_coherence=TRUE,7.16667%,0.596667
>1072|F88L|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000090315.1|88|fusA_F88L|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,7.15328%,0.513869
>1073|Q115L|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000090315.1|115|fusA_Q115L|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.575182
>1074|P404Q|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000090315.1|404|fusA_P404Q|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.29927
>1075|V407F|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000090315.1|407|fusA_V407F|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.40292
>1076|D434N|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000090315.1|434|fusA_D434N|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,8.32117%,0.381022
>1077|G451V|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000090315.1|451|fusA_G451V|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,7.59124%,0.490511
>1078|R464S|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000090315.1|464|fusA_R464S|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.42336%,0.283212
>1079|A376V|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000090315.1|376|fusA_A376V|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.309489
>107|R267H|ARO:3003092|Enterococcus faecium cls conferring resistance to daptomycin|MEG_1732|Drugs|Lipopeptides|Daptomycin-resistant_mutant|CLS|RequiresSNPConfirmation|Enterococcus_faecium|WP_002289473.1|267|cls_R267H|LIPOPEPTIDE|DAPTOMYCIN|Enterococcus_faecium_daptomycin_resistant_Cls|wt_coherence=TRUE,8.84211%,0.770526
>1080|G452C|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000090315.1|452|fusA_G452C|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.86131%,0.940146
>1081|L461S|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000090315.1|461|fusA_L461S|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.265693
>1082|G452S|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000090315.1|452|fusA_G452S|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.71533%,0.350365
>1083|G452V|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000090315.1|452|fusA_G452V|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.414599
>1084|R464H|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000090315.1|464|fusA_R464H|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.513869
>1085|R464L|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000090315.1|464|fusA_R464L|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.418978
>1086|L461F|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000090315.1|461|fusA_L461F|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.557664
>1087|T436I|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000090315.1|436|fusA_T436I|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.27737%,0.475912
>1088|H457Y|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000090315.1|457|fusA_H457Y|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.931387
>1089|V90I|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000090315.1|90|fusA_V90I|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.922628
>108|G258A|ARO:3003438|Enterococcus faecium EF-Tu mutants conferring resistance to GE2270A|MEG_7303|Drugs|Elfamycins|EF-Tu_inhibition|TUFAB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.1205%,0.915663
>1090|V90A|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000090315.1|90|fusA_V90A|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.531387
>1091|F441Y|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.13139%,0.50219
>1092|L456F|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000090315.1|456|fusA_L456F|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.421898
>1093|R464C|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000090315.1|464|fusA_R464C|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.579562
>1094|P406L|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000090315.1|406|fusA_P406L|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.986861
>1095|L461K|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000090315.1|461|fusA_L461K|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.71533%,0.545985
>1096|P404L|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000090315.1|404|fusA_P404L|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.556204
>1097|M453I|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000090315.1|453|fusA_M453I|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.475912
>1098|H457Q|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000090315.1|457|fusA_H457Q|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.71533%,0.354745
>1099|Q140L|ARO:3003737|Staphylococcus aureus fusE with mutation conferring resistance to fusidic acid|MEG_3071|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSE|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000091975.1|140|fusE_Q140L|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusE|wt_coherence=TRUE,24.7059%,1.81176
>109|G275A|ARO:3003438|Enterococcus faecium EF-Tu mutants conferring resistance to GE2270A|MEG_7303|Drugs|Elfamycins|EF-Tu_inhibition|TUFAB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.1205%,0.754217
>10|M159T|ARO:3004045|Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.5354%,1.27165
>1100|D222N|ARO:3004097|Streptococcus mitis CdsA with mutation conferring daptomycin resistance|MEG_1642|Drugs|Lipopeptides|Daptomycin-resistant_mutant|CDSA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.2162%,1.59846
>1101|S82F|ARO:3003311|Streptococcus pneumoniae parC conferring resistance to fluoroquinolones|MEG_5327|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.13447%,0.850856
>1103|S82Y|ARO:3003311|Streptococcus pneumoniae parC conferring resistance to fluoroquinolones|MEG_5327|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.13447%,0.909535
>1104|N609D|ARO:3003041|Streptococcus pneumoniae PBP1a conferring resistance to amoxicillin|MEG_5399|Drugs|betalactams|Penicillin_binding_protein|PBP1A|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.90717%,0.312236
>1105|S575T|ARO:3003041|Streptococcus pneumoniae PBP1a conferring resistance to amoxicillin|MEG_5399|Drugs|betalactams|Penicillin_binding_protein|PBP1A|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.90717%,0.509142
>1106|T488A|ARO:3003042|Streptococcus pneumoniae PBP2b conferring resistance to amoxicillin|MEG_5406|Drugs|betalactams|Penicillin_binding_protein|PBP2B|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.20384%,0.506647
>1107|E475G|ARO:3003042|Streptococcus pneumoniae PBP2b conferring resistance to amoxicillin|MEG_5406|Drugs|betalactams|Penicillin_binding_protein|PBP2B|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.35155%,0.462334
>1108|T445A|ARO:3003042|Streptococcus pneumoniae PBP2b conferring resistance to amoxicillin|MEG_5406|Drugs|betalactams|Penicillin_binding_protein|PBP2B|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.20384%,0.319055
>1109|N514H|ARO:3003043|Streptococcus pneumoniae PBP2x conferring resistance to amoxicillin|MEG_5407|Drugs|betalactams|Penicillin_binding_protein|PBP2X|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.66038%,0.365229
>110|L39F|ARO:3003790|Enterococcus faecium liaF mutant conferring daptomycin resistance|MEG_3591|Drugs|Lipopeptides|Daptomycin-resistant_mutant|LIAFSR|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,17.8723%,1.3617
>1110|M400T|ARO:3003043|Streptococcus pneumoniae PBP2x conferring resistance to amoxicillin|MEG_5407|Drugs|betalactams|Penicillin_binding_protein|PBP2X|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.29111%,0.032345
>1111|L546V|ARO:3003043|Streptococcus pneumoniae PBP2x conferring resistance to amoxicillin|MEG_5407|Drugs|betalactams|Penicillin_binding_protein|PBP2X|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.66038%,0.451482
>1112|N605T|ARO:3003043|Streptococcus pneumoniae PBP2x conferring resistance to amoxicillin|MEG_5407|Drugs|betalactams|Penicillin_binding_protein|PBP2X|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.66038%,0.5
>1113|I371T|ARO:3003043|Streptococcus pneumoniae PBP2x conferring resistance to amoxicillin|MEG_5407|Drugs|betalactams|Penicillin_binding_protein|PBP2X|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.66038%,0.606469
>1114|R384G|ARO:3003043|Streptococcus pneumoniae PBP2x conferring resistance to amoxicillin|MEG_5407|Drugs|betalactams|Penicillin_binding_protein|PBP2X|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,7.81671%,0.597035
>1115|M339F|ARO:3003043|Streptococcus pneumoniae PBP2x conferring resistance to amoxicillin|MEG_5407|Drugs|betalactams|Penicillin_binding_protein|PBP2X|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.66038%,0.40566
>1116|F25I|ARO:3003387|Streptococcus pyogenes folP with mutation conferring resistance to sulfonamides|MEG_2934|Drugs|Sulfonamides|Sulfonamide-resistant_dihydropteroate_synthases|FOLP|RequiresSNPConfirmation|Streptococcus_pyogenes|WP_011017740.1|25|folP_F25I|SULFONAMIDE|SULFONAMIDE|Streptococcus_pyogenes_sulfonamide_resistant_FolP|wt_coherence=TRUE,2.71318%,0.186047
>1118|R144H|ARO:3005081|Thermus thermophilus uL3 mutations conferring resistance to pleuromutilin antibiotics|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,21.2121%,1.58586
>1119|R144C|ARO:3005081|Thermus thermophilus uL3 mutations conferring resistance to pleuromutilin antibiotics|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,21.2121%,0.909091
>111|I144T|ARO:3003790|Enterococcus faecium liaF mutant conferring daptomycin resistance|MEG_3591|Drugs|Lipopeptides|Daptomycin-resistant_mutant|LIAFSR|RequiresSNPConfirmation|Enterococcus_faecium|WP_002295408.1|144|liaF_I144T|LIPOPEPTIDE|DAPTOMYCIN|Enterococcus_faecium_daptomycin_resistant_LiaF|wt_coherence=TRUE,17.8723%,1.61277
>1120|P462S|ARO:3003305|Ureaplasma urealyticum  gyrB conferring resistance to fluoroquinolones|MEG_3240|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.20561%,0.0903427
>1121|E502Q|ARO:3003305|Ureaplasma urealyticum  gyrB conferring resistance to fluoroquinolones|MEG_3240|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.54206%,0.422118
>1122|E87Q|ARO:3003309|Ureaplasma urealyticum parC conferring resistance to fluoroquinolones|MEG_5328|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.98812%,0.30285
>1124|S83L|ARO:3003309|Ureaplasma urealyticum parC conferring resistance to fluoroquinolones|MEG_5328|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.950119%,0.0380048
>1125|S84P|ARO:3003309|Ureaplasma urealyticum parC conferring resistance to fluoroquinolones|MEG_5328|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.18765%,0.0154394
>112|W73C|ARO:3003078|Enterococcus faecium liaR mutant conferring daptomycin resistance|MEG_3590|Drugs|Lipopeptides|Daptomycin-resistant_mutant|LIAFSR|RequiresSNPConfirmation|Enterococcus_faecium|WP_002289153.1|73|liaR_W73C|LIPOPEPTIDE|DAPTOMYCIN|Enterococcus_faecium_daptomycin_resistant_LiaR|wt_coherence=TRUE,20.7921%,1.11386
>1134|Y304STOP|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.37838%,0.0439189
>1135|W91STOP|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,18.0723%,0.349398
>113|E192G|ARO:3003079|Enterococcus faecium liaS mutant conferring daptomycin resistance|MEG_3589|Drugs|Lipopeptides|Daptomycin-resistant_mutant|LIAFSR|RequiresSNPConfirmation|Enterococcus_faecium|WP_002289154.1|192|liaS_E192G|LIPOPEPTIDE|DAPTOMYCIN|Enterococcus_faecium_daptomycin_resistant_LiaS|wt_coherence=TRUE,12.1037%,0.429395
>1140|W68STOP|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.66667%,0.0666667
>1141|W119STOP|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,12.6126%,0.135135
>1144|Y41STOP|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,30.303%,0.575758
>114|A180T|ARO:3003079|Enterococcus faecium liaS mutant conferring daptomycin resistance|MEG_3589|Drugs|Lipopeptides|Daptomycin-resistant_mutant|LIAFSR|RequiresSNPConfirmation|Enterococcus_faecium|WP_002289154.1|180|liaS_A180T|LIPOPEPTIDE|DAPTOMYCIN|Enterococcus_faecium_daptomycin_resistant_LiaS|wt_coherence=TRUE,12.1037%,0.645533
>115|H264Q|ARO:3003079|Enterococcus faecium liaS mutant conferring daptomycin resistance|MEG_3589|Drugs|Lipopeptides|Daptomycin-resistant_mutant|LIAFSR|RequiresSNPConfirmation|Enterococcus_faecium|WP_002289154.1|264|liaS_H264Q|LIPOPEPTIDE|DAPTOMYCIN|Enterococcus_faecium_daptomycin_resistant_LiaS|wt_coherence=TRUE,12.1037%,1.02594
>1160|F330S|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.74312%,0.0247706
>1162|N296H|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.272477
>1163|A454T|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.277982
>1164|L402V|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.36789
>1165|Y319S|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.58716%,0.121101
>1167|H281P|ARO:3003458|Mycobacterium tuberculosis ethA with mutation conferring resistance to ethionamide|MEG_2866|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethionamide-resistant_mutant|ETHA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.93971%,0.83368
>1168|N379D|ARO:3003458|Mycobacterium tuberculosis ethA with mutation conferring resistance to ethionamide|MEG_2866|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethionamide-resistant_mutant|ETHA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.8108%,0.970894
>1169|D94H|ARO:3003295|Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones|MEG_3180|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.33735%,0.0915663
>116|T120A|ARO:3003079|Enterococcus faecium liaS mutant conferring daptomycin resistance|MEG_3589|Drugs|Lipopeptides|Daptomycin-resistant_mutant|LIAFSR|RequiresSNPConfirmation|Enterococcus_faecium|WP_002289154.1|120|liaS_T120A|LIPOPEPTIDE|DAPTOMYCIN|Enterococcus_faecium_daptomycin_resistant_LiaS|wt_coherence=TRUE,12.1037%,0.855908
>1170|E501D|ARO:3003459|Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones|MEG_3243|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=FALSE,5.94901%,0.334278
>1171|N499T|ARO:3003459|Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones|MEG_3243|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=FALSE,5.94901%,0.332861
>1172|T162S|ARO:3003393|Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid|MEG_3429|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|INHA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.092%,1.28352
>1173|I317V|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.87432%,0.461749
>1174|W191R|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.461749
>1175|D63G|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.57865
>1176|Y34D|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.94944
>1178|D49N|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.83146
>1179|D49G|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,27.5281%,1.96629
>117|S352T|ARO:3003900|Escherichia coli cyaA with mutation conferring resistance to fosfomycin|NA|NA|NA|NA|NA|NA|Escherichia|WP_000281668.1|352|cyaA_S352T|FOSMIDOMYCIN|FOSMIDOMYCIN|Escherichia_fosmidomycin_resistant_CyaA|wt_coherence=TRUE,5%,0.344048
>1180|I5T|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.74157%,0.0674157
>1181|H51R|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.60112
>1182|H57R|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,31.4607%,2.48315
>1183|F58S|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,29.2135%,2.34831
>1185|P62S|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,25.2809%,1.48315
>1188|D8E|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.17978%,0.0617978
>1190|C138R|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.41573
>1191|V139G|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,33.1461%,2.67416
>1192|A146E|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.65169
>1193|A146V|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,29.2135%,2.43258
>1194|L151S|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,0.955056
>1198|I1106T|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.278351
>1199|Q975H|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.203608
>119|Y161C|ARO:3003368|Escherichia coli EF-Tu mutants conferring resistance to kirromycin|MEG_7302|Drugs|Elfamycins|EF-Tu_inhibition|TUFAB|RequiresSNPConfirmation|Escherichia|WP_000031783.1|161|tufA_Y161C|POLYKETIDE|KIRROMYCIN|Escherichia_kirromycin_resistant_TufA|wt_coherence=TRUE,10.8808%,0.61658
>11|F203L|ARO:3004045|Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan|NA|NA|NA|NA|NA|NA|Escherichia|WP_000506490.1|203|fabI_F203L|ISONIAZID/TRICLOSAN|ISONIAZID/TRICLOSAN|Escherichia_isoniazid/triclosan_resistant_FabI|wt_coherence=TRUE,16.5354%,1.59449
>1200|G836S|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.256014
>1201|H835R|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.304983
>1202|R827H|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.325601
>1203|L731P|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.30756
>1204|F503S|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.43643%,0.0841924
>1205|I480V|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.278351
>1206|P45L|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.120275
>1207|S450W|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.310137
>1208|H445R|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.38144%,0.209622
>1209|H445Y|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.89003%,0.0189003
>120|Q125K|ARO:3003368|Escherichia coli EF-Tu mutants conferring resistance to kirromycin|MEG_7302|Drugs|Elfamycins|EF-Tu_inhibition|TUFAB|RequiresSNPConfirmation|Escherichia|WP_000031783.1|125|tufA_Q125K|POLYKETIDE|KIRROMYCIN|Escherichia_kirromycin_resistant_TufA|wt_coherence=TRUE,10.8808%,0.940415
>1210|D435V|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.43643%,0.133162
>1211|D435G|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.103093
>1212|M434I|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.46735%,0.227663
>1213|Q432P|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.09278%,0.0919244
>1214|H445D|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.54639%,0.0532646
>1215|A412V|ARO:3004721|Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide|MEG_6142|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|RPSA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.87949%,0.752643
>1216|A381V|ARO:3004721|Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide|MEG_6142|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|RPSA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.87949%,0.566596
>1217|A440T|ARO:3004721|Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide|MEG_6142|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|RPSA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.87949%,0.733615
>1219|I548M;R505K|ARO:3004563|Clostridioides difficile rpoB with mutation conferring resistance to rifampicin|MEG_6095|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.2966%,0.0372771
>121|G317D|ARO:3003368|Escherichia coli EF-Tu mutants conferring resistance to kirromycin|MEG_7302|Drugs|Elfamycins|EF-Tu_inhibition|TUFAB|RequiresSNPConfirmation|Escherichia|WP_000031783.1|317|tufA_G317D|POLYKETIDE|KIRROMYCIN|Escherichia_kirromycin_resistant_TufA|wt_coherence=TRUE,10.8808%,0.873057
>1220|L487F;H502Y|ARO:3004563|Clostridioides difficile rpoB with mutation conferring resistance to rifampicin|MEG_6095|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.59319%,0.132091
>1221|E448K;G33R|ARO:3003889|Escherichia coli GlpT with mutation conferring resistance to fosfomycin|MEG_3144|Drugs|Fosfomycin|Fosfomycin_target_mutation|GLPT|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.45946%,0.725225
>1222|E448K;G302D|ARO:3003889|Escherichia coli GlpT with mutation conferring resistance to fosfomycin|MEG_3144|Drugs|Fosfomycin|Fosfomycin_target_mutation|GLPT|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.45946%,0.720721
>1223|E448K;Q444E;E443Q;L297F|ARO:3003889|Escherichia coli GlpT with mutation conferring resistance to fosfomycin|MEG_3144|Drugs|Fosfomycin|Fosfomycin_target_mutation|GLPT|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.45946%,0.558559
>1224|S83L;D87Y|ARO:3003294|Escherichia coli gyrA conferring resistance to fluoroquinolones|MEG_3187|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.88351%,0.0519031
>1225|S83L;D87N|ARO:3003294|Escherichia coli gyrA conferring resistance to fluoroquinolones|MEG_3187|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.99885%,0.0599769
>1226|A314G;Y322C|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=FALSE,7.24771%,3.08349
>1227|I161V;G324R|ARO:3005105;ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to isoniazid;Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,17.4636%,1.41996
>1228|Q254P;S266R|ARO:3005105|Mycobacterium tuberculosis ethA mutations conferring resistance to isoniazid|not corresponding|ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,11.2266%,2.17672
>1229|R239Q;S266R|ARO:3005105;ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to isoniazid;Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,14.3451%,1.62994
>122|Q125R|ARO:3003368|Escherichia coli EF-Tu mutants conferring resistance to kirromycin|MEG_7302|Drugs|Elfamycins|EF-Tu_inhibition|TUFAB|RequiresSNPConfirmation|Escherichia|WP_000031783.1|125|tufA_Q125R|POLYKETIDE|KIRROMYCIN|Escherichia_kirromycin_resistant_TufA|wt_coherence=TRUE,10.8808%,0.891192
>1230|Q246R;L446P|ARO:3005105;ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to isoniazid;Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,17.4636%,1.5343
>1231|S266R;P454L|ARO:3005105;ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to isoniazid;Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.627859
>1232|S266R;M373T|ARO:3005105;ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to isoniazid;Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.476091
>1233|A90V;D94G|ARO:3003295|Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones|MEG_3180|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.18072%,0.131325
>1234|R485C;T539N|ARO:3003459|Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones|MEG_3243|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,11.898%,1.69688
>1235|N538D;T546M|ARO:3003459|Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones|MEG_3243|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,7.08215%,0.803116
>1236|R485C;T546M|ARO:3003459|Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones|MEG_3243|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.94901%,0.131728
>1237|N538T;T546M|ARO:3003459|Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones|MEG_3243|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,7.08215%,0.311615
>1238|G279V;L436P|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.3825%,0.580601
>1239|V431A;G490S|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,11.7486%,1.23497
>123|Y161D|ARO:3003368|Escherichia coli EF-Tu mutants conferring resistance to kirromycin|MEG_7302|Drugs|Elfamycins|EF-Tu_inhibition|TUFAB|RequiresSNPConfirmation|Escherichia|WP_000031783.1|161|tufA_Y161D|POLYKETIDE|KIRROMYCIN|Escherichia_kirromycin_resistant_TufA|wt_coherence=TRUE,11.1399%,0.979275
>1240|P92S;S315T|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.374317
>1241|S315T;G466R|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,11.7486%,3.10383
>1242|S315T;V581G|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.378415
>1243|S211G;S315T|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.64481%,0.0983607
>1245|N596S;Y597H|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.87432%,1.00546
>1246|M126I;R496L|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.342896
>1247|S134S;T308P|ARO:3005102|Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.3934%,5.5724
>1248|T275A;S315T|ARO:3005102|Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,11.2022%,0.494536
>1249|L251R;A254G;T270I|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.98527%,1.24954
>124|Y161N|ARO:3003368|Escherichia coli EF-Tu mutants conferring resistance to kirromycin|MEG_7302|Drugs|Elfamycins|EF-Tu_inhibition|TUFAB|RequiresSNPConfirmation|Escherichia|WP_000031783.1|161|tufA_Y161N|POLYKETIDE|KIRROMYCIN|Escherichia_kirromycin_resistant_TufA|wt_coherence=TRUE,10.8808%,0.867876
>1250|T270I;I297T|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.276243%,0.00276243
>1251|A244T;G288W;V303G|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.03867%,0.239411
>1253|T270I;Y296H;G308D;G325S|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.53775%,0.544199
>1255|V287F;Y309N|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.89319%,0.31768
>1256|Y296S;R302G|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.69613%,0.444751
>1257|A247P;T270I;I297T|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.72192%,0.424494
>1258|G272S;H285Y;M300R;A307T|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.90608%,0.925414
>125|L121Q|ARO:3003368|Escherichia coli EF-Tu mutants conferring resistance to kirromycin|MEG_7302|Drugs|Elfamycins|EF-Tu_inhibition|TUFAB|RequiresSNPConfirmation|Escherichia|WP_000031783.1|121|tufA_L121Q|POLYKETIDE|KIRROMYCIN|Escherichia_kirromycin_resistant_TufA|wt_coherence=TRUE,10.8808%,0.966321
>1260|T270I;G288W;V303G|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.72192%,0.962247
>1261|G288V;M310K;Y327N|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,7.45856%,1.09853
>1262|Q10P;Y99D|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,2.20787
>1263|A25E;A26G;A28D|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,24.7191%,3.26404
>1264|D63Y;T142K|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,47.191%,4.77528
>1265|S531L;S622A|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=FALSE,3.60825%,0.248282
>1266|H526S;M515V|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=FALSE,2.14777%,0.0274914
>1267|H526S;P535H|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=FALSE,4.0378%,0.0919244
>1268|H526Y;E541G|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=FALSE,2.83505%,0.0429553
>1269|D516Y;L511R|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=FALSE,4.63918%,0.989691
>1270|-S512;-Q513;-F514;H526Q|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=FALSE,7.32127%,7.25323
>1271|D516E;S522L|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=FALSE,3.60825%,0.0592784
>1272|S531L;H526C|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=FALSE,2.66323%,0.0429553
>1273|L511R;D516V|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=FALSE,2.57732%,0.238832
>1275|L524W;T525P;H526Q;-527K|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=FALSE,1.54506%,0.0206009
>1277|-519N;S522L;S531L|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=FALSE,4.54936%,0.544206
>1278|H526D;S531|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=FALSE,2.83749%,0.105761
>1279|L511P;S512T;D516V|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=FALSE,1.6323%,0.0180412
>127|Q125E|ARO:3003368|Escherichia coli EF-Tu mutants conferring resistance to kirromycin|MEG_7302|Drugs|Elfamycins|EF-Tu_inhibition|TUFAB|RequiresSNPConfirmation|Escherichia|WP_000031783.1|125|tufA_Q125E|POLYKETIDE|KIRROMYCIN|Escherichia_kirromycin_resistant_TufA|wt_coherence=TRUE,10.8808%,0.867876
>1280|T516I;G523W;D525Y|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=FALSE,2.66323%,0.0438144
>1281|H526D;E541G;S553A|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=FALSE,1.89003%,0.0300687
>1282|H526P;K527Q|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=FALSE,0.429553%,0.00429553
>1283|E562G;P564L|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=FALSE,3.78007%,0.546392
>1284|-515M;-516D;-517Q;-518N|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.19521%,0.244863
>1285|G120P;A121P|ARO:3000464|Neisseria gonorrhoeae porin PIB (por)|MEG_5808|Drugs|Multi-drug_resistance|MDR_mutant_porin_proteins|POR|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,12.6471%,1.80588
>1286|G120R;A121H|ARO:3000464|Neisseria gonorrhoeae porin PIB (por)|MEG_5808|Drugs|Multi-drug_resistance|MDR_mutant_porin_proteins|POR|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,12.6471%,1.52353
>1287|T83I;D87G|ARO:3003684|Pseudomonas aeruginosa gyrA conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.983607%,0.00983607
>1288|T83I;D87H|ARO:3003684|Pseudomonas aeruginosa gyrA conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.983607%,0.0163934
>1289|T83I;D87N|ARO:3003684|Pseudomonas aeruginosa gyrA conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.85792%,0.0185792
>1290|G452C;R659L|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.13139%,0.691971
>1291|A70V;A160V;H457Y|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.13139%,0.30219
>1292|T387I;E449K|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=FALSE,12.2628%,1.60146
>1293|D189V;L430S|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,12.2628%,1.89343
>1294|F652S;Y654N|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.42336%,0.770803
>1295|V90I;H457Q;L461K;A655V|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,12.5547%,1.64526
>1296|A67T;P406L|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.13139%,0.461314
>1297|H457Y;S416F|ARO:3003735|Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid|MEG_3065|Drugs|Fusidic_acid|Fusidic_acid-resistant_mutation|FUSA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.13139%,0.839416
>1299|R231C|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000031783.1|231|tufA_R231C|POLYKETIDE|PULVOMYCIN|Escherichia_pulvomycin_resistant_TufA|wt_coherence=TRUE,6.73575%,0.0829016
>129|Q330H|ARO:3003368|Escherichia coli EF-Tu mutants conferring resistance to kirromycin|MEG_7302|Drugs|Elfamycins|EF-Tu_inhibition|TUFAB|RequiresSNPConfirmation|Escherichia|WP_000031783.1|330|tufA_Q330H|POLYKETIDE|KIRROMYCIN|Escherichia_kirromycin_resistant_TufA|wt_coherence=TRUE,10.8808%,0.792746
>12|F203C|ARO:3004045|Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan|NA|NA|NA|NA|NA|NA|Escherichia|WP_000506490.1|203|fabI_F203C|ISONIAZID/TRICLOSAN|ISONIAZID/TRICLOSAN|Escherichia_isoniazid/triclosan_resistant_FabI|wt_coherence=TRUE,16.5354%,1.56693
>1300|R231V|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000031783.1|231|tufA_R231V|POLYKETIDE|PULVOMYCIN|Escherichia_pulvomycin_resistant_TufA|wt_coherence=TRUE,1.03627%,0.0103627
>1301|R234F|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000031783.1|234|tufA_R234F|POLYKETIDE|PULVOMYCIN|Escherichia_pulvomycin_resistant_TufA|wt_coherence=TRUE,8.54922%,0.0906736
>1302|R234S|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000031783.1|234|tufA_R234S|POLYKETIDE|PULVOMYCIN|Escherichia_pulvomycin_resistant_TufA|wt_coherence=TRUE,10.8808%,0.326425
>1303|R334C|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000031783.1|334|tufA_R334C|POLYKETIDE|PULVOMYCIN|Escherichia_pulvomycin_resistant_TufA|wt_coherence=TRUE,10.8808%,0.629534
>1304|T335A|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000031783.1|335|tufA_T335A|POLYKETIDE|PULVOMYCIN|Escherichia_pulvomycin_resistant_TufA|wt_coherence=TRUE,10.8808%,0.686528
>1305|Y421C|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_000072047.1|421|gyrB_Y421C|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_GyrB|wt_coherence=TRUE,5.27638%,0.44598
>1306|R438L|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_000072047.1|438|gyrB_R438L|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_GyrB|wt_coherence=TRUE,5.27638%,0.243719
>1307|S464F|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_000072047.1|464|gyrB_S464F|QUINOLONE|CIPROFLOXACIN|Salmonella_ciprofloxacin_resistant_GyrB|wt_coherence=TRUE,5.27638%,0.295226
>1308|S464T|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_000072047.1|464|gyrB_S464T|QUINOLONE|CIPROFLOXACIN|Salmonella_ciprofloxacin_resistant_GyrB|wt_coherence=TRUE,5.27638%,0.590452
>1309|S464Y|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_000072047.1|464|gyrB_S464Y|QUINOLONE|CIPROFLOXACIN|Salmonella_ciprofloxacin_resistant_GyrB|wt_coherence=TRUE,5.27638%,0.507538
>1310|D426N|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000072067.1|426|gyrB_D426N|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_GyrB|wt_coherence=TRUE,1.38191%,0.139447
>1311|K447E|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000072067.1|447|gyrB_K447E|QUINOLONE|NALIDIXIC_ACID|Escherichia_nalidixic_acid_resistant_GyrB|wt_coherence=TRUE,6.40704%,0.586683
>1312|P114H|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000090315.1|114|fusA_P114H|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.430657
>1313|A160V|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000090315.1|160|fusA_A160V|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.948905
>1314|D189G|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000090315.1|189|fusA_D189G|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.283212
>1316|E233Q|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000090315.1|233|fusA_E233Q|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.359124
>1317|D373N|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000090315.1|373|fusA_D373N|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.42336%,0.369343
>1318|T385N|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000090315.1|385|fusA_T385N|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.456934
>131|R234S|ARO:3003369|Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin|MEG_7301|Drugs|Elfamycins|EF-Tu_inhibition|TUFAB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,12.2195%,0.830424
>1322|H438N|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000090315.1|438|fusA_H438N|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,8.0292%,0.424818
>1323|E444K|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000090315.1|444|fusA_E444K|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,7.44526%,0.589781
>1324|E444V|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000090315.1|444|fusA_E444V|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,7.88321%,0.611679
>1326|L456K|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000090315.1|456|fusA_L456K|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.478832
>1327|D463G|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000090315.1|463|fusA_D463G|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.535766
>1328|C473S|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000090315.1|473|fusA_C473S|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.347445
>1329|P478S|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000090315.1|478|fusA_P478S|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.483212
>132|R234F|ARO:3003369|Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin|MEG_7301|Drugs|Elfamycins|EF-Tu_inhibition|TUFAB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,14.9626%,3.84539
>1330|G556S|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000090315.1|556|fusA_G556S|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.478832
>1331|V607I|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000090315.1|607|fusA_V607I|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.318248
>1332|G617D|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000090315.1|617|fusA_G617D|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.39562
>1333|M651I|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000090315.1|651|fusA_M651I|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,7.29927%,0.335766
>1334|F652S|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000090315.1|652|fusA_F652S|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,5.83942%,0.274453
>1335|Y654N|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000090315.1|654|fusA_Y654N|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.27737%,0.50073
>1336|A655E|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000090315.1|655|fusA_A655E|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.369343
>1337|A655P|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000090315.1|655|fusA_A655P|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.519708
>1339|T656K|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000090315.1|656|fusA_T656K|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.367883
>133|R334C|ARO:3003369|Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin|MEG_7301|Drugs|Elfamycins|EF-Tu_inhibition|TUFAB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.4738%,1.03491
>1340|R659C|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000090315.1|659|fusA_R659C|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.414599
>1341|R659H|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000090315.1|659|fusA_R659H|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.475912
>1343|R659S|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000090315.1|659|fusA_R659S|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.548905
>1344|G664S|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000090315.1|664|fusA_G664S|FUSIDIC_ACID|FUSIDIC_ACID|Staphylococcus_aureus_fusidic_acid_resistant_FusA|wt_coherence=TRUE,6.13139%,0.538686
>1345|R45C|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000101737.1|45|acrR_R45C|MULTIDRUG|AMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE|Escherichia_ampicillin/chloramphenicol/quinolone/rifampin/tetracycline_resistant_AcrR|wt_coherence=TRUE,7.72947%,0.516908
>1346|S569A|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000138348.1|569|pbp2_S569A|BETA-LACTAM|CEPHALOSPORIN|Staphylococcus_aureus_cephalosporin_resistant_Pbp2|wt_coherence=TRUE,5.84145%,0.279555
>1347|G139R|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000160212.1|139|rplC_G139R|OXAZOLIDINONE|LINEZOLID|Staphylococcus_aureus_linezolid_resistant_RplC|wt_coherence=TRUE,19.8113%,2.08491
>1348|S145DEL|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000160212.1|145|rplC_S145DEL|OXAZOLIDINONE|LINEZOLID|Staphylococcus_aureus_linezolid_resistant_RplC|wt_coherence=TRUE,19.6262%,1.22897
>1349|G152D|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000160212.1|152|rplC_G152D|OXAZOLIDINONE|LINEZOLID|Staphylococcus_aureus_linezolid_resistant_RplC|wt_coherence=TRUE,19.8113%,1.5566
>134|T336A|ARO:3003369|Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin|MEG_7301|Drugs|Elfamycins|EF-Tu_inhibition|TUFAB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.4738%,0.9601
>1350|G155R|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000160212.1|155|rplC_G155R|OXAZOLIDINONE|LINEZOLID|Staphylococcus_aureus_linezolid_resistant_RplC|wt_coherence=TRUE,19.8113%,1.65566
>1351|M169L|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000160212.1|169|rplC_M169L|OXAZOLIDINONE|LINEZOLID|Staphylococcus_aureus_linezolid_resistant_RplC|wt_coherence=TRUE,19.8113%,1.11792
>1352|L21V|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000175752.1|21|dfrB_L21V|TRIMETHOPRIM|TRIMETHOPRIM|Staphylococcus_aureus_trimethoprim_resistant_DfrB|wt_coherence=TRUE,3.97351%,0.0397351
>1353|H31N|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000175752.1|31|dfrB_H31N|TRIMETHOPRIM|TRIMETHOPRIM|Staphylococcus_aureus_trimethoprim_resistant_DfrB|wt_coherence=TRUE,27.8146%,2.21854
>1354|L41F|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000175752.1|41|dfrB_L41F|TRIMETHOPRIM|TRIMETHOPRIM|Staphylococcus_aureus_trimethoprim_resistant_DfrB|wt_coherence=TRUE,27.8146%,2.40397
>1355|N60I|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000175752.1|60|dfrB_N60I|TRIMETHOPRIM|TRIMETHOPRIM|Staphylococcus_aureus_trimethoprim_resistant_DfrB|wt_coherence=TRUE,27.8146%,2.15232
>1356|F99I|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000175752.1|99|dfrB_F99I|TRIMETHOPRIM|TRIMETHOPRIM|Staphylococcus_aureus_trimethoprim_resistant_DfrB|wt_coherence=TRUE,27.8146%,1.57616
>1357|F99S|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000175752.1|99|dfrB_F99S|TRIMETHOPRIM|TRIMETHOPRIM|Staphylococcus_aureus_trimethoprim_resistant_DfrB|wt_coherence=TRUE,27.8146%,2.5298
>1358|F99Y|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000175752.1|99|dfrB_F99Y|TRIMETHOPRIM|TRIMETHOPRIM|Staphylococcus_aureus_trimethoprim_resistant_DfrB|wt_coherence=TRUE,27.8146%,1.36424
>135|R231V|ARO:3003369|Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin|MEG_7301|Drugs|Elfamycins|EF-Tu_inhibition|TUFAB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.4738%,0.481297
>1360|M438I|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_000195318.1|438|parE_M438I|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_ParE|wt_coherence=TRUE,2.57235%,0.0305466
>1361|E454G|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_000195318.1|454|parE_E454G|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_ParE|wt_coherence=TRUE,6.75241%,0.590032
>1362|S458P|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_000195318.1|458|parE_S458P|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_ParE|wt_coherence=TRUE,6.75241%,0.459807
>1363|H462Y|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_000195318.1|462|parE_H462Y|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_ParE|wt_coherence=TRUE,6.75241%,0.348875
>1364|A499T|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_000195318.1|499|parE_A499T|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_ParE|wt_coherence=TRUE,6.75241%,0.472669
>1365|V514G|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_000195318.1|514|parE_V514G|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_ParE|wt_coherence=TRUE,6.75241%,0.55627
>1366|V521F|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_000195318.1|521|parE_V521F|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_ParE|wt_coherence=TRUE,6.75241%,0.371383
>1367|S84F|NA|NA|NA|NA|NA|NA|NA|NA|Acinetobacter_baumannii|WP_000202259.1|84|parC_S84F|QUINOLONE|QUINOLONE|Acinetobacter_baumannii_quinolone_resistant_ParC|wt_coherence=TRUE,3.41997%,0.276334
>1368|S84W|NA|NA|NA|NA|NA|NA|NA|NA|Acinetobacter_baumannii|WP_000202259.1|84|parC_S84W|QUINOLONE|QUINOLONE|Acinetobacter_baumannii_quinolone_resistant_ParC|wt_coherence=TRUE,3.55677%,0.0820793
>1369|E88K|NA|NA|NA|NA|NA|NA|NA|NA|Acinetobacter_baumannii|WP_000202259.1|88|parC_E88K|QUINOLONE|QUINOLONE|Acinetobacter_baumannii_quinolone_resistant_ParC|wt_coherence=TRUE,3.69357%,0.0766074
>136|R231C|ARO:3003369|Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin|MEG_7301|Drugs|Elfamycins|EF-Tu_inhibition|TUFAB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.4738%,1.10723
>1370|A515V|NA|NA|NA|NA|NA|NA|NA|NA|Acinetobacter_baumannii|WP_000227936.1|515|ftsI_A515V|BETA-LACTAM|CARBAPENEM|Acinetobacter_baumannii_carbapenem_resistant_FtsI|wt_coherence=TRUE,6.97674%,0.5
>1371|I572F|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000263098.1|572|rpoB_I572F|RIFAMYCIN|RIFAMYCIN|Escherichia_rifamycin_resistant_RpoB|wt_coherence=TRUE,0.749625%,0.0562219
>1372|I572L|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000263098.1|572|rpoB_I572L|RIFAMYCIN|RIFAMYCIN|Escherichia_rifamycin_resistant_RpoB|wt_coherence=TRUE,1.94903%,0.0652174
>1373|I572N|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000263098.1|572|rpoB_I572N|RIFAMYCIN|RIFAMYCIN|Escherichia_rifamycin_resistant_RpoB|wt_coherence=TRUE,3.14843%,0.267616
>1375|V65A|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000358006.1|65|murA_V65A|FOSFOMYCIN|FOSFOMYCIN|Staphylococcus_aureus_fosfomycin_resistant_MurA|wt_coherence=TRUE,10.1695%,0.837772
>1376|G257D|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000358006.1|257|murA_G257D|FOSFOMYCIN|FOSFOMYCIN|Staphylococcus_aureus_fosfomycin_resistant_MurA|wt_coherence=TRUE,7.02179%,0.0702179
>1377|Q362R|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000358006.1|362|murA_Q362R|FOSFOMYCIN|FOSFOMYCIN|Staphylococcus_aureus_fosfomycin_resistant_MurA|wt_coherence=TRUE,10.1695%,1.90073
>1379|L64R|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000378442.1|64|emrR_L64R|QUINOLONE|NITROXOLINE|Escherichia_nitroxoline_resistant_EmrR|wt_coherence=TRUE,25%,2.21429
>137|P64A|ARO:3003386|Escherichia coli folP with mutation conferring resistance to sulfonamides|NA|NA|NA|NA|NA|NA|Escherichia|WP_000764731.1|64|folP_P64A|SULFONAMIDE|SULFONAMIDE|Escherichia_sulfonamide_resistant_FolP|wt_coherence=TRUE,6.93431%,0.189781
>1380|L113P|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000378442.1|113|emrR_L113P|QUINOLONE|NITROXOLINE|Escherichia_nitroxoline_resistant_EmrR|wt_coherence=TRUE,25%,2.45238
>1381|H67Q|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000384706.1|67|ileS_H67Q|MUPIROCIN|MUPIROCIN|Staphylococcus_aureus_mupirocin_resistant_IleS|wt_coherence=TRUE,4.62046%,0.375138
>1382|F563L|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000384706.1|563|ileS_F563L|MUPIROCIN|MUPIROCIN|Staphylococcus_aureus_mupirocin_resistant_IleS|wt_coherence=TRUE,4.62046%,0.40044
>1383|G593V|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000384706.1|593|ileS_G593V|MUPIROCIN|MUPIROCIN|Staphylococcus_aureus_mupirocin_resistant_IleS|wt_coherence=TRUE,4.62046%,0.30143
>1384|R816C|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000384706.1|816|ileS_R816C|MUPIROCIN|MUPIROCIN|Staphylococcus_aureus_mupirocin_resistant_IleS|wt_coherence=TRUE,4.62046%,0.315732
>1388|G53E|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_000697899.1|53|pmrA_G53E|COLISTIN|COLISTIN|Salmonella_colistin_resistant_PmrA|wt_coherence=TRUE,8.8785%,0.476636
>1389|G53R|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_000697899.1|53|pmrA_G53R|COLISTIN|COLISTIN|Salmonella_colistin_resistant_PmrA|wt_coherence=TRUE,14.486%,0.514019
>138|P64H|ARO:3003386|Escherichia coli folP with mutation conferring resistance to sulfonamides|NA|NA|NA|NA|NA|NA|Escherichia|WP_000764731.1|64|folP_P64H|SULFONAMIDE|SULFONAMIDE|Escherichia_sulfonamide_resistant_FolP|wt_coherence=TRUE,13.5036%,0.437956
>1390|R81C|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_000697899.1|81|pmrA_R81C|COLISTIN|COLISTIN|Salmonella_colistin_resistant_PmrA|wt_coherence=TRUE,19.6262%,0.873832
>1391|R81H|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_000697899.1|81|pmrA_R81H|COLISTIN|COLISTIN|Salmonella_colistin_resistant_PmrA|wt_coherence=TRUE,19.6262%,0.803738
>1392|F28I|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000764731.1|28|folP_F28I|SULFONAMIDE|SULFONAMIDE|Escherichia_sulfonamide_resistant_FolP|wt_coherence=TRUE,12.0438%,0.291971
>1393|F28L|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000764731.1|28|folP_F28L|SULFONAMIDE|SULFONAMIDE|Escherichia_sulfonamide_resistant_FolP|wt_coherence=TRUE,15.3285%,1.20073
>1394|D73G|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000819084.1|73|gyrA_D73G|QUINOLONE|QUINOLONE|Staphylococcus_aureus_quinolone_resistant_GyrA|wt_coherence=TRUE,0.227531%,0.00227531
>1395|G82C|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000819084.1|82|gyrA_G82C|QUINOLONE|QUINOLONE|Staphylococcus_aureus_quinolone_resistant_GyrA|wt_coherence=TRUE,2.27531%,0.0546075
>1396|S84A|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000819084.1|84|gyrA_S84A|QUINOLONE|QUINOLONE|Staphylococcus_aureus_quinolone_resistant_GyrA|wt_coherence=TRUE,2.95791%,0.583618
>1398|S84V|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000819084.1|84|gyrA_S84V|QUINOLONE|QUINOLONE|Staphylococcus_aureus_quinolone_resistant_GyrA|wt_coherence=TRUE,0.910125%,0.108077
>139|P64L|ARO:3003386|Escherichia coli folP with mutation conferring resistance to sulfonamides|NA|NA|NA|NA|NA|NA|Escherichia|WP_000764731.1|64|folP_P64L|SULFONAMIDE|SULFONAMIDE|Escherichia_sulfonamide_resistant_FolP|wt_coherence=TRUE,14.9635%,0.39781
>13|F203A|ARO:3004045|Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan|NA|NA|NA|NA|NA|NA|Escherichia|WP_000506490.1|203|fabI_F203A|ISONIAZID/TRICLOSAN|ISONIAZID/TRICLOSAN|Escherichia_isoniazid/triclosan_resistant_FabI|wt_coherence=TRUE,16.5354%,1.14173
>1400|E88G|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000819084.1|88|gyrA_E88G|QUINOLONE|QUINOLONE|Staphylococcus_aureus_quinolone_resistant_GyrA|wt_coherence=TRUE,0.682594%,0.0409556
>1402|E88L|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000819084.1|88|gyrA_E88L|QUINOLONE|QUINOLONE|Staphylococcus_aureus_quinolone_resistant_GyrA|wt_coherence=TRUE,1.70648%,0.032992
>1403|E88R|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000819084.1|88|gyrA_E88R|QUINOLONE|QUINOLONE|Staphylococcus_aureus_quinolone_resistant_GyrA|wt_coherence=TRUE,1.13766%,0.0170648
>1404|G106D|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000819084.1|106|gyrA_G106D|QUINOLONE|QUINOLONE|Staphylococcus_aureus_quinolone_resistant_GyrA|wt_coherence=TRUE,0.796359%,0.0113766
>1407|V45E|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000843414.1|45|marR_V45E|MULTIDRUG|AMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE|Escherichia_ampicillin/chloramphenicol/quinolone/rifampin/tetracycline_resistant_MarR|wt_coherence=TRUE,30.8824%,1.97794
>1408|I49S|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000843414.1|49|marR_I49S|MULTIDRUG|AMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE|Escherichia_ampicillin/chloramphenicol/quinolone/rifampin/tetracycline_resistant_MarR|wt_coherence=TRUE,30.8824%,1.35294
>1409|A70T|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000843414.1|70|marR_A70T|MULTIDRUG|AMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE|Escherichia_ampicillin/chloramphenicol/quinolone/rifampin/tetracycline_resistant_MarR|wt_coherence=TRUE,30.8824%,3.41912
>140|P64R|ARO:3003386|Escherichia coli folP with mutation conferring resistance to sulfonamides|NA|NA|NA|NA|NA|NA|Escherichia|WP_000764731.1|64|folP_P64R|SULFONAMIDE|SULFONAMIDE|Escherichia_sulfonamide_resistant_FolP|wt_coherence=TRUE,15.6934%,0.518248
>1410|R73C|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000843414.1|73|marR_R73C|MULTIDRUG|AMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE|Escherichia_ampicillin/chloramphenicol/quinolone/rifampin/tetracycline_resistant_MarR|wt_coherence=TRUE,30.8824%,2.64706
>1411|R73S|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000843414.1|73|marR_R73S|MULTIDRUG|AMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE|Escherichia_ampicillin/chloramphenicol/quinolone/rifampin/tetracycline_resistant_MarR|wt_coherence=TRUE,31.6176%,2.83088
>1412|R77C|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000843414.1|77|marR_R77C|MULTIDRUG|AMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE|Escherichia_ampicillin/chloramphenicol/quinolone/rifampin/tetracycline_resistant_MarR|wt_coherence=TRUE,30.8824%,1.14706
>1413|R77L|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000843414.1|77|marR_R77L|MULTIDRUG|AMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE|Escherichia_ampicillin/chloramphenicol/quinolone/rifampin/tetracycline_resistant_MarR|wt_coherence=TRUE,30.8824%,1.95588
>1414|L78M|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000843414.1|78|marR_L78M|MULTIDRUG|AMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE|Escherichia_ampicillin/chloramphenicol/quinolone/rifampin/tetracycline_resistant_MarR|wt_coherence=TRUE,31.6176%,2.27941
>1415|R94H|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000843414.1|94|marR_R94H|MULTIDRUG|AMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE|Escherichia_ampicillin/chloramphenicol/quinolone/rifampin/tetracycline_resistant_MarR|wt_coherence=TRUE,30.8824%,2.02206
>1416|R94S|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000843414.1|94|marR_R94S|MULTIDRUG|AMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE|Escherichia_ampicillin/chloramphenicol/quinolone/rifampin/tetracycline_resistant_MarR|wt_coherence=TRUE,32.3529%,1.36765
>1417|V96E|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_000843414.1|96|marR_V96E|MULTIDRUG|AMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE|Escherichia_ampicillin/chloramphenicol/quinolone/rifampin/tetracycline_resistant_MarR|wt_coherence=TRUE,30.8824%,1.77941
>1418|S463N|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000918664.1|463|rpoB_S463N|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,2.89362%,0.0417021
>1419|S463P|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000918664.1|463|rpoB_S463P|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,2.6383%,0.0297872
>141|P64S|ARO:3003386|Escherichia coli folP with mutation conferring resistance to sulfonamides|NA|NA|NA|NA|NA|NA|Escherichia|WP_000764731.1|64|folP_P64S|SULFONAMIDE|SULFONAMIDE|Escherichia_sulfonamide_resistant_FolP|wt_coherence=TRUE,8.39416%,0.182482
>1420|S464P|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000918664.1|464|rpoB_S464P|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,2.97872%,0.0570213
>1421|Q465K|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000918664.1|465|rpoB_Q465K|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,4%,0.124255
>1422|Q468I|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000918664.1|468|rpoB_Q468I|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,3.57447%,0.295319
>1423|Q468L|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000918664.1|468|rpoB_Q468L|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,2.6383%,0.0731915
>1424|Q468R|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000918664.1|468|rpoB_Q468R|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,3.82979%,0.265532
>1425|M470T|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000918664.1|470|rpoB_M470T|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,4.17021%,0.29617
>1426|D471G|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000918664.1|471|rpoB_D471G|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,3.23404%,0.101277
>1427|D471Y|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000918664.1|471|rpoB_D471Y|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,3.57447%,0.212766
>1428|N474K|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000918664.1|474|rpoB_N474K|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,4.17021%,0.0757447
>1429|N474KG|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000918664.1|474|rpoB_N474KG|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,2.72109%,0.037415
>1430|N474NH|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000918664.1|474|rpoB_N474NH|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,5.18707%,0.420068
>1431|A477D|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000918664.1|477|rpoB_A477D|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,3.14894%,0.0434043
>1432|A477G|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000918664.1|477|rpoB_A477G|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,2.04255%,0.0204255
>1433|A477V|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000918664.1|477|rpoB_A477V|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,2.97872%,0.0612766
>1434|H481D|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000918664.1|481|rpoB_H481D|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,0.765957%,0.0621277
>1435|H481Y|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000918664.1|481|rpoB_H481Y|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,2.6383%,0.0748936
>1436|R484C|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000918664.1|484|rpoB_R484C|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,0.425532%,0.00425532
>1437|R484H|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000918664.1|484|rpoB_R484H|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,2.97872%,0.0748936
>1439|I527F|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000918664.1|527|rpoB_I527F|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,1.2766%,0.092766
>143|A67S|ARO:3003294|Escherichia coli gyrA conferring resistance to fluoroquinolones|MEG_3187|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.65167%,0.136101
>1440|I527L|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000918664.1|527|rpoB_I527L|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,0.851064%,0.0680851
>1441|I527M|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000918664.1|527|rpoB_I527M|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,1.2766%,0.0195745
>1442|S529L|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000918664.1|529|rpoB_S529L|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,2.80851%,0.0468085
>1443|D550G|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_000918664.1|550|rpoB_D550G|RIFAMYCIN|RIFAMPIN|Staphylococcus_aureus_rifampin_resistant_RpoB|wt_coherence=TRUE,1.78723%,0.0314894
>1448|R717L|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001132507.1|717|acrB_R717L|MACROLIDE|AZITHROMYCIN|Salmonella_azithromycin_resistant_AcrB|wt_coherence=TRUE,4.03458%,0.251681
>1449|R717Q|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001132507.1|717|acrB_R717Q|MACROLIDE|AZITHROMYCIN|Salmonella_azithromycin_resistant_AcrB|wt_coherence=TRUE,4.03458%,0.302594
>144|A84P|ARO:3003294|Escherichia coli gyrA conferring resistance to fluoroquinolones|MEG_3187|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.61361%,0.102653
>1453|S29R|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001212189.1|29|pmrB_S29R|COLISTIN|COLISTIN|Salmonella_colistin_resistant_PmrB|wt_coherence=TRUE,12.069%,0.497126
>1454|T92A|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001212189.1|92|pmrB_T92A|COLISTIN|COLISTIN|Salmonella_colistin_resistant_PmrB|wt_coherence=TRUE,12.069%,0.962644
>1455|P94Q|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001212189.1|94|pmrB_P94Q|COLISTIN|COLISTIN|Salmonella_colistin_resistant_PmrB|wt_coherence=TRUE,7.18391%,0.517241
>1456|E121A|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001212189.1|121|pmrB_E121A|COLISTIN|COLISTIN|Salmonella_colistin_resistant_PmrB|wt_coherence=TRUE,12.069%,1.07184
>1457|S124P|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001212189.1|124|pmrB_S124P|COLISTIN|COLISTIN|Salmonella_colistin_resistant_PmrB|wt_coherence=TRUE,12.069%,1.17241
>1458|N130Y|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001212189.1|130|pmrB_N130Y|COLISTIN|COLISTIN|Salmonella_colistin_resistant_PmrB|wt_coherence=TRUE,12.069%,0.813218
>1459|T147P|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001212189.1|147|pmrB_T147P|COLISTIN|COLISTIN|Salmonella_colistin_resistant_PmrB|wt_coherence=TRUE,12.069%,0.772989
>145|S83L|ARO:3003294|Escherichia coli gyrA conferring resistance to fluoroquinolones|MEG_3187|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.49827%,0.083045
>1460|R155P|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001212189.1|155|pmrB_R155P|COLISTIN|COLISTIN|Salmonella_colistin_resistant_PmrB|wt_coherence=TRUE,12.069%,1.07471
>1461|T156M|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001212189.1|156|pmrB_T156M|COLISTIN|COLISTIN|Salmonella_colistin_resistant_PmrB|wt_coherence=TRUE,3.73563%,0.232759
>1462|T156P|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001212189.1|156|pmrB_T156P|COLISTIN|COLISTIN|Salmonella_colistin_resistant_PmrB|wt_coherence=TRUE,8.62069%,0.304598
>1463|V161G|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001212189.1|161|pmrB_V161G|COLISTIN|COLISTIN|Salmonella_colistin_resistant_PmrB|wt_coherence=TRUE,11.2069%,0.448276
>1464|V161L|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001212189.1|161|pmrB_V161L|COLISTIN|COLISTIN|Salmonella_colistin_resistant_PmrB|wt_coherence=TRUE,12.069%,1.19253
>1465|V161M|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001212189.1|161|pmrB_V161M|COLISTIN|COLISTIN|Salmonella_colistin_resistant_PmrB|wt_coherence=TRUE,12.069%,0.732759
>1466|E166K|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001212189.1|166|pmrB_E166K|COLISTIN|COLISTIN|Salmonella_colistin_resistant_PmrB|wt_coherence=TRUE,9.77011%,0.29023
>1467|M186I|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001212189.1|186|pmrB_M186I|COLISTIN|COLISTIN|Salmonella_colistin_resistant_PmrB|wt_coherence=TRUE,12.069%,0.951149
>1468|G206R|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001212189.1|206|pmrB_G206R|COLISTIN|COLISTIN|Salmonella_colistin_resistant_PmrB|wt_coherence=TRUE,12.069%,0.632184
>1469|G206W|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001212189.1|206|pmrB_G206W|COLISTIN|COLISTIN|Salmonella_colistin_resistant_PmrB|wt_coherence=TRUE,12.069%,0.557471
>146|S83W|ARO:3003294|Escherichia coli gyrA conferring resistance to fluoroquinolones|MEG_3187|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.84429%,0.132641
>1470|S305R|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001212189.1|305|pmrB_S305R|COLISTIN|COLISTIN|Salmonella_colistin_resistant_PmrB|wt_coherence=TRUE,12.069%,0.859195
>1471|A51V|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281243.1|51|gyrA_A51V|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_GyrA|wt_coherence=TRUE,4.82759%,0.375862
>1476|G81D|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281243.1|81|gyrA_G81D|QUINOLONE|CIPROFLOXACIN|Escherichia_ciprofloxacin_resistant_GyrA|wt_coherence=TRUE,1.6092%,0.0597701
>1477|D82G|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281243.1|82|gyrA_D82G|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_GyrA|wt_coherence=TRUE,4.82759%,0.78046
>1478|S83A|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281243.1|83|gyrA_S83A|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_GyrA|wt_coherence=TRUE,4.82759%,0.0942529
>1479|S83F|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281243.1|83|gyrA_S83F|QUINOLONE/TRICLOSAN|QUINOLONE/TRICLOSAN|Escherichia_quinolone/triclosan_resistant_GyrA|wt_coherence=TRUE,0.229885%,0.00344828
>147|D87V|ARO:3003294|Escherichia coli gyrA conferring resistance to fluoroquinolones|MEG_3187|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.92157%,0.0519031
>1481|S83L|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281243.1|83|gyrA_S83L|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_GyrA|wt_coherence=TRUE,0.229885%,0.0137931
>1482|S83V|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281243.1|83|gyrA_S83V|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_GyrA|wt_coherence=TRUE,0.229885%,0.00229885
>1485|A84V|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281243.1|84|gyrA_A84V|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_GyrA|wt_coherence=TRUE,5.05747%,0.243678
>1488|D87N|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281243.1|87|gyrA_D87N|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_GyrA|wt_coherence=TRUE,0.45977%,0.0045977
>148|Q106H|ARO:3003294|Escherichia coli gyrA conferring resistance to fluoroquinolones|MEG_3187|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.07497%,0.22722
>1491|Q106H|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281243.1|106|gyrA_Q106H|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_GyrA|wt_coherence=TRUE,0.804598%,0.114943
>1492|Q106R|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281243.1|106|gyrA_Q106R|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_GyrA|wt_coherence=TRUE,3.33333%,0.0390805
>1493|A196E|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281243.1|196|gyrA_A196E|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_GyrA|wt_coherence=TRUE,4.82759%,0.222989
>1494|A67P|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001281271.1|67|gyrA_A67P|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_GyrA|wt_coherence=TRUE,3.21839%,0.0390805
>1495|D72G|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001281271.1|72|gyrA_D72G|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_GyrA|wt_coherence=TRUE,4.48276%,0.0597701
>1496|V73I|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001281271.1|73|gyrA_V73I|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_GyrA|wt_coherence=TRUE,4.25287%,0.106897
>1499|G81H|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001281271.1|81|gyrA_G81H|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_GyrA|wt_coherence=TRUE,4.82759%,0.431034
>149|G81C|ARO:3003294|Escherichia coli gyrA conferring resistance to fluoroquinolones|MEG_3187|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.19146%,0.0380623
>14|F203V|ARO:3004045|Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.5354%,1.09843
>1500|G81S|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001281271.1|81|gyrA_G81S|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_GyrA|wt_coherence=TRUE,4.82759%,0.472414
>1502|D82N|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001281271.1|82|gyrA_D82N|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_GyrA|wt_coherence=TRUE,3.33333%,0.0528736
>1505|D87K|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001281271.1|87|gyrA_D87K|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_GyrA|wt_coherence=TRUE,0.91954%,0.0103448
>1506|L98V|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001281271.1|98|gyrA_L98V|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_GyrA|wt_coherence=TRUE,0.91954%,0.0091954
>1507|A119E|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001281271.1|119|gyrA_A119E|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_GyrA|wt_coherence=TRUE,4.82759%,0.165517
>1508|A119S|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001281271.1|119|gyrA_A119S|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_GyrA|wt_coherence=TRUE,4.82759%,0.351724
>1509|A119V|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001281271.1|119|gyrA_A119V|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_GyrA|wt_coherence=TRUE,4.82759%,0.257471
>150|S83I|ARO:3003294|Escherichia coli gyrA conferring resistance to fluoroquinolones|MEG_3187|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.692042%,0.00692042
>1510|A131G|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001281271.1|131|gyrA_A131G|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_GyrA|wt_coherence=TRUE,2.52874%,0.0563218
>1511|E139A|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001281271.1|139|gyrA_E139A|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_GyrA|wt_coherence=TRUE,3.56322%,0.0586207
>1512|A56T|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281881.1|56|parC_A56T|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParC|wt_coherence=TRUE,5.64516%,0.514785
>1513|S57T|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281881.1|57|parC_S57T|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParC|wt_coherence=TRUE,4.83871%,0.225806
>1515|F60L|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281881.1|60|parC_F60L|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParC|wt_coherence=TRUE,4.03226%,0.0725806
>1516|G78C|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281881.1|78|parC_G78C|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParC|wt_coherence=TRUE,3.36022%,0.0416667
>1517|G78D|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281881.1|78|parC_G78D|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParC|wt_coherence=TRUE,4.03226%,0.0456989
>1518|G78K|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281881.1|78|parC_G78K|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParC|wt_coherence=TRUE,5.64516%,0.403226
>1519|S80F|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281881.1|80|parC_S80F|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParC|wt_coherence=TRUE,1.47849%,0.0147849
>151|D87Y|ARO:3003294|Escherichia coli gyrA conferring resistance to fluoroquinolones|MEG_3187|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.80623%,0.123414
>1520|S80L|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281881.1|80|parC_S80L|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParC|wt_coherence=TRUE,2.95699%,0.0295699
>1522|S80W|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281881.1|80|parC_S80W|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParC|wt_coherence=TRUE,0.94086%,0.0430108
>1523|S80Y|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281881.1|80|parC_S80Y|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParC|wt_coherence=TRUE,3.36022%,0.112903
>1524|E84A|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281881.1|84|parC_E84A|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParC|wt_coherence=TRUE,1.07527%,0.0147849
>1526|E84R|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281881.1|84|parC_E84R|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParC|wt_coherence=TRUE,5.24194%,0.127688
>1527|E84V|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281881.1|84|parC_E84V|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParC|wt_coherence=TRUE,5.24194%,0.150538
>1528|A108T|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281881.1|108|parC_A108T|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParC|wt_coherence=TRUE,5.64516%,0.354839
>1529|A108V|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001281881.1|108|parC_A108V|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParC|wt_coherence=TRUE,5.77957%,0.252688
>152|D87H|ARO:3003294|Escherichia coli gyrA conferring resistance to fluoroquinolones|MEG_3187|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.65283%,0.0507497
>1530|T66I|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001281910.1|66|parC_T66I|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_ParC|wt_coherence=TRUE,3.89785%,2.3078
>1532|S80I|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001281910.1|80|parC_S80I|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_ParC|wt_coherence=TRUE,3.22581%,0.0456989
>1533|S80R|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001281910.1|80|parC_S80R|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_ParC|wt_coherence=TRUE,2.15054%,0.0228495
>1536|W106G|NA|NA|NA|NA|NA|NA|NA|NA|Salmonella|WP_001281910.1|106|parC_W106G|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_ParC|wt_coherence=TRUE,5.64516%,0.788978
>1538|S80Y|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_001289586.1|80|parC_S80Y|QUINOLONE|QUINOLONE|Staphylococcus_aureus_quinolone_resistant_ParC|wt_coherence=TRUE,5.30303%,0.622475
>1539|Y83N|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_001289586.1|83|parC_Y83N|QUINOLONE|QUINOLONE|Staphylococcus_aureus_quinolone_resistant_ParC|wt_coherence=TRUE,5.30303%,0.396465
>153|D87G|ARO:3003294|Escherichia coli gyrA conferring resistance to fluoroquinolones|MEG_3187|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.53749%,0.0553633
>1541|E84K|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_001289586.1|84|parC_E84K|QUINOLONE|QUINOLONE|Staphylococcus_aureus_quinolone_resistant_ParC|wt_coherence=TRUE,5.30303%,0.469697
>1542|E84L|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_001289586.1|84|parC_E84L|QUINOLONE|QUINOLONE|Staphylococcus_aureus_quinolone_resistant_ParC|wt_coherence=TRUE,5.30303%,0.366162
>1543|E84V|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_001289586.1|84|parC_E84V|QUINOLONE|QUINOLONE|Staphylococcus_aureus_quinolone_resistant_ParC|wt_coherence=TRUE,5.30303%,0.366162
>1544|A116E|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_001289586.1|116|parC_A116E|QUINOLONE|QUINOLONE|Staphylococcus_aureus_quinolone_resistant_ParC|wt_coherence=TRUE,5.30303%,0.429293
>1545|A116V|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_001289586.1|116|parC_A116V|QUINOLONE|QUINOLONE|Staphylococcus_aureus_quinolone_resistant_ParC|wt_coherence=TRUE,5.30303%,0.460859
>1546|P403L|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001295325.1|403|lon_P403L|TETRACYCLINE|TIGECYCLINE|Escherichia_tigecycline_resistant_Lon|wt_coherence=TRUE,5.41237%,0.502577
>1550|C84R|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001300761.1|84|pmrB_C84R|COLISTIN|COLISTIN|Escherichia_colistin_resistant_PmrB|wt_coherence=TRUE,11.831%,0.707042
>1551|C84Y|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001300761.1|84|pmrB_C84Y|COLISTIN|COLISTIN|Escherichia_colistin_resistant_PmrB|wt_coherence=TRUE,11.831%,0.622535
>1552|P94L|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001300761.1|94|pmrB_P94L|COLISTIN|COLISTIN|Escherichia_colistin_resistant_PmrB|wt_coherence=TRUE,11.831%,0.687324
>1553|P94Q|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001300761.1|94|pmrB_P94Q|COLISTIN|COLISTIN|Escherichia_colistin_resistant_PmrB|wt_coherence=TRUE,7.04225%,0.402817
>1554|P94S|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001300761.1|94|pmrB_P94S|COLISTIN|COLISTIN|Escherichia_colistin_resistant_PmrB|wt_coherence=TRUE,11.831%,1.05634
>1555|E121K|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001300761.1|121|pmrB_E121K|COLISTIN|COLISTIN|Escherichia_colistin_resistant_PmrB|wt_coherence=TRUE,11.831%,0.929577
>1556|E121Q|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001300761.1|121|pmrB_E121Q|COLISTIN|COLISTIN|Escherichia_colistin_resistant_PmrB|wt_coherence=TRUE,11.831%,0.901408
>1557|T147A|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001300761.1|147|pmrB_T147A|COLISTIN|COLISTIN|Escherichia_colistin_resistant_PmrB|wt_coherence=TRUE,11.831%,1.40282
>1558|T156M|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001300761.1|156|pmrB_T156M|COLISTIN|COLISTIN|Escherichia_colistin_resistant_PmrB|wt_coherence=TRUE,9.57746%,0.380282
>1559|A159P|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001300761.1|159|pmrB_A159P|COLISTIN|COLISTIN|Escherichia_colistin_resistant_PmrB|wt_coherence=TRUE,11.831%,0.904225
>155|S83F|ARO:3004335|Escherichia coli gyrA with mutation conferring resistance to triclosan|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.38408%,0.0449827
>1560|A159V|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001300761.1|159|pmrB_A159V|COLISTIN|COLISTIN|Escherichia_colistin_resistant_PmrB|wt_coherence=TRUE,11.831%,1.01127
>1561|V161G|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001300761.1|161|pmrB_V161G|COLISTIN|COLISTIN|Escherichia_colistin_resistant_PmrB|wt_coherence=TRUE,9.57746%,0.267606
>1562|E166K|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001300761.1|166|pmrB_E166K|COLISTIN|COLISTIN|Escherichia_colistin_resistant_PmrB|wt_coherence=TRUE,8.4507%,0.304225
>1563|G206D|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001300761.1|206|pmrB_G206D|COLISTIN|COLISTIN|Escherichia_colistin_resistant_PmrB|wt_coherence=TRUE,11.831%,1.05915
>1564|Y151V|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_001718014.1|151|fabG_Y151V|TRICLOSAN|TRICLOSAN|Escherichia_triclosan_resistant_FabG|wt_coherence=TRUE,15.2542%,0.351695
>1567|D83H|NA|NA|NA|NA|NA|NA|NA|NA|Streptococcus_pneumoniae|WP_001836116.1|83|parC_D83H|QUINOLONE|QUINOLONE|Streptococcus_pneumoniae_quinolone_resistant_ParC|wt_coherence=TRUE,4.29448%,0.0429448
>156|R136H|ARO:3003303|Escherichia coli gyrB conferring resistance to aminocoumarin|MEG_3244|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|GYRBA|RequiresSNPConfirmation|Escherichia|WP_000072067.1|136|gyrB_R136H|AMINOCOUMARIN|AMINOCOUMARIN|Escherichia_aminocoumarin_resistant_GyrB|wt_coherence=TRUE,5.27638%,0.256281
>1571|D432N|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_001837315.1|432|parE_D432N|AMINOCOUMARIN|AMINOCOUMARIN|Staphylococcus_aureus_aminocoumarin_resistant_ParE|wt_coherence=TRUE,4.12214%,0.135878
>1572|D432V|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_001837315.1|432|parE_D432V|QUINOLONE|QUINOLONE|Staphylococcus_aureus_quinolone_resistant_ParE|wt_coherence=TRUE,6.41221%,0.363359
>1573|D443E|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_001837315.1|443|parE_D443E|QUINOLONE|QUINOLONE|Staphylococcus_aureus_quinolone_resistant_ParE|wt_coherence=TRUE,6.41221%,0.438168
>1574|R444S|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_001837315.1|444|parE_R444S|QUINOLONE|QUINOLONE|Staphylococcus_aureus_quinolone_resistant_ParE|wt_coherence=TRUE,6.41221%,0.458015
>1575|P451S|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_001837315.1|451|parE_P451S|QUINOLONE|QUINOLONE|Staphylococcus_aureus_quinolone_resistant_ParE|wt_coherence=TRUE,2.44275%,0.080916
>1576|N470S|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_001837315.1|470|parE_N470S|AMINOCOUMARIN|AMINOCOUMARIN|Staphylococcus_aureus_aminocoumarin_resistant_ParE|wt_coherence=TRUE,6.41221%,0.369466
>1578|S80I|NA|NA|NA|NA|NA|NA|NA|NA|Enterococcus_faecalis|WP_002371880.1|82|parC_S80I|QUINOLONE|QUINOLONE|Enterococcus_faecalis_quinolone_resistant_ParC|wt_coherence=FALSE,4.6798%,0.371921
>1579|S80R|NA|NA|NA|NA|NA|NA|NA|NA|Enterococcus_faecalis|WP_002371880.1|82|parC_S80R|QUINOLONE|QUINOLONE|Enterococcus_faecalis_quinolone_resistant_ParC|wt_coherence=FALSE,3.57143%,0.100985
>157|R136S|ARO:3003303|Escherichia coli gyrB conferring resistance to aminocoumarin|MEG_3244|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|GYRBA|RequiresSNPConfirmation|Escherichia|WP_000072067.1|136|gyrB_R136S|AMINOCOUMARIN|AMINOCOUMARIN|Escherichia_aminocoumarin_resistant_GyrB|wt_coherence=TRUE,5.27638%,0.427136
>1580|E84A|NA|NA|NA|NA|NA|NA|NA|NA|Enterococcus_faecalis|WP_002371880.1|86|parC_E84A|QUINOLONE|QUINOLONE|Enterococcus_faecalis_quinolone_resistant_ParC|wt_coherence=FALSE,5.17241%,0.100985
>1581|E84K|NA|NA|NA|NA|NA|NA|NA|NA|Enterococcus_faecalis|WP_002371880.1|86|parC_E84K|QUINOLONE|QUINOLONE|Enterococcus_faecalis_quinolone_resistant_ParC|wt_coherence=FALSE,5.17241%,0.70936
>1582|R177RI|NA|NA|NA|NA|NA|NA|NA|NA|Enterococcus_faecalis|WP_002381168.1|177|liaF_R177RI|LIPOPEPTIDE|DAPTOMYCIN|Enterococcus_faecalis_daptomycin_resistant_LiaF|wt_coherence=TRUE,24.5763%,1.58898
>1583|R177del|NA|NA|NA|NA|NA|NA|NA|NA|Enterococcus_faecalis|WP_002381168.1|177|liaF_R177del|LIPOPEPTIDE|DAPTOMYCIN|Enterococcus_faecalis_daptomycin_resistant_LiaF|wt_coherence=TRUE,24.7863%,1.97436
>1584|NFQ77del|NA|NA|NA|NA|NA|NA|NA|NA|Enterococcus_faecalis|WP_002413481.1|77|cls_NFQ77del|LIPOPEPTIDE|DAPTOMYCIN|Enterococcus_faecalis_daptomycin_resistant_Cls|wt_coherence=TRUE,9.14894%,0.768085
>1585|T86A|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_002779062.1|86|gyrA_T86A|QUINOLONE|QUINOLONE|Campylobacter_quinolone_resistant_GyrA|wt_coherence=TRUE,1.53483%,0.0165289
>1587|T86K|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_002779062.1|86|gyrA_T86K|QUINOLONE|QUINOLONE|Campylobacter_quinolone_resistant_GyrA|wt_coherence=TRUE,2.36128%,0.172373
>1588|T86V|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_002779062.1|86|gyrA_T86V|QUINOLONE|QUINOLONE|Campylobacter_quinolone_resistant_GyrA|wt_coherence=TRUE,1.65289%,0.0649351
>1589|D90N|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_002779062.1|90|gyrA_D90N|QUINOLONE|QUINOLONE|Campylobacter_quinolone_resistant_GyrA|wt_coherence=TRUE,1.77096%,0.081464
>158|R136L|ARO:3003303|Escherichia coli gyrB conferring resistance to aminocoumarin|MEG_3244|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|GYRBA|RequiresSNPConfirmation|Escherichia|WP_000072067.1|136|gyrB_R136L|AMINOCOUMARIN|AMINOCOUMARIN|Escherichia_aminocoumarin_resistant_GyrB|wt_coherence=TRUE,5.27638%,0.48995
>1590|D90Y|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_002779062.1|90|gyrA_D90Y|QUINOLONE|QUINOLONE|Campylobacter_quinolone_resistant_GyrA|wt_coherence=TRUE,2.5974%,0.138135
>1592|A84D|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_002779996.1|84|50S_L22_A84D|MACROLIDE|MACROLIDE|Campylobacter_macrolide_resistant_50S_L22|wt_coherence=TRUE,20.4724%,2.15748
>1593|G86E|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_002779996.1|86|50S_L22_G86E|MACROLIDE|MACROLIDE|Campylobacter_macrolide_resistant_50S_L22|wt_coherence=TRUE,20.4724%,1.79528
>1594|G86V|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_002779996.1|86|50S_L22_G86V|MACROLIDE|MACROLIDE|Campylobacter_macrolide_resistant_50S_L22|wt_coherence=TRUE,24.4094%,1.72441
>1595|A88E|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_002779996.1|88|50S_L22_A88E|MACROLIDE|MACROLIDE|Campylobacter_macrolide_resistant_50S_L22|wt_coherence=TRUE,20.4724%,1.45669
>1596|A103V|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_002779996.1|103|50S_L22_A103V|MACROLIDE|MACROLIDE|Campylobacter_macrolide_resistant_50S_L22|wt_coherence=TRUE,29.9213%,1.62992
>1597|G86A|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_002843095.1|86|cmeR_G86A|MACROLIDE|MACROLIDE|Campylobacter_macrolide_resistant_CmeR|wt_coherence=TRUE,20.7921%,1.69802
>1598|A84D|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_002851214.1|84|50S_L22_A84D|MACROLIDE|MACROLIDE|Campylobacter_macrolide_resistant_50S_L22|wt_coherence=TRUE,19.5489%,1.59398
>1599|G86E|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_002851214.1|86|50S_L22_G86E|MACROLIDE|MACROLIDE|Campylobacter_macrolide_resistant_50S_L22|wt_coherence=TRUE,19.5489%,1.45865
>159|R136E|ARO:3003303|Escherichia coli gyrB conferring resistance to aminocoumarin|MEG_3244|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|GYRBA|RequiresSNPConfirmation|Escherichia|WP_000072067.1|136|gyrB_R136E|AMINOCOUMARIN|AMINOCOUMARIN|Escherichia_aminocoumarin_resistant_GyrB|wt_coherence=TRUE,5.27638%,0.55402
>15|V29G|ARO:3004145|AxyZ|MEG_1187|Multi-compound|Drug_and_biocide_resistance|Drug_and_biocide_RND_efflux_pumps|AXYZ|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,20.5882%,1.39216
>1600|G86V|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_002851214.1|86|50S_L22_G86V|MACROLIDE|MACROLIDE|Campylobacter_macrolide_resistant_50S_L22|wt_coherence=TRUE,19.5489%,1.65414
>1601|A88E|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_002851214.1|88|50S_L22_A88E|MACROLIDE|MACROLIDE|Campylobacter_macrolide_resistant_50S_L22|wt_coherence=TRUE,19.5489%,1.43609
>1602|A103C|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_002851214.1|103|50S_L22_A103C|MACROLIDE|ERYTHROMYCIN|Campylobacter_erythromycin_resistant_50S_L22|wt_coherence=TRUE,31.5789%,2.3609
>1603|A103V|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_002851214.1|103|50S_L22_A103V|MACROLIDE|MACROLIDE|Campylobacter_macrolide_resistant_50S_L22|wt_coherence=TRUE,17.2932%,0.902256
>1604|A70T|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_002857904.1|70|gyrA_A70T|QUINOLONE|QUINOLONE|Campylobacter_quinolone_resistant_GyrA|wt_coherence=TRUE,5.73099%,0.125146
>1605|D85Y|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_002857904.1|85|gyrA_D85Y|QUINOLONE|QUINOLONE|Campylobacter_quinolone_resistant_GyrA|wt_coherence=TRUE,4.91228%,0.392982
>1606|T86A|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_002857904.1|86|gyrA_T86A|QUINOLONE|QUINOLONE|Campylobacter_quinolone_resistant_GyrA|wt_coherence=TRUE,1.9883%,0.019883
>1607|T86K|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_002857904.1|86|gyrA_T86K|QUINOLONE|QUINOLONE|Campylobacter_quinolone_resistant_GyrA|wt_coherence=TRUE,4.44444%,0.11462
>1609|D90A|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_002857904.1|90|gyrA_D90A|QUINOLONE|QUINOLONE|Campylobacter_quinolone_resistant_GyrA|wt_coherence=TRUE,3.15789%,0.0526316
>160|R136I|ARO:3003303|Escherichia coli gyrB conferring resistance to aminocoumarin|MEG_3244|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|GYRBA|RequiresSNPConfirmation|Escherichia|WP_000072067.1|136|gyrB_R136I|AMINOCOUMARIN|AMINOCOUMARIN|Escherichia_aminocoumarin_resistant_GyrB|wt_coherence=TRUE,5.27638%,0.501256
>1610|D90N|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_002857904.1|90|gyrA_D90N|QUINOLONE|QUINOLONE|Campylobacter_quinolone_resistant_GyrA|wt_coherence=TRUE,0.818713%,0.00818713
>1611|D90T|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_002857904.1|90|gyrA_D90T|QUINOLONE|QUINOLONE|Campylobacter_quinolone_resistant_GyrA|wt_coherence=TRUE,4.5614%,0.0736842
>1612|D90Y|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_002857904.1|90|gyrA_D90Y|QUINOLONE|QUINOLONE|Campylobacter_quinolone_resistant_GyrA|wt_coherence=TRUE,0.350877%,0.00350877
>1614|S42N|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_002895659.1|42|pmrA_S42N|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_PmrA|wt_coherence=TRUE,19.5349%,1.65581
>1615|G53C|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_002895659.1|53|pmrA_G53C|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_PmrA|wt_coherence=TRUE,13.9535%,0.353488
>1616|G53S|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_002895659.1|53|pmrA_G53S|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_PmrA|wt_coherence=TRUE,6.04651%,0.0976744
>161|R136G|ARO:3003303|Escherichia coli gyrB conferring resistance to aminocoumarin|MEG_3244|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|GYRBA|RequiresSNPConfirmation|Escherichia|WP_000072067.1|136|gyrB_R136G|AMINOCOUMARIN|AMINOCOUMARIN|Escherichia_aminocoumarin_resistant_GyrB|wt_coherence=TRUE,5.27638%,0.537688
>162|R136C|ARO:3003303|Escherichia coli gyrB conferring resistance to aminocoumarin|MEG_3244|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|GYRBA|RequiresSNPConfirmation|Escherichia|WP_000072067.1|136|gyrB_R136C|AMINOCOUMARIN|AMINOCOUMARIN|Escherichia_aminocoumarin_resistant_GyrB|wt_coherence=TRUE,5.27638%,0.396985
>1631|L26P|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_004147969.1|26|phoQ_L26P|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_PhoQ|wt_coherence=TRUE,8.75%,0.547917
>1632|L96P|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_004147969.1|96|phoQ_L96P|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_PhoQ|wt_coherence=TRUE,8.75%,0.591667
>1633|S174N|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_004147969.1|174|phoQ_S174N|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_PhoQ|wt_coherence=TRUE,8.75%,0.710417
>1634|L348Q|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_004147969.1|348|phoQ_L348Q|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_PhoQ|wt_coherence=TRUE,8.75%,0.472917
>1635|G385S|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_004147969.1|385|phoQ_G385S|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_PhoQ|wt_coherence=TRUE,8.75%,0.891667
>1636|L396Q|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_004147969.1|396|phoQ_L396Q|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_PhoQ|wt_coherence=TRUE,10.4167%,0.529167
>1637|D438N|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_004147969.1|438|phoQ_D438N|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_PhoQ|wt_coherence=TRUE,8.75%,0.654167
>163|D369N|ARO:3003775|Escherichia coli murA with mutation conferring resistance to fosfomycin|MEG_4095|Drugs|Fosfomycin|Fosfomycin_target_mutation|MURA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.219%,1.02676
>1642|L82R|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_004179093.1|82|pmrB_L82R|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_PmrB|wt_coherence=TRUE,11.7647%,0.64986
>1643|S85R|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_004179093.1|85|pmrB_S85R|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_PmrB|wt_coherence=TRUE,11.7647%,0.722689
>1644|T140P|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_004179093.1|140|pmrB_T140P|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_PmrB|wt_coherence=TRUE,11.7647%,0.557423
>1645|T157P|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_004179093.1|157|pmrB_T157P|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_PmrB|wt_coherence=TRUE,7.0028%,0.187675
>1646|S208N|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_004179093.1|208|pmrB_S208N|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_PmrB|wt_coherence=TRUE,9.52381%,0.159664
>1647|Y209del|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_004179093.1|209|pmrB_Y209del|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_PmrB|wt_coherence=TRUE,12.0787%,1.22753
>1648|R256G|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_004179093.1|256|pmrB_R256G|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_PmrB|wt_coherence=TRUE,11.7647%,0.915966
>164|C115S|ARO:3003775|Escherichia coli murA with mutation conferring resistance to fosfomycin|MEG_4095|Drugs|Fosfomycin|Fosfomycin_target_mutation|MURA|RequiresSNPConfirmation|Escherichia|WP_000357259.1|115|murA_C115S|FOSFOMYCIN|FOSFOMYCIN|Escherichia_fosfomycin_resistant_MurA|wt_coherence=TRUE,10.219%,1.17762
>1650|Y31H|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_004184324.1|31|crrB_Y31H|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_CrrB|wt_coherence=TRUE,12.1739%,1.02609
>1651|F84S|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_004184324.1|84|crrB_F84S|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_CrrB|wt_coherence=TRUE,12.1739%,0.655072
>1652|L94M|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_004184324.1|94|crrB_L94M|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_CrrB|wt_coherence=TRUE,12.1739%,1.2087
>1653|W140R|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_004184324.1|140|crrB_W140R|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_CrrB|wt_coherence=TRUE,12.1739%,0.715942
>1654|N141I|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_004184324.1|141|crrB_N141I|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_CrrB|wt_coherence=TRUE,12.1739%,1.16812
>1655|N141Y|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_004184324.1|141|crrB_N141Y|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_CrrB|wt_coherence=TRUE,12.1739%,0.727536
>1656|P151L|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_004184324.1|151|crrB_P151L|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_CrrB|wt_coherence=TRUE,14.2029%,1.06087
>1657|P151S|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_004184324.1|151|crrB_P151S|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_CrrB|wt_coherence=TRUE,12.1739%,1.09565
>1658|G183V|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_004184324.1|183|crrB_G183V|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_CrrB|wt_coherence=TRUE,12.1739%,1.21159
>1659|S195N|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_004184324.1|195|crrB_S195N|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_CrrB|wt_coherence=TRUE,12.1739%,0.785507
>165|C115E|ARO:3003775|Escherichia coli murA with mutation conferring resistance to fosfomycin|MEG_4095|Drugs|Fosfomycin|Fosfomycin_target_mutation|MURA|RequiresSNPConfirmation|Escherichia|WP_000357259.1|115|murA_C115E|FOSFOMYCIN|FOSFOMYCIN|Escherichia_fosfomycin_resistant_MurA|wt_coherence=TRUE,10.219%,1.01703
>1660|S127L|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_010956585.1|127|gyrB_S127L|AMINOCOUMARIN|AMINOCOUMARIN|Staphylococcus_aureus_aminocoumarin_resistant_GyrB|wt_coherence=TRUE,6.77165%,0.576378
>1661|D436N|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_010956585.1|436|gyrB_D436N|QUINOLONE|QUINOLONE|Staphylococcus_aureus_quinolone_resistant_GyrB|wt_coherence=TRUE,0.472441%,0.0598425
>1662|E476D|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_010956585.1|476|gyrB_E476D|QUINOLONE|QUINOLONE|Staphylococcus_aureus_quinolone_resistant_GyrB|wt_coherence=TRUE,6.61417%,0.538583
>1663|A473AA|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_pseudintermedius|WP_014614750.1|473|rpoB_A473AA|RIFAMYCIN|RIFAMPIN|Staphylococcus_pseudintermedius_rifampin_resistant_RpoB|wt_coherence=TRUE,5.35259%,1.69244
>1664|H481Y|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_pseudintermedius|WP_014614750.1|481|rpoB_H481Y|RIFAMYCIN|RIFAMPIN|Staphylococcus_pseudintermedius_rifampin_resistant_RpoB|wt_coherence=TRUE,0.85034%,0.0085034
>1665|S486L|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_pseudintermedius|WP_014614750.1|486|rpoB_S486L|RIFAMYCIN|RIFAMPIN|Staphylococcus_pseudintermedius_rifampin_resistant_RpoB|wt_coherence=TRUE,0.680272%,0.115646
>1666|C161Y|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_014906821.1|161|arnC_C161Y|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_ArnC|wt_coherence=TRUE,13.1661%,0.996865
>1667|Q557E|NA|NA|NA|NA|NA|NA|NA|NA|Streptococcus_agalactiae|WP_017647104.1|557|pbp2x_Q557E|BETA-LACTAM|BETA-LACTAM|Streptococcus_agalactiae_beta-lactam_resistant_Pbp2x|wt_coherence=TRUE,5.64516%,0.388441
>1668|S80I|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_pseudintermedius|WP_019167736.1|80|grlA_S80I|QUINOLONE|QUINOLONE|Staphylococcus_pseudintermedius_quinolone_resistant_GrlA|wt_coherence=TRUE,5.28302%,0.391195
>1669|S80R|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_pseudintermedius|WP_019167736.1|80|grlA_S80R|QUINOLONE|QUINOLONE|Staphylococcus_pseudintermedius_quinolone_resistant_GrlA|wt_coherence=TRUE,5.28302%,0.361006
>166|L370I|ARO:3003775|Escherichia coli murA with mutation conferring resistance to fosfomycin|MEG_4095|Drugs|Fosfomycin|Fosfomycin_target_mutation|MURA|RequiresSNPConfirmation|Escherichia|WP_000357259.1|370|murA_L370I|FOSFOMYCIN|FOSFOMYCIN|Escherichia_fosfomycin_resistant_MurA|wt_coherence=TRUE,10.219%,0.79562
>1670|D84G|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_pseudintermedius|WP_019167736.1|84|grlA_D84G|QUINOLONE|QUINOLONE|Staphylococcus_pseudintermedius_quinolone_resistant_GrlA|wt_coherence=TRUE,2.89308%,0.345912
>1671|D84H|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_pseudintermedius|WP_019167736.1|84|grlA_D84H|QUINOLONE|QUINOLONE|Staphylococcus_pseudintermedius_quinolone_resistant_GrlA|wt_coherence=TRUE,5.28302%,0.474214
>1672|D84N|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_pseudintermedius|WP_019167736.1|84|grlA_D84N|QUINOLONE|QUINOLONE|Staphylococcus_pseudintermedius_quinolone_resistant_GrlA|wt_coherence=TRUE,5.28302%,0.325786
>1673|D84Y|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_pseudintermedius|WP_019167736.1|84|grlA_D84Y|QUINOLONE|QUINOLONE|Staphylococcus_pseudintermedius_quinolone_resistant_GrlA|wt_coherence=TRUE,5.28302%,0.428931
>1674|N125K|NA|NA|NA|NA|NA|NA|NA|NA|Acinetobacter_baumannii|WP_031379793.1|125|adeS_N125K|EFFLUX|EFFLUX|Acinetobacter_baumannii_efflux_resistant_AdeS|wt_coherence=TRUE,11.898%,1.24929
>1675|R152K|NA|NA|NA|NA|NA|NA|NA|NA|Acinetobacter_baumannii|WP_031379793.1|152|adeS_R152K|EFFLUX|EFFLUX|Acinetobacter_baumannii_efflux_resistant_AdeS|wt_coherence=TRUE,11.898%,0.790368
>1676|T153M|NA|NA|NA|NA|NA|NA|NA|NA|Acinetobacter_baumannii|WP_031379793.1|153|adeS_T153M|EFFLUX|EFFLUX|Acinetobacter_baumannii_efflux_resistant_AdeS|wt_coherence=TRUE,11.898%,0.739377
>1678|H189Y|NA|NA|NA|NA|NA|NA|NA|NA|Acinetobacter_baumannii|WP_031379793.1|189|adeS_H189Y|EFFLUX|EFFLUX|Acinetobacter_baumannii_efflux_resistant_AdeS|wt_coherence=TRUE,11.898%,0.883853
>1679|I252S|NA|NA|NA|NA|NA|NA|NA|NA|Acinetobacter_baumannii|WP_031379793.1|252|adeS_I252S|EFFLUX|EFFLUX|Acinetobacter_baumannii_efflux_resistant_AdeS|wt_coherence=TRUE,11.898%,0.849858
>167|C115D|ARO:3003775|Escherichia coli murA with mutation conferring resistance to fosfomycin|MEG_4095|Drugs|Fosfomycin|Fosfomycin_target_mutation|MURA|RequiresSNPConfirmation|Escherichia|WP_000357259.1|115|murA_C115D|FOSFOMYCIN|FOSFOMYCIN|Escherichia_fosfomycin_resistant_MurA|wt_coherence=TRUE,10.219%,0.615572
>1680|G336S|NA|NA|NA|NA|NA|NA|NA|NA|Acinetobacter_baumannii|WP_031379793.1|336|adeS_G336S|EFFLUX|EFFLUX|Acinetobacter_baumannii_efflux_resistant_AdeS|wt_coherence=TRUE,11.898%,0.770538
>1682|P56S|NA|NA|NA|NA|NA|NA|NA|NA|Acinetobacter_baumannii|WP_031379794.1|56|adeR_P56S|EFFLUX|EFFLUX|Acinetobacter_baumannii_efflux_resistant_AdeR|wt_coherence=TRUE,17.5732%,1.16736
>1683|A91V|NA|NA|NA|NA|NA|NA|NA|NA|Acinetobacter_baumannii|WP_031379794.1|91|adeR_A91V|EFFLUX|EFFLUX|Acinetobacter_baumannii_efflux_resistant_AdeR|wt_coherence=TRUE,17.5732%,0.912134
>1684|P116L|NA|NA|NA|NA|NA|NA|NA|NA|Acinetobacter_baumannii|WP_031379794.1|116|adeR_P116L|EFFLUX|EFFLUX|Acinetobacter_baumannii_efflux_resistant_AdeR|wt_coherence=TRUE,17.5732%,1.43096
>1685|L192R|NA|NA|NA|NA|NA|NA|NA|NA|Acinetobacter_baumannii|WP_031379794.1|192|adeR_L192R|EFFLUX|EFFLUX|Acinetobacter_baumannii_efflux_resistant_AdeR|wt_coherence=TRUE,17.5732%,1.05439
>1686|E219A|NA|NA|NA|NA|NA|NA|NA|NA|Acinetobacter_baumannii|WP_031379794.1|219|adeR_E219A|EFFLUX|EFFLUX|Acinetobacter_baumannii_efflux_resistant_AdeR|wt_coherence=TRUE,17.5732%,0.899582
>1687|P601L|NA|NA|NA|NA|NA|NA|NA|NA|Streptococcus_pyogenes|WP_032462817.1|601|pbp2x_P601L|BETA-LACTAM|BETA-LACTAM|Streptococcus_pyogenes_beta-lactam_resistant_Pbp2x|wt_coherence=TRUE,5.65276%,0.514132
>1688|I355T|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_033554192.1|355|parE_I355T|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParE|wt_coherence=TRUE,6.75241%,0.540193
>1689|L416F|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_033554192.1|416|parE_L416F|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParE|wt_coherence=TRUE,6.75241%,0.635048
>1690|G423R|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_033554192.1|423|parE_G423R|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParE|wt_coherence=TRUE,6.75241%,0.395498
>1692|I444F|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_033554192.1|444|parE_I444F|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParE|wt_coherence=TRUE,8.36013%,0.546624
>1693|L445H|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_033554192.1|445|parE_L445H|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParE|wt_coherence=TRUE,6.75241%,0.672026
>1694|S458A|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_033554192.1|458|parE_S458A|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParE|wt_coherence=TRUE,6.75241%,0.313505
>1695|S458T|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_033554192.1|458|parE_S458T|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParE|wt_coherence=TRUE,9.00322%,0.607717
>1696|E460D|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_033554192.1|460|parE_E460D|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParE|wt_coherence=TRUE,6.75241%,0.384244
>1697|E460K|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_033554192.1|460|parE_E460K|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParE|wt_coherence=TRUE,6.75241%,0.672026
>1698|I464F|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_033554192.1|464|parE_I464F|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParE|wt_coherence=TRUE,6.75241%,0.466238
>1699|I470M|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_033554192.1|470|parE_I470M|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParE|wt_coherence=TRUE,7.23473%,0.504823
>169|R203L|ARO:3003751|Escherichia coli nfsA mutations conferring resistance to nitrofurantoin|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,18.1034%,3.05603
>16|A64V|ARO:3003788|Bacillus subtilis pgsA with mutation conferring resistance to daptomycin|MEG_5779|Drugs|Lipopeptides|Daptomycin-resistant_mutant|PGSA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,11.2903%,0.733871
>1700|D475E|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_033554192.1|475|parE_D475E|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParE|wt_coherence=TRUE,7.71704%,0.565916
>1702|I529L|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_033554192.1|529|parE_I529L|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParE|wt_coherence=TRUE,6.75241%,0.358521
>1703|S83I|NA|NA|NA|NA|NA|NA|NA|NA|Enterococcus_faecalis|WP_033785346.1|84|gyrA_S83I|QUINOLONE|QUINOLONE|Enterococcus_faecalis_quinolone_resistant_GyrA|wt_coherence=TRUE,3.0303%,0.494545
>1704|S83L|NA|NA|NA|NA|NA|NA|NA|NA|Enterococcus_faecalis|WP_033785346.1|84|gyrA_S83L|QUINOLONE|QUINOLONE|Enterococcus_faecalis_quinolone_resistant_GyrA|wt_coherence=TRUE,1.57576%,0.0193939
>1705|S83N|NA|NA|NA|NA|NA|NA|NA|NA|Enterococcus_faecalis|WP_033785346.1|84|gyrA_S83N|QUINOLONE|QUINOLONE|Enterococcus_faecalis_quinolone_resistant_GyrA|wt_coherence=TRUE,0.484848%,0.0169697
>1706|S83R|NA|NA|NA|NA|NA|NA|NA|NA|Enterococcus_faecalis|WP_033785346.1|84|gyrA_S83R|QUINOLONE|QUINOLONE|Enterococcus_faecalis_quinolone_resistant_GyrA|wt_coherence=TRUE,0.969697%,0.0484848
>1707|S83Y|NA|NA|NA|NA|NA|NA|NA|NA|Enterococcus_faecalis|WP_033785346.1|84|gyrA_S83Y|QUINOLONE|QUINOLONE|Enterococcus_faecalis_quinolone_resistant_GyrA|wt_coherence=TRUE,0.121212%,0.0109091
>1708|E87G|NA|NA|NA|NA|NA|NA|NA|NA|Enterococcus_faecalis|WP_033785346.1|88|gyrA_E87G|QUINOLONE|QUINOLONE|Enterococcus_faecalis_quinolone_resistant_GyrA|wt_coherence=TRUE,0.242424%,0.00727273
>170|R203C|ARO:3003751|Escherichia coli nfsA mutations conferring resistance to nitrofurantoin|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,18.1034%,2.69397
>1711|E87Y|NA|NA|NA|NA|NA|NA|NA|NA|Enterococcus_faecalis|WP_033785346.1|88|gyrA_E87Y|QUINOLONE|QUINOLONE|Enterococcus_faecalis_quinolone_resistant_GyrA|wt_coherence=TRUE,0.363636%,0.00363636
>1712|K43R|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_057042458.1|43|rpsL_K43R|AMINOGLYCOSIDE|STREPTOMYCIN|Campylobacter_streptomycin_resistant_RpsL|wt_coherence=TRUE,15%,1.35833
>1713|K88E|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_057042458.1|88|rpsL_K88E|AMINOGLYCOSIDE|STREPTOMYCIN|Campylobacter_streptomycin_resistant_RpsL|wt_coherence=TRUE,35%,2.83333
>1714|K88Q|NA|NA|NA|NA|NA|NA|NA|NA|Campylobacter|WP_057042458.1|88|rpsL_K88Q|AMINOGLYCOSIDE|STREPTOMYCIN|Campylobacter_streptomycin_resistant_RpsL|wt_coherence=TRUE,6.66667%,0.591667
>1715|R620C|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_086259262.1|620|acrB_R620C|TETRACYCLINE|TIGECYCLINE|Escherichia_tigecycline_resistant_AcrB|wt_coherence=TRUE,4.03458%,0.245917
>1717|S33R|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_089631889.1|33|nfsA_S33R|NITROFURAN|NITROFURANTOIN|Escherichia_nitrofurantoin_resistant_NfsA|wt_coherence=TRUE,14.2241%,0.836207
>171|S33R|ARO:3003751|Escherichia coli nfsA mutations conferring resistance to nitrofurantoin|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,15.5172%,1.39224
>1724|S39I|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_094970923.1|39|basR_S39I|COLISTIN|COLISTIN|Escherichia_colistin_resistant_BasR|wt_coherence=TRUE,19.6262%,1.36916
>1725|G53A|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_094970923.1|53|basR_G53A|COLISTIN|COLISTIN|Escherichia_colistin_resistant_BasR|wt_coherence=TRUE,19.6262%,1.8271
>1726|G53C|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_094970923.1|53|basR_G53C|COLISTIN|COLISTIN|Escherichia_colistin_resistant_BasR|wt_coherence=TRUE,18.6916%,0.448598
>1727|G53E|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_094970923.1|53|basR_G53E|COLISTIN|COLISTIN|Escherichia_colistin_resistant_BasR|wt_coherence=TRUE,14.9533%,0.728972
>1728|G53R|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_094970923.1|53|basR_G53R|COLISTIN|COLISTIN|Escherichia_colistin_resistant_BasR|wt_coherence=TRUE,19.1589%,0.565421
>1729|G53S|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_094970923.1|53|basR_G53S|COLISTIN|COLISTIN|Escherichia_colistin_resistant_BasR|wt_coherence=TRUE,18.6916%,0.5
>172|G131D|ARO:3003751|Escherichia coli nfsA mutations conferring resistance to nitrofurantoin|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,18.1034%,3.31897
>1730|G53V|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_094970923.1|53|basR_G53V|COLISTIN|COLISTIN|Escherichia_colistin_resistant_BasR|wt_coherence=TRUE,19.6262%,1.40654
>1731|G53W|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_094970923.1|53|basR_G53W|COLISTIN|COLISTIN|Escherichia_colistin_resistant_BasR|wt_coherence=TRUE,19.6262%,1.47664
>1732|R81L|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_094970923.1|81|basR_R81L|COLISTIN|COLISTIN|Escherichia_colistin_resistant_BasR|wt_coherence=TRUE,19.6262%,1.43925
>1733|R81S|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_094970923.1|81|basR_R81S|COLISTIN|COLISTIN|Escherichia_colistin_resistant_BasR|wt_coherence=TRUE,19.6262%,1.88785
>1734|L105P|NA|NA|NA|NA|NA|NA|NA|NA|Escherichia|WP_094970923.1|105|basR_L105P|COLISTIN|COLISTIN|Escherichia_colistin_resistant_BasR|wt_coherence=TRUE,19.6262%,1.5
>1737|S84A|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_pseudintermedius|WP_103263503.1|84|gyrA_S84A|QUINOLONE|QUINOLONE|Staphylococcus_pseudintermedius_quinolone_resistant_GyrA|wt_coherence=TRUE,0.45977%,0.00804598
>1739|S84W|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_pseudintermedius|WP_103263503.1|84|gyrA_S84W|QUINOLONE|QUINOLONE|Staphylococcus_pseudintermedius_quinolone_resistant_GyrA|wt_coherence=TRUE,0.804598%,0.0114943
>173|R133S|ARO:3003751|Escherichia coli nfsA mutations conferring resistance to nitrofurantoin|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,18.1034%,2.1681
>1740|S85A|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_pseudintermedius|WP_103263503.1|85|gyrA_S85A|QUINOLONE|QUINOLONE|Staphylococcus_pseudintermedius_quinolone_resistant_GyrA|wt_coherence=TRUE,2.29885%,1.50805
>1741|E88G|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_pseudintermedius|WP_103263503.1|88|gyrA_E88G|QUINOLONE|QUINOLONE|Staphylococcus_pseudintermedius_quinolone_resistant_GyrA|wt_coherence=TRUE,0.574713%,0.00574713
>1746|S337L|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_111724484.1|337|mprF_S337L|LIPOPEPTIDE|DAPTOMYCIN|Staphylococcus_aureus_daptomycin_resistant_MprF|wt_coherence=TRUE,4.08654%,0.27524
>1747|L341S|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_111724484.1|341|mprF_L341S|LIPOPEPTIDE|DAPTOMYCIN|Staphylococcus_aureus_daptomycin_resistant_MprF|wt_coherence=TRUE,4.08654%,0.152644
>1748|T345A|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_111724484.1|345|mprF_T345A|LIPOPEPTIDE|DAPTOMYCIN|Staphylococcus_aureus_daptomycin_resistant_MprF|wt_coherence=TRUE,5.16827%,0.0625
>1749|T345I|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_111724484.1|345|mprF_T345I|LIPOPEPTIDE|DAPTOMYCIN|Staphylococcus_aureus_daptomycin_resistant_MprF|wt_coherence=TRUE,5.52885%,0.475962
>174|E84G|ARO:3003308|Escherichia coli parC conferring resistance to fluoroquinolones|MEG_5333|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|Escherichia|WP_001281881.1|84|parC_E84G|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParC|wt_coherence=TRUE,4.83871%,0.139785
>1750|T345K|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_111724484.1|345|mprF_T345K|LIPOPEPTIDE|DAPTOMYCIN|Staphylococcus_aureus_daptomycin_resistant_MprF|wt_coherence=TRUE,0.961538%,0.00961538
>1751|M347R|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_111724484.1|347|mprF_M347R|LIPOPEPTIDE|DAPTOMYCIN|Staphylococcus_aureus_daptomycin_resistant_MprF|wt_coherence=TRUE,5.04808%,0.126202
>1752|V351E|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_111724484.1|351|mprF_V351E|LIPOPEPTIDE|DAPTOMYCIN|Staphylococcus_aureus_daptomycin_resistant_MprF|wt_coherence=TRUE,5.04808%,0.53726
>1753|I420N|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_111724484.1|420|mprF_I420N|LIPOPEPTIDE|DAPTOMYCIN|Staphylococcus_aureus_daptomycin_resistant_MprF|wt_coherence=TRUE,5.04808%,0.389423
>1754|T472K|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_111724484.1|472|mprF_T472K|LIPOPEPTIDE|DAPTOMYCIN|Staphylococcus_aureus_daptomycin_resistant_MprF|wt_coherence=TRUE,5.04808%,0.379808
>1756|S80I|NA|NA|NA|NA|NA|NA|NA|NA|Enterococcus_faecium|WP_115256011.1|82|parC_S80I|QUINOLONE|QUINOLONE|Enterococcus_faecium_quinolone_resistant_ParC|wt_coherence=FALSE,2.47525%,0.165842
>1757|S80R|NA|NA|NA|NA|NA|NA|NA|NA|Enterococcus_faecium|WP_115256011.1|82|parC_S80R|QUINOLONE|QUINOLONE|Enterococcus_faecium_quinolone_resistant_ParC|wt_coherence=FALSE,2.47525%,0.0915842
>1758|E84A|NA|NA|NA|NA|NA|NA|NA|NA|Enterococcus_faecium|WP_115256011.1|86|parC_E84A|QUINOLONE|QUINOLONE|Enterococcus_faecium_quinolone_resistant_ParC|wt_coherence=FALSE,1.9802%,0.0247525
>1759|E84K|NA|NA|NA|NA|NA|NA|NA|NA|Enterococcus_faecium|WP_115256011.1|86|parC_E84K|QUINOLONE|QUINOLONE|Enterococcus_faecium_quinolone_resistant_ParC|wt_coherence=FALSE,4.70297%,0.0977723
>1760|E84T|NA|NA|NA|NA|NA|NA|NA|NA|Enterococcus_faecium|WP_115256011.1|86|parC_E84T|QUINOLONE|QUINOLONE|Enterococcus_faecium_quinolone_resistant_ParC|wt_coherence=FALSE,5.69307%,0.579208
>1761|S83F|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_117036963.1|83|gyrA_S83F|QUINOLONE|QUINOLONE|Klebsiella_quinolone_resistant_GyrA|wt_coherence=TRUE,0.115075%,0.00115075
>1763|S83L|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_117036963.1|83|gyrA_S83L|QUINOLONE|QUINOLONE|Klebsiella_quinolone_resistant_GyrA|wt_coherence=TRUE,0.345224%,0.00345224
>1764|S83T|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_117036963.1|83|gyrA_S83T|QUINOLONE|QUINOLONE|Klebsiella_quinolone_resistant_GyrA|wt_coherence=TRUE,6.32911%,0.81473
>1766|D87A|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_117036963.1|87|gyrA_D87A|QUINOLONE|QUINOLONE|Klebsiella_quinolone_resistant_GyrA|wt_coherence=TRUE,4.48792%,0.0817031
>176|D476N|ARO:3003316|Escherichia coli parE conferring resistance to fluoroquinolones|MEG_5394|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PAREF|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.75241%,1.13666
>1770|D87Y|NA|NA|NA|NA|NA|NA|NA|NA|Klebsiella|WP_117036963.1|87|gyrA_D87Y|QUINOLONE|QUINOLONE|Klebsiella_quinolone_resistant_GyrA|wt_coherence=TRUE,0.575374%,0.00575374
>1771|E183A|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_123090655.1|183|pbp4_E183A|BETA-LACTAM|CEPHALOSPORIN|Staphylococcus_aureus_cephalosporin_resistant_Pbp4|wt_coherence=TRUE,9.92908%,0.661939
>1772|F241R|NA|NA|NA|NA|NA|NA|NA|NA|Staphylococcus_aureus|WP_123090655.1|241|pbp4_F241R|BETA-LACTAM|CEPHALOSPORIN|Staphylococcus_aureus_cephalosporin_resistant_Pbp4|wt_coherence=TRUE,9.92908%,0.638298
>1773|S83I|NA|NA|NA|NA|NA|NA|NA|NA|Enterococcus_faecium|WP_137277832.1|84|gyrA_S83I|QUINOLONE|QUINOLONE|Enterococcus_faecium_quinolone_resistant_GyrA|wt_coherence=TRUE,0.858896%,0.00981595
>1775|S83N|NA|NA|NA|NA|NA|NA|NA|NA|Enterococcus_faecium|WP_137277832.1|84|gyrA_S83N|QUINOLONE|QUINOLONE|Enterococcus_faecium_quinolone_resistant_GyrA|wt_coherence=TRUE,2.20859%,0.0478528
>1781|S97N|NA|NA|NA|NA|NA|NA|NA|NA|Enterococcus_faecium|WP_137277832.1|98|gyrA_S97N|QUINOLONE|QUINOLONE|Enterococcus_faecium_quinolone_resistant_GyrA|wt_coherence=TRUE,1.84049%,0.0785276
>178|R687H|ARO:3003288|Escherichia coli rpoB mutants conferring resistance to rifampicin|MEG_6094|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|Escherichia|WP_000263098.1|687|rpoB_R687H|RIFAMYCIN|RIFAMYCIN|Escherichia_rifamycin_resistant_RpoB|wt_coherence=TRUE,3.14843%,0.265367
>179|H526Y|ARO:3003288|Escherichia coli rpoB mutants conferring resistance to rifampicin|MEG_6094|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|Escherichia|WP_000263098.1|526|rpoB_H526Y|RIFAMYCIN|RIFAMYCIN|Escherichia_rifamycin_resistant_RpoB|wt_coherence=TRUE,3.14843%,0.232384
>17|D90G|ARO:3003297|Bartonella bacilliformis gyrA conferring resistance to fluoroquinolones|MEG_3179|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.82609%,0.048913
>180|Q513P|ARO:3003288|Escherichia coli rpoB mutants conferring resistance to rifampicin|MEG_6094|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|Escherichia|WP_000263098.1|513|rpoB_Q513P|RIFAMYCIN|RIFAMYCIN|Escherichia_rifamycin_resistant_RpoB|wt_coherence=TRUE,1.1994%,0.0427286
>181|V146F|ARO:3003288|Escherichia coli rpoB mutants conferring resistance to rifampicin|MEG_6094|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|Escherichia|WP_000263098.1|146|rpoB_V146F|RIFAMYCIN|RIFAMYCIN|Escherichia_rifamycin_resistant_RpoB|wt_coherence=TRUE,3.14843%,0.317841
>182|Q513L|ARO:3003288|Escherichia coli rpoB mutants conferring resistance to rifampicin|MEG_6094|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|Escherichia|WP_000263098.1|513|rpoB_Q513L|RIFAMYCIN|RIFAMYCIN|Escherichia_rifamycin_resistant_RpoB|wt_coherence=TRUE,1.34933%,0.05997
>183|P564L|ARO:3003288|Escherichia coli rpoB mutants conferring resistance to rifampicin|MEG_6094|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|Escherichia|WP_000263098.1|564|rpoB_P564L|RIFAMYCIN|RIFAMYCIN|Escherichia_rifamycin_resistant_RpoB|wt_coherence=TRUE,3.14843%,0.1994
>184|T563P|ARO:3003288|Escherichia coli rpoB mutants conferring resistance to rifampicin|MEG_6094|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|Escherichia|WP_000263098.1|563|rpoB_T563P|RIFAMYCIN|RIFAMYCIN|Escherichia_rifamycin_resistant_RpoB|wt_coherence=TRUE,3.14843%,0.270615
>185|L533P|ARO:3003288|Escherichia coli rpoB mutants conferring resistance to rifampicin|MEG_6094|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|Escherichia|WP_000263098.1|533|rpoB_L533P|RIFAMYCIN|RIFAMYCIN|Escherichia_rifamycin_resistant_RpoB|wt_coherence=TRUE,3.14843%,0.295352
>186|S531F|ARO:3003288|Escherichia coli rpoB mutants conferring resistance to rifampicin|MEG_6094|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|Escherichia|WP_000263098.1|531|rpoB_S531F|RIFAMYCIN|RIFAMYCIN|Escherichia_rifamycin_resistant_RpoB|wt_coherence=TRUE,3.14843%,0.167916
>187|R529S|ARO:3003288|Escherichia coli rpoB mutants conferring resistance to rifampicin|MEG_6094|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|Escherichia|WP_000263098.1|529|rpoB_R529S|RIFAMYCIN|RIFAMYCIN|Escherichia_rifamycin_resistant_RpoB|wt_coherence=TRUE,3.14843%,0.197151
>188|R529C|ARO:3003288|Escherichia coli rpoB mutants conferring resistance to rifampicin|MEG_6094|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|Escherichia|WP_000263098.1|529|rpoB_R529C|RIFAMYCIN|RIFAMYCIN|Escherichia_rifamycin_resistant_RpoB|wt_coherence=TRUE,3.14843%,0.269865
>189|G97D|ARO:3003893|Escherichia coli UhpA with mutation conferring resistance to fosfomycin|NA|NA|NA|NA|NA|NA|Escherichia|WP_000633668.1|97|uhpA_G97D|FOSFOMYCIN|FOSFOMYCIN|Escherichia_fosfomycin_resistant_UhpA|wt_coherence=TRUE,22.3404%,1.64362
>18|D95N|ARO:3003297|Bartonella bacilliformis gyrA conferring resistance to fluoroquinolones|MEG_3179|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.434783%,0.00869565
>190|E350Q|ARO:3003890|Escherichia coli UhpT with mutation conferring resistance to fosfomycin|MEG_7330|Drugs|Fosfomycin|Fosfomycin_target_mutation|UHPT|RequiresSNPConfirmation|Escherichia|WP_000879194.1|350|uhpT_E350Q|FOSFOMYCIN|FOSFOMYCIN|Escherichia_fosfomycin_resistant_UhpT|wt_coherence=TRUE,9.23077%,0.802198
>191|S357N|ARO:3004446|Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics|MEG_5408|Drugs|betalactams|Penicillin_binding_protein|PBP3|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.97674%,0.524917
>192|L389F|ARO:3004446|Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics|MEG_5408|Drugs|betalactams|Penicillin_binding_protein|PBP3|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.97674%,0.667774
>193|D350N|ARO:3004446|Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics|MEG_5408|Drugs|betalactams|Penicillin_binding_protein|PBP3|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.97674%,0.719269
>194|V562L|ARO:3004446|Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics|MEG_5408|Drugs|betalactams|Penicillin_binding_protein|PBP3|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.97674%,0.69103
>195|S385T|ARO:3004446|Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics|MEG_5408|Drugs|betalactams|Penicillin_binding_protein|PBP3|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.97674%,0.742525
>196|S84Y|ARO:3003924|Haemophilus parainfluenzae gyrA conferring resistance to fluoroquinolones|MEG_3184|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.66552%,0.093929
>197|S84F|ARO:3003925|Haemophilus parainfluenzae parC conferring resistance to fluoroquinolones|MEG_3251|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.30686%,0.126514
>198|R45C|ARO:3003374|Klebsiella aerogenes acrR with mutation conferring multidrug antibiotic resistance|MEG_413|Multi-compound|Drug_and_biocide_resistance|Drug_and_biocide_RND_efflux_regulator|ACRR|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,15.8654%,0.677885
>199|G133D|ARO:3003385|Klebsiella aerogenes Omp36|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,11.4441%,1.13896
>19|T214I|ARO:3003302|Bartonella bacilliformis gyrB conferring resistance to aminocoumarin|MEG_3246|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|GYRBA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.24345%,0.330836
>1|S81L|ARO:3003817|Acinetobacter baumannii gyrA conferring resistance to fluoroquinolones|MEG_3183|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|Acinetobacter_baumannii|WP_000116450.1|81|gyrA_S81L|QUINOLONE|QUINOLONE|Acinetobacter_baumannii_quinolone_resistant_GyrA|wt_coherence=TRUE,4.91071%,0.175223
>200|D191Y|ARO:3003585|Klebsiella mutant PhoP conferring antibiotic resistance to colistin|MEG_5783|Multi-compound|Drug_and_biocide_resistance|Drug_and_biocide_ABC_efflux_regulator|PHOB|RequiresSNPConfirmation|Klebsiella|WP_004150807.1|191|phoP_D191Y|COLISTIN|COLISTIN|Klebsiella_colistin_resistant_PhoP|wt_coherence=TRUE,19.5349%,1.90233
>201|V165I|ARO:3003373|Klebsiella pneumoniae acrR with mutation conferring multidrug antibiotic resistance|MEG_414|Multi-compound|Drug_and_biocide_resistance|Drug_and_biocide_RND_efflux_regulator|ACRR|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,20.1923%,1.75962
>202|Y114F|ARO:3003373|Klebsiella pneumoniae acrR with mutation conferring multidrug antibiotic resistance|MEG_414|Multi-compound|Drug_and_biocide_resistance|Drug_and_biocide_RND_efflux_regulator|ACRR|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,20.1923%,2.01923
>203|M109I|ARO:3003373|Klebsiella pneumoniae acrR with mutation conferring multidrug antibiotic resistance|MEG_414|Multi-compound|Drug_and_biocide_resistance|Drug_and_biocide_RND_efflux_regulator|ACRR|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,20.1923%,1.53365
>205|I88N|ARO:3003380|Klebsiella pneumoniae ramR mutants|MEG_6045|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|RAMR|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,22.7027%,2.37297
>207|G96D|ARO:3003380|Klebsiella pneumoniae ramR mutants|MEG_6045|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|RAMR|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,22.7027%,1.9027
>208|T162I|ARO:3003380|Klebsiella pneumoniae ramR mutants|MEG_6045|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|RAMR|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,22.7027%,1.92432
>209|T43M|ARO:3003380|Klebsiella pneumoniae ramR mutants|MEG_6045|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|RAMR|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,22.7027%,1.93514
>20|T214A|ARO:3003302|Bartonella bacilliformis gyrB conferring resistance to aminocoumarin|MEG_3246|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|GYRBA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.24345%,0.458177
>211|Q52P|ARO:3003028|lmrA|MEG_3594|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|LMRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.09091%,0.811839
>212|Q72K|ARO:3003573|LpxA|MEG_3626|Drugs|Lipopeptides|Colistin-resistant_mutant|LPXA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.5354%,1.0315
>213|H159D|ARO:3003573|LpxA|MEG_3626|Drugs|Lipopeptides|Colistin-resistant_mutant|LPXA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.5354%,1.57874
>214|G68D|ARO:3003573|LpxA|MEG_3626|Drugs|Lipopeptides|Colistin-resistant_mutant|LPXA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.5354%,1.40551
>215|P30L|ARO:3003574|LpxC|MEG_3627|Drugs|Lipopeptides|Colistin-resistant_mutant|LPXC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,14.3836%,1
>216|S464Y|ARO:3003306|Morganella morganii gyrB conferring resistance to fluoroquinolones|MEG_3242|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.27638%,0.413317
>217|S464A|ARO:3003306|Morganella morganii gyrB conferring resistance to fluoroquinolones|MEG_3242|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.27638%,0.342965
>218|G45D|ARO:3000817|mtrR|MEG_4088|Multi-compound|Drug_and_biocide_resistance|Drug_and_biocide_MFS_efflux_regulator|MTRR|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,20.7921%,1.31188
>219|P55R|ARO:3003389|Mycobacterium leprae folP with mutation conferring resistance to dapsone|MEG_2935|Drugs|Sulfonamides|Sulfonamide-resistant_dihydropteroate_synthases|FOLP|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,14.8551%,0.434783
>21|R184Q|ARO:3003302|Bartonella bacilliformis gyrB conferring resistance to aminocoumarin|MEG_3246|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|GYRBA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.24345%,0.429463
>220|P55L|ARO:3003389|Mycobacterium leprae folP with mutation conferring resistance to dapsone|MEG_2935|Drugs|Sulfonamides|Sulfonamide-resistant_dihydropteroate_synthases|FOLP|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,13.4058%,0.228261
>221|P55S|ARO:3003389|Mycobacterium leprae folP with mutation conferring resistance to dapsone|MEG_2935|Drugs|Sulfonamides|Sulfonamide-resistant_dihydropteroate_synthases|FOLP|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.88406%,0.144928
>222|V48F|ARO:3003389|Mycobacterium leprae folP with mutation conferring resistance to dapsone|MEG_2935|Drugs|Sulfonamides|Sulfonamide-resistant_dihydropteroate_synthases|FOLP|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,15.2174%,1.22826
>223|V48A|ARO:3003389|Mycobacterium leprae folP with mutation conferring resistance to dapsone|MEG_2935|Drugs|Sulfonamides|Sulfonamide-resistant_dihydropteroate_synthases|FOLP|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,15.2174%,1.35507
>224|V48G|ARO:3003389|Mycobacterium leprae folP with mutation conferring resistance to dapsone|MEG_2935|Drugs|Sulfonamides|Sulfonamide-resistant_dihydropteroate_synthases|FOLP|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,15.2174%,1.16304
>225|R54G|ARO:3003389|Mycobacterium leprae folP with mutation conferring resistance to dapsone|MEG_2935|Drugs|Sulfonamides|Sulfonamide-resistant_dihydropteroate_synthases|FOLP|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,15.2174%,1.19565
>226|T53I|ARO:3003389|Mycobacterium leprae folP with mutation conferring resistance to dapsone|MEG_2935|Drugs|Sulfonamides|Sulfonamide-resistant_dihydropteroate_synthases|FOLP|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,15.2174%,1.62681
>227|T53A|ARO:3003389|Mycobacterium leprae folP with mutation conferring resistance to dapsone|MEG_2935|Drugs|Sulfonamides|Sulfonamide-resistant_dihydropteroate_synthases|FOLP|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,15.2174%,1.19928
>228|T53P|ARO:3003389|Mycobacterium leprae folP with mutation conferring resistance to dapsone|MEG_2935|Drugs|Sulfonamides|Sulfonamide-resistant_dihydropteroate_synthases|FOLP|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,15.2174%,1.84058
>229|T53N|ARO:3003389|Mycobacterium leprae folP with mutation conferring resistance to dapsone|MEG_2935|Drugs|Sulfonamides|Sulfonamide-resistant_dihydropteroate_synthases|FOLP|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,15.2174%,1.25
>22|G125S|ARO:3003302|Bartonella bacilliformis gyrB conferring resistance to aminocoumarin|MEG_3246|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|GYRBA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.24345%,0.421973
>230|P55T|ARO:3003389|Mycobacterium leprae folP with mutation conferring resistance to dapsone|MEG_2935|Drugs|Sulfonamides|Sulfonamide-resistant_dihydropteroate_synthases|FOLP|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,15.2174%,1.55072
>231|P55A|ARO:3003389|Mycobacterium leprae folP with mutation conferring resistance to dapsone|MEG_2935|Drugs|Sulfonamides|Sulfonamide-resistant_dihydropteroate_synthases|FOLP|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.42029%,0.235507
>232|P55H|ARO:3003389|Mycobacterium leprae folP with mutation conferring resistance to dapsone|MEG_2935|Drugs|Sulfonamides|Sulfonamide-resistant_dihydropteroate_synthases|FOLP|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,13.0435%,0.228261
>233|D464N|ARO:3003304|Mycobacterium leprae gyrB conferring resistance to fluoroquinolones|MEG_3239|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.9403%,0.0238806
>234|E504V|ARO:3003304|Mycobacterium leprae gyrB conferring resistance to fluoroquinolones|MEG_3239|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.26866%,0.765672
>235|N502D|ARO:3003304|Mycobacterium leprae gyrB conferring resistance to fluoroquinolones|MEG_3239|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.97015%,0.513433
>236|S456L|ARO:3003284|Mycobacterium leprae rpoB mutations conferring resistance to rifampicin|MEG_6091|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.512821%,0.00683761
>237|V472I|ARO:3003284|Mycobacterium leprae rpoB mutations conferring resistance to rifampicin|MEG_6091|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.58974%,0.359829
>239|G350D|ARO:3003453|Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol|MEG_2709|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.8674%,0.291897
>23|L71R|ARO:3003582|basR|MEG_1197|Drugs|Cationic_antimicrobial_peptides|Polymyxin_B_resistance_regulator|BASRS|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.7183%,1.78404
>240|A462V|ARO:3003453|Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol|MEG_2709|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.8674%,0.310313
>241|D833A|ARO:3003453|Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol|MEG_2709|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.8674%,0.323204
>243|P913S|ARO:3003453|Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol|MEG_2709|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.8674%,0.405157
>244|A201T|ARO:3003453|Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol|MEG_2709|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.8674%,0.229282
>245|G321S|ARO:3003453|Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol|MEG_2709|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.8674%,0.211786
>246|Y319D|ARO:3003465|Mycobacterium tuberculosis embB with mutation conferring resistance to rifampicin|MEG_7259|Drugs|Aminoglycosides|Aminoglycoside-resistant_arabinosyltransferase|TLYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.02752%,0.0458716
>247|Y333H|ARO:3003465|Mycobacterium tuberculosis embB with mutation conferring resistance to rifampicin|MEG_7259|Drugs|Aminoglycosides|Aminoglycoside-resistant_arabinosyltransferase|TLYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.21101%,0.0559633
>248|P375A|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.33945
>249|D328G|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.02752%,0.0779817
>24|L157Q|ARO:3003582|basR|MEG_1197|Drugs|Cationic_antimicrobial_peptides|Polymyxin_B_resistance_regulator|BASRS|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.7183%,1.22535
>251|F330V|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.20183%,0.0284404
>252|G406A|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.32844
>253|L413P|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.295413
>254|S297A|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.110092
>255|D299E|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.49541%,0.165138
>256|M306L|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.58716%,0.187156
>257|M306V|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.57798%,0.106422
>258|M306I|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.12844%,0.0614679
>259|M306T|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.31193%,0.105505
>25|D116C|ARO:3003777|Borreliella burgdorferi murA with mutation conferring resistance to fosfomycin|MEG_4092|Drugs|Fosfomycin|Fosfomycin_target_mutation|MURA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.0239%,0.983294
>260|D311H|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.56881%,0.0256881
>261|E504Q|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.355963
>262|R507G|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.290826
>263|D1024N|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.211009
>264|Y319C|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.76147%,0.0550459
>265|Y333C|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.11927%,0.0504587
>266|Y319N|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.156881
>267|T630I|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.309174
>268|M1000R|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.256881
>269|D959A|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.304587
>26|T83I|ARO:3004860|Burkholderia dolosa gyrA conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.09546%,0.422584
>270|G745D|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.242202
>271|Q497K|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.370642
>272|Q497R|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.291743
>273|R471P|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.30367
>274|R469P|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.242202
>275|I465D|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.27156
>276|R460C|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.199083
>277|P446H|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.13761%,0.353211
>278|G406D|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.285321
>279|G406C|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.33945
>27|D87H|ARO:3004860|Burkholderia dolosa gyrA conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.814901%,0.0186263
>280|G406S|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.225688
>281|N399H|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.30367
>282|P397Q|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.493578
>283|S380R|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.294495
>284|E378A|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.26055
>285|L239P|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.94495%,0.26789
>286|D240H|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.391743
>287|Y334H|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.02752%,0.0880734
>288|A356V|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.27156
>289|A357S|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.399083
>28|G81D|ARO:3004860|Burkholderia dolosa gyrA conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.74622%,0.144354
>290|E368A|ARO:3003326|Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol|MEG_2710|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.363303
>292|C110Y|ARO:3003455|Mycobacterium tuberculosis embR mutant conferring resistance to ethambutol|MEG_2713|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBR|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,11.0526%,1.10263
>293|P28S|ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.648649
>294|L35R|ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.648649
>295|G42D|ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.879418
>296|D56Y|ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.696466
>297|D58G|ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.790021
>298|W69C|ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.675676
>299|H102P|ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.438669
>29|T86I|ARO:3003789|Campylobacter jejuni gyrA conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|Campylobacter|WP_002857904.1|86|gyrA_T86I|QUINOLONE|QUINOLONE|Campylobacter_quinolone_resistant_GyrA|wt_coherence=TRUE,1.40351%,0.0292398
>2|G79C|ARO:3003817|Acinetobacter baumannii gyrA conferring resistance to fluoroquinolones|MEG_3183|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|Acinetobacter_baumannii|WP_000116450.1|79|gyrA_G79C|QUINOLONE|QUINOLONE|Acinetobacter_baumannii_quinolone_resistant_GyrA|wt_coherence=TRUE,2.12054%,0.0680804
>300|Y141N|ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.858628
>301|T186P|ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.555094
>302|T189R|ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.829522
>303|S329P|ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.409563
>304|A341V|ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.735967
>305|N345K|ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.634096
>306|A352E|ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.648649
>307|M372R|ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.902287
>308|C403Y|ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.621622
>30|G80N|ARO:3003931|Capnocytophaga gingivalis gyrA conferring resistance to fluoroquinolones|MEG_3176|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.07246%,0.381643
>310|L267V|ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.632017
>311|V179F|ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.652807
>312|A395D|ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.77131%,0.790021
>313|Q246P|ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.800416
>314|Q254P|ARO:3005106|Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.8108%,0.137214
>315|G43C|ARO:3003458|Mycobacterium tuberculosis ethA with mutation conferring resistance to ethionamide|MEG_2866|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethionamide-resistant_mutant|ETHA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.781705
>316|E223K|ARO:3003458|Mycobacterium tuberculosis ethA with mutation conferring resistance to ethionamide|MEG_2866|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethionamide-resistant_mutant|ETHA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.81289
>317|I338S|ARO:3003458|Mycobacterium tuberculosis ethA with mutation conferring resistance to ethionamide|MEG_2866|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethionamide-resistant_mutant|ETHA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.480249
>318|T392A|ARO:3003458|Mycobacterium tuberculosis ethA with mutation conferring resistance to ethionamide|MEG_2866|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethionamide-resistant_mutant|ETHA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.775468
>319|G385D|ARO:3003458|Mycobacterium tuberculosis ethA with mutation conferring resistance to ethionamide|MEG_2866|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethionamide-resistant_mutant|ETHA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.611227
>31|G261E|ARO:3003357|Clostridioides difficile EF-Tu mutants conferring resistance to elfamycin|MEG_7304|Drugs|Elfamycins|EF-Tu_inhibition|TUFAB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.7969%,1.00514
>320|T342K|ARO:3003458|Mycobacterium tuberculosis ethA with mutation conferring resistance to ethionamide|MEG_2866|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethionamide-resistant_mutant|ETHA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.802495
>321|D58A|ARO:3003458|Mycobacterium tuberculosis ethA with mutation conferring resistance to ethionamide|MEG_2866|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethionamide-resistant_mutant|ETHA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.340956
>322|P51L|ARO:3003458|Mycobacterium tuberculosis ethA with mutation conferring resistance to ethionamide|MEG_2866|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethionamide-resistant_mutant|ETHA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.827443
>323|D56A|ARO:3003458|Mycobacterium tuberculosis ethA with mutation conferring resistance to ethionamide|MEG_2866|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethionamide-resistant_mutant|ETHA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.862786
>324|Y84D|ARO:3003458|Mycobacterium tuberculosis ethA with mutation conferring resistance to ethionamide|MEG_2866|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethionamide-resistant_mutant|ETHA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.1871%,0.891892
>325|T186K|ARO:3003458|Mycobacterium tuberculosis ethA with mutation conferring resistance to ethionamide|MEG_2866|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethionamide-resistant_mutant|ETHA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.515593
>326|R463S|ARO:3003458|Mycobacterium tuberculosis ethA with mutation conferring resistance to ethionamide|MEG_2866|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethionamide-resistant_mutant|ETHA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.68815
>327|G413D|ARO:3003458|Mycobacterium tuberculosis ethA with mutation conferring resistance to ethionamide|MEG_2866|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethionamide-resistant_mutant|ETHA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.775468
>328|A381P|ARO:3003458|Mycobacterium tuberculosis ethA with mutation conferring resistance to ethionamide|MEG_2866|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethionamide-resistant_mutant|ETHA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.73181%,0.642412
>329|G43S|ARO:3003458|Mycobacterium tuberculosis ethA with mutation conferring resistance to ethionamide|MEG_2866|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethionamide-resistant_mutant|ETHA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.14761%,0.881497
>32|T82I|ARO:3003995|Clostridioides difficile gyrA conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.625%,0.16875
>330|L56V|ARO:3004157|Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid|MEG_2933|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|FOLC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.76827%,0.939457
>331|R49W|ARO:3004157|Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid|MEG_2933|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|FOLC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.76827%,0.551148
>332|R49P|ARO:3004157|Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid|MEG_2933|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|FOLC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.76827%,0.826722
>333|I43A|ARO:3004157|Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid|MEG_2933|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|FOLC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.76827%,0.580376
>334|I43S|ARO:3004157|Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid|MEG_2933|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|FOLC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.97704%,0.60334
>335|I43T|ARO:3004157|Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid|MEG_2933|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|FOLC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.76827%,0.457203
>337|A420V|ARO:3004157|Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid|MEG_2933|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|FOLC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.76827%,0.818372
>338|E153G|ARO:3004157|Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid|MEG_2933|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|FOLC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.76827%,0.862213
>339|E153A|ARO:3004157|Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid|MEG_2933|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|FOLC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.76827%,0.68476
>33|A384D|ARO:3003995|Clostridioides difficile gyrA conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.25%,0.66625
>340|S150C|ARO:3004157|Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid|MEG_2933|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|FOLC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.76827%,0.59499
>341|E40Q|ARO:3004157|Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid|MEG_2933|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|FOLC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.6472%,0.636743
>342|S150G|ARO:3004157|Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid|MEG_2933|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|FOLC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.76827%,0.732777
>343|R91W|ARO:3004157|Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid|MEG_2933|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|FOLC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.76827%,0.480167
>344|E40G|ARO:3004157|Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid|MEG_2933|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|FOLC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.97704%,0.901879
>345|N51T|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.9074%,1.14352
>346|I55S|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,0.939815
>347|D67H|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,1.21759
>348|E92A|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,1.32407
>349|S70R|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,1.44907
>34|C245T|ARO:3003995|Clostridioides difficile gyrA conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.25%,0.29125
>350|G71V|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,1.06944
>351|Q127P|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,1.17593
>352|A138E|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,1.31481
>353|A183T|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,1.76389
>354|L79F|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,1.41667
>355|G117E|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,2.02778
>356|R47Q|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,0.949074
>357|W45C|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,1.46296
>358|L49F|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,1.2963
>359|G164C|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,1.6713
>35|D71V|ARO:3003995|Clostridioides difficile gyrA conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.5%,0.055
>360|P84C|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,2.09259
>361|V188M|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,1.38426
>362|A134E|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,1.56019
>363|P75S|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,1.86574
>364|V124G|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,1.43981
>365|A183E|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,1.05556
>366|V188G|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,1.50926
>367|G37V|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,1.5
>368|A200E|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,1.90741
>369|V139A|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,1.50926
>36|T82V|ARO:3003995|Clostridioides difficile gyrA conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.625%,0.10875
>370|P84L|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,1.72222
>371|G30R|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,1.47222
>372|H48Y|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,25.9259%,1.75
>373|L79S|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,2.16667
>374|W148R|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,1.22685
>375|W45S|ARO:3003470|Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin|MEG_3135|Drugs|Aminoglycosides|Aminoglycoside-resistant_gidB|GIDB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.4444%,1.68519
>377|P102H|ARO:3003295|Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones|MEG_3180|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.28916%,0.0228916
>378|T80A|ARO:3003295|Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones|MEG_3180|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.09639%,0.0903614
>379|D94T|ARO:3003295|Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones|MEG_3180|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.33735%,0.0722892
>380|A74S|ARO:3003295|Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones|MEG_3180|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.6988%,0.0831325
>381|D94V|ARO:3003295|Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones|MEG_3180|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.21687%,0.0746988
>382|D94G|ARO:3003295|Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones|MEG_3180|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.09639%,0.0843373
>383|D89V|ARO:3003295|Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones|MEG_3180|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.06024%,0.508434
>384|D94A|ARO:3003295|Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones|MEG_3180|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.09639%,0.0638554
>385|D89N|ARO:3003295|Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones|MEG_3180|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.06024%,0.450602
>386|D89G|ARO:3003295|Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones|MEG_3180|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.25301%,0.0626506
>387|G88C|ARO:3003295|Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones|MEG_3180|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.06024%,0.484337
>388|D94Y|ARO:3003295|Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones|MEG_3180|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.77108%,0.0337349
>389|G88A|ARO:3003295|Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones|MEG_3180|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.06024%,0.491566
>38|D71G|ARO:3003995|Clostridioides difficile gyrA conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.25%,0.035
>390|A90V|ARO:3003295|Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones|MEG_3180|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.89157%,0.053012
>391|A90G|ARO:3003295|Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones|MEG_3180|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.06024%,0.339759
>392|S91P|ARO:3003295|Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones|MEG_3180|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.06024%,0.419277
>393|N538D|ARO:3003459|Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones|MEG_3243|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,7.08215%,1.04958
>394|N510D|ARO:3003459|Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones|MEG_3243|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.94901%,0.389518
>395|E540V|ARO:3003459|Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones|MEG_3243|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.25779%,0.0467422
>396|N538K|ARO:3003459|Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones|MEG_3243|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.94901%,0.405099
>397|E540D|ARO:3003459|Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones|MEG_3243|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.94901%,0.34136
>398|T539P|ARO:3003459|Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones|MEG_3243|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.94901%,0.375354
>399|V340L|ARO:3003459|Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones|MEG_3243|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.94901%,0.389518
>39|T82A|ARO:3003995|Clostridioides difficile gyrA conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1%,0.105
>3|D105E|ARO:3003818|Acinetobacter baumannii parC conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.74555%,0.452804
>400|D500H|ARO:3003459|Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones|MEG_3243|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.27479%,0.101983
>402|S94A|ARO:3003393|Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid|MEG_3429|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|INHA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.092%,1.42912
>404|I194T|ARO:3003393|Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid|MEG_3429|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|INHA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.092%,1.4023
>405|I47T|ARO:3003393|Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid|MEG_3429|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|INHA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.092%,1.57088
>407|I95P|ARO:3003393|Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid|MEG_3429|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|INHA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.092%,1
>408|G141E|ARO:3003393|Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid|MEG_3429|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|INHA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.092%,1.40996
>40|D81N|ARO:3003995|Clostridioides difficile gyrA conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.375%,0.02125
>410|V78A|ARO:3003393|Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid|MEG_3429|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|INHA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.092%,1.17625
>412|S501W|ARO:3003448|Mycobacterium tuberculosis iniA mutant conferring resistance to Ethambutol|MEG_3430|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol-resistant_mutant|INIA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.64557%,0.623418
>413|G308R|ARO:3003448|Mycobacterium tuberculosis iniA mutant conferring resistance to Ethambutol|MEG_3430|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol-resistant_mutant|INIA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.64557%,0.593354
>414|R537H|ARO:3003448|Mycobacterium tuberculosis iniA mutant conferring resistance to Ethambutol|MEG_3430|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol-resistant_mutant|INIA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.64557%,0.653481
>415|A47T|ARO:3004135|Mycobacterium tuberculosis iniB with mutation conferring resistance to ethambutol|MEG_3431|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol-resistant_mutant|INIB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.9172%,0.895966
>416|W83G|ARO:3003451|Mycobacterium tuberculosis iniC mutant conferring resistance to ethambutol|MEG_3432|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol-resistant_mutant|INIC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.65979%,0.686598
>417|P248A|ARO:3003451|Mycobacterium tuberculosis iniC mutant conferring resistance to ethambutol|MEG_3432|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol-resistant_mutant|INIC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.65979%,0.550515
>418|C117D|ARO:3003784|Mycobacterium tuberculosis intrinsic murA conferring resistance to fosfomycin|MEG_4096|Drugs|Fosfomycin|Fosfomycin_target_mutation|MURA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.2439%,0.85122
>419|R121K|ARO:3003463|Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid|MEG_3445|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KASA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.2941%,0.607843
>41|R90K|ARO:3003995|Clostridioides difficile gyrA conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.75%,0.0175
>420|G387D|ARO:3003463|Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid|MEG_3445|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KASA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.2941%,0.92402
>421|D66N|ARO:3003463|Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid|MEG_3445|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KASA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.2941%,0.754902
>423|G269S|ARO:3003463|Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid|MEG_3445|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KASA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.2941%,0.781863
>424|G312S|ARO:3003463|Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid|MEG_3445|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KASA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.2941%,0.781863
>425|R418L|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.318306
>426|W328F|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.525956
>427|W321F|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.420765
>428|T275V|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.423497
>429|M255Y|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.3224%,0.023224
>42|D103N|ARO:3003995|Clostridioides difficile gyrA conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.125%,0.04125
>430|M255I|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,7.10383%,0.403005
>431|M255C|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.23497%,0.068306
>432|W107F|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.639344
>433|V473N|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.401639
>434|V473G|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.06011%,0.621585
>435|V473Y|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.565574
>436|V473W|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.491803
>437|V473F|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.474044
>438|V473S|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.599727
>439|V473M|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.5
>43|Q123K|ARO:3003995|Clostridioides difficile gyrA conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.5%,0.1775
>440|V473R|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.452186
>441|V473K|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.554645
>442|V473I|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.288251
>443|V473D|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.333333
>444|L472I|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.403005
>445|L472Q|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.504098
>446|L472K|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.52459
>447|Q471H|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.01093%,0.519126
>448|Q471Y|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.377049
>449|L436G|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.45902%,0.0245902
>44|P116A|ARO:3003995|Clostridioides difficile gyrA conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.625%,0.3275
>450|T435R|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.586066
>451|L430V|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.285519
>452|L427I|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.430328
>453|D311S|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.550546
>454|D311N|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.63388
>455|S303C|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.357923
>456|S303L|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.234973
>457|S315I|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.321038
>458|M126I|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.46448%,0.155738
>459|S315N|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.534153
>45|A92E|ARO:3003995|Clostridioides difficile gyrA conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.75%,0.0275
>460|A234G|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,11.8852%,3.01913
>461|V68G|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.389344
>462|P131Q|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.484973
>463|R128Q|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.424863
>464|L101P|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,7.10383%,0.468579
>465|R463L|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.684426
>466|W91R|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,7.9235%,0.346995
>467|P131R|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.87432%,0.0928962
>468|A350S|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.367486
>469|Y337C|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.434426
>46|A118S|ARO:3003995|Clostridioides difficile gyrA conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.5%,0.18
>470|W328G|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.381148
>471|T275P|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.325137
>472|T262R|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.454918
>473|W300G|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.364754
>474|Y229F|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.96175%,0.0696721
>475|N138S|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.273224%,0.00273224
>476|N138D|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.178962
>477|H108Q|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.55738%,0.394809
>478|H108E|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.396175
>479|W107R|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.35929
>47|L345I|ARO:3003995|Clostridioides difficile gyrA conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.25%,0.41375
>480|R104L|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.515027
>481|G33V|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.547814
>482|G111S|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.14754%,0.234973
>483|H417Q|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.125683
>484|E607A|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.424863
>485|Q461P|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.318306
>486|G125S|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.23497%,0.0478142
>487|N508D|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.441257
>488|L147P|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.819672%,0.00819672
>489|N660D|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.352459
>48|D409N|ARO:3004562|Clostridioides difficile gyrB conferring resistance to fluoroquinolones|MEG_3241|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.67727%,0.399046
>490|A312P|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.45082
>491|S383P|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.613388
>492|H97R|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.01093%,0.463115
>493|R489S|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.69399%,0.385246
>494|M420T|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.60109%,0.13388
>495|D387H|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.326503
>496|G123E|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.60109%,0.151639
>497|G299S|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.01093%,0.508197
>498|D419H|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.60109%,0.150273
>499|M176T|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.599727
>49|R457T|ARO:3004562|Clostridioides difficile gyrB conferring resistance to fluoroquinolones|MEG_3241|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.67727%,0.432432
>4|S84L|ARO:3003818|Acinetobacter baumannii parC conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|Acinetobacter_baumannii|WP_000202259.1|84|parC_S84L|QUINOLONE|QUINOLONE|Acinetobacter_baumannii_quinolone_resistant_ParC|wt_coherence=TRUE,3.28317%,0.192886
>500|R632C|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.551913
>501|D542H|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.394809
>502|Y64S|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.446721
>503|Y95C|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.222678
>504|P131T|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.281421
>506|D142G|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.68306%,0.0068306
>507|A162V|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.54235
>508|G269D|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.336066
>509|T306P|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.55738%,0.607923
>50|D465Y|ARO:3004562|Clostridioides difficile gyrB conferring resistance to fluoroquinolones|MEG_3241|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.67727%,0.5469
>510|R385W|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.55738%,0.602459
>511|D387G|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.8306%,0.653005
>512|T394M|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.494536
>513|Q439P|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.77596%,0.0177596
>514|F483L|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.453552
>515|A541D|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.539617
>516|G32D|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.258197
>517|V47E|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.28415%,0.387978
>518|D194G|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.498634
>519|A256T|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.37158%,0.105191
>51|R447L|ARO:3004562|Clostridioides difficile gyrB conferring resistance to fluoroquinolones|MEG_3241|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.67727%,0.559618
>520|T667P|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.465847
>521|M624V|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.504098
>522|A716P|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.370219
>523|I335T|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.42077%,0.45082
>524|Q127P|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.398907
>525|Q352E|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.510929
>526|Y98C|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,7.10383%,0.321038
>527|A379T|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.336066
>528|G269R|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.379781
>529|A431V|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.74317%,2.76639
>52|E467V|ARO:3004562|Clostridioides difficile gyrB conferring resistance to fluoroquinolones|MEG_3241|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.67727%,0.483307
>530|D194Y|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.513661
>532|A93T|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.418033
>533|D37E|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.34153
>534|A110V|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.497268
>535|A139V|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.59563%,0.0259563
>536|G299W|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.577869
>537|H276M|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.471311
>538|Q295H|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.87432%,0.39071
>53|S416A|ARO:3004562|Clostridioides difficile gyrB conferring resistance to fluoroquinolones|MEG_3241|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.67727%,0.5469
>541|Q224E|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.173497
>542|A243S|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.86885%,0.0314208
>543|A550D|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.420765
>545|S140N|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.82514%,0.0464481
>546|G279D|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.523224
>547|G285D|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.393443
>548|G316D|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.87432%,0.286885
>549|S457I|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.14754%,0.546448
>54|D426V|ARO:3004562|Clostridioides difficile gyrB conferring resistance to fluoroquinolones|MEG_3241|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.99523%,0.553259
>550|G593D|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.519126
>551|D63E|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.377049
>552|N133T|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.270492
>553|P232S|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.19126%,0.0587432
>554|Q127E|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.400273
>556|G629S|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.36612
>557|L587M|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.7377%,0.562842
>559|S315R|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.01093%,0.698087
>55|R447K|ARO:3004562|Clostridioides difficile gyrB conferring resistance to fluoroquinolones|MEG_3241|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.67727%,0.443561
>560|S315G|ARO:3003392|Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid|MEG_3446|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|KATG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,7.51366%,0.491803
>561|A264V|ARO:3005102|Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.28415%,0.512295
>563|F355S|ARO:3005108|Mycobacterium tuberculosis mshA mutations conferring resistance to prothionamide|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.89831%,0.597458
>564|H285Y|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.23573%,0.207182
>565|R738Q|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.8674%,0.287293
>566|V287F|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.3407%,0.719153
>567|G288W|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.59116%,0.475138
>568|G288V|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.14365%,0.164825
>569|Y296H|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.77532%,0.307551
>56|E467K|ARO:3004562|Clostridioides difficile gyrB conferring resistance to fluoroquinolones|MEG_3241|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.67727%,0.561208
>570|Y296S|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.8674%,0.54512
>571|I297L|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.8674%,0.822284
>572|I297T|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.8674%,0.815838
>573|M300R|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.39411%,0.0561694
>574|R302G|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.77532%,0.0709024
>575|V303G|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.97238%,0.155617
>576|S244T|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.8674%,0.61326
>577|V981L|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.48619%,0.053407
>578|T270I|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.8011%,0.55709
>579|P398S|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.8674%,0.258748
>57|S366V|ARO:3004562|Clostridioides difficile gyrB conferring resistance to fluoroquinolones|MEG_3241|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.67727%,0.344992
>580|Q491R|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.8674%,0.358195
>581|L502P|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.8674%,0.280847
>582|G308D|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.24862%,0.276243
>583|N394D|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.8674%,0.333333
>584|Y309N|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.41989%,0.103131
>585|M310K|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.78821%,0.144567
>586|Y327N|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.31492%,0.282689
>587|W326R|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.8674%,0.794659
>588|A247P|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.3407%,0.677716
>589|L251R|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.8674%,0.0764273
>58|K444F|ARO:3004562|Clostridioides difficile gyrB conferring resistance to fluoroquinolones|MEG_3241|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.67727%,0.502385
>590|G325S|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.41989%,0.325967
>591|A254G|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.41989%,0.12523
>592|A307T|ARO:3003327|Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol|MEG_2712|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.407%,0.25046
>593|L50V|ARO:3003461|Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid|MEG_4130|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|NDH|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.23077%,0.745055
>594|G339A|ARO:3003461|Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid|MEG_4130|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|NDH|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.23077%,0.501099
>596|G313R|ARO:3003461|Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid|MEG_4130|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|NDH|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,12.7473%,1.2967
>597|A300P|ARO:3003461|Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid|MEG_4130|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|NDH|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.23077%,0.782418
>598|R268H|ARO:3003461|Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid|MEG_4130|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|NDH|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.23077%,0.615385
>599|T110A|ARO:3003461|Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid|MEG_4130|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|NDH|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.23077%,0.767033
>59|S464T|ARO:3004562|Clostridioides difficile gyrB conferring resistance to fluoroquinolones|MEG_3241|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.67727%,0.534181
>5|V104I|ARO:3003818|Acinetobacter baumannii parC conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.74555%,0.451436
>603|T47S|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,28.6517%,2.20787
>604|D49V|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.70787
>605|S66P|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,2.25281
>606|K96E|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,25.8427%,1.58427
>607|A102T|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,2.09551
>608|A102V|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.58989
>609|L116R|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,28.0899%,2.26966
>60|I139R|ARO:3004562|Clostridioides difficile gyrB conferring resistance to fluoroquinolones|MEG_3241|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.10811%,0.759936
>610|V125D|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.28652
>611|I133T|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,28.0899%,2.0618
>612|Q141P|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,24.7191%,1.77528
>613|R154G|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,26.9663%,1.54494
>614|T160P|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.62921
>615|A161P|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,2.18539
>618|H51Q|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,35.3933%,1.81461
>61|V130I|ARO:3004562|Clostridioides difficile gyrB conferring resistance to fluoroquinolones|MEG_3241|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.81558%,0.0858506
>620|H57D|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,31.4607%,1.51124
>621|W68L|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.75281
>622|V139A|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,24.1573%,1.46067
>623|R121P|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.12921
>624|H137R|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,2.05618
>625|W119R|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,26.9663%,2.3427
>626|F94P|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.72472
>627|T76P|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,32.0225%,2.12921
>629|S104C|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.89326
>62|V423F|ARO:3004562|Clostridioides difficile gyrB conferring resistance to fluoroquinolones|MEG_3241|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.10811%,0.887122
>630|I90S|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.61236
>637|C14R|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.68539%,0.0168539
>638|C14Y|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.49438%,0.0449438
>63|D426N|ARO:3004562|Clostridioides difficile gyrB conferring resistance to fluoroquinolones|MEG_3241|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.67727%,0.597774
>640|V45G|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,25.8427%,1.62921
>641|A46E|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.97753
>642|D49A|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,25.2809%,2.6573
>643|F58L|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,41.0112%,2.67416
>644|Y68D|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.66854
>645|S67P|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.38202
>646|W68R|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,32.5843%,2.12921
>647|W68G|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.95506
>648|W68S|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.73596
>649|T76I|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.81461
>64|S366A|ARO:3004562|Clostridioides difficile gyrB conferring resistance to fluoroquinolones|MEG_3241|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.67727%,0.408585
>650|G78D|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.86517
>651|L85R|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.83146
>652|K96Q|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,24.7191%,2.04494
>653|Y103H|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.43258
>654|Y103S|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.76966
>655|T135P|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.92135
>656|D136N|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,27.5281%,2.04494
>657|D136Y|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.83146
>658|V139M|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.76966
>659|A146T|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,27.5281%,2.02247
>65|R377G|ARO:3004562|Clostridioides difficile gyrB conferring resistance to fluoroquinolones|MEG_3241|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.67727%,0.445151
>660|V155G|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.42697
>661|L159R|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,24.7191%,2.20225
>662|L172P|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,13.4831%,0.134831
>666|H51Y|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,25.2809%,1.14045
>667|P62H|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,33.1461%,3.07865
>669|D136H|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.77528
>66|R388P|ARO:3004562|Clostridioides difficile gyrB conferring resistance to fluoroquinolones|MEG_3241|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.67727%,0.667727
>671|L27P|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.8427
>672|P54L|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,25.8427%,1.39888
>673|C72W|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,32.5843%,2.00562
>675|H59D|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,2.09551
>676|A46V|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,25.2809%,2.10112
>677|D53A|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,29.7753%,3.19101
>678|H71E|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,28.6517%,1.76404
>679|H82R|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,2.08427
>67|E399K|ARO:3004562|Clostridioides difficile gyrB conferring resistance to fluoroquinolones|MEG_3241|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.67727%,0.572337
>680|G97S|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.3764
>681|A134V|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.80899
>682|C138S|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,24.1573%,2.01124
>683|T168N|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.17978%,0.0617978
>684|T47P|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,2.1236
>685|Y34S|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,2.19663
>686|G17D|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.80899%,0.0280899
>687|P54T|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.8427
>688|A140S|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,42.1348%,2.01685
>689|T47A|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,2.11798
>68|P107L|ARO:3004561|Clostridioides difficile murG with mutation conferring resistance to vancomycin|MEG_4097|Drugs|Glycopeptides|Vancomycin-resistant_mutation|MURG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,11.9658%,0.837607
>690|D12E|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,13.4831%,0.134831
>691|W68C|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,2.24157
>692|T142M|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,2.23034
>694|V139L|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,29.7753%,2.24719
>695|C138Y|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,33.7079%,1.83708
>696|H137P|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.51685
>697|G132S|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,2.28652
>698|N118T|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,28.0899%,1.32022
>699|K96N|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,24.1573%,1.54494
>69|D492N|ARO:3004563|Clostridioides difficile rpoB with mutation conferring resistance to rifampicin|MEG_6095|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.72771%,0.332253
>6|Y151V|ARO:3004049|Escherichia coli fabG mutations conferring resistance to triclosan|MEG_2873|Biocides|Phenolic_compound_resistance|Triclosan-resistant_mutation|FABG|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,17.7966%,1.91102
>700|L85P|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,24.7191%,1.82022
>701|C72R|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,32.0225%,1.57865
>702|P69R|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,25.2809%,2.19101
>703|Y41H|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.51124
>704|A26G|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,2.25843
>706|Q10R|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.8539%,0.179775
>70|H502Y|ARO:3004563|Clostridioides difficile rpoB with mutation conferring resistance to rifampicin|MEG_6095|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.91734%,0.0388979
>711|L72P|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.60112
>712|A161G|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.61798
>713|V157G|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,25.8427%,3.16292
>714|R157W|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.51685
>715|T100P|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,24.7191%,1.91573
>716|R140G|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,25.2809%,2.47753
>717|C138W|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,33.1461%,1.64607
>718|K96M|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,23.5955%,1.35393
>71|H502L|ARO:3004563|Clostridioides difficile rpoB with mutation conferring resistance to rifampicin|MEG_6095|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.24149%,0.0680713
>720|H57Q|ARO:3003394|Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide|MEG_5803|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|PNCA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,29.7753%,2.30899
>724|S531L|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.11684%,0.0154639
>725|N518T|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.46048%,0.0171821
>727|K527N|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.0816151
>728|R528H|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.429553%,0.00429553
>729|S512R|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.37457%,0.016323
>72|P496S|ARO:3004563|Clostridioides difficile rpoB with mutation conferring resistance to rifampicin|MEG_6095|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.99838%,0.0567261
>730|L521M|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.773196%,0.0103093
>732|F505L|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.0378%,0.0962199
>733|S574L|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.258591
>735|G507D|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.43643%,0.0627148
>736|T508P|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.601375%,0.00859107
>737|T508A|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.687285%,0.00687285
>738|T508H|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.0704467
>73|S498T|ARO:3004563|Clostridioides difficile rpoB with mutation conferring resistance to rifampicin|MEG_6095|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.78282%,0.0923825
>740|Q513E|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.83505%,0.0335052
>741|S456W|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.246564
>742|D515H|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.54639%,0.0154639
>744|G523A|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.09278%,0.0352234
>745|H526F|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.28866%,0.0128866
>746|H526Q|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.14777%,0.0429553
>748|S531C|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.03093%,0.0103093
>749|S512T|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.06186%,0.0292096
>74|S488P|ARO:3004563|Clostridioides difficile rpoB with mutation conferring resistance to rifampicin|MEG_6095|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.45867%,0.0162075
>750|L511R|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,7.04467%,8.92268
>751|S512I|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.945017%,0.00945017
>753|R529Q|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.601375%,0.00601375
>754|H526T|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.35739%,0.748282
>756|L525S|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.09278%,0.0395189
>757|Q517L|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.57732%,0.0352234
>758|S509Q|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.09278%,0.0541237
>759|S509R|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.71821%,0.024055
>75|H502N|ARO:3004563|Clostridioides difficile rpoB with mutation conferring resistance to rifampicin|MEG_6095|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.75527%,0.0988655
>760|E672D|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.2689
>762|L511V|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.46048%,0.0154639
>763|L533P|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.84192%,0.0979381
>764|T508N|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.37457%,0.0197595
>765|S512N|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.86598%,0.0678694
>768|S531G|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.89003%,0.0189003
>769|H526D|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.35052%,0.04811
>76|R505K|ARO:3004563|Clostridioides difficile rpoB with mutation conferring resistance to rifampicin|MEG_6095|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.45867%,0.0372771
>770|H526S|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.83505%,0.0549828
>771|K527Q|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.257732%,0.00257732
>772|D515T|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.257732%,0.00257732
>773|D515Y|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.6323%,0.0171821
>774|M515I|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.17869%,0.0412371
>775|M515V|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.14777%,0.0283505
>776|L511P|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.78007%,0.36512
>777|I572F|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.370275
>778|S522L|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.28866%,0.0128866
>779|H526Y|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.71821%,0.0292096
>77|S488T|ARO:3004563|Clostridioides difficile rpoB with mutation conferring resistance to rifampicin|MEG_6095|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.32253%,0.0615883
>781|V176F|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.258591
>782|Q438K|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.341924
>783|L533R|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.06186%,0.0292096
>784|D441V|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.331615
>785|D441Y|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.227663
>786|S447Q|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.283505
>787|H451Y|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.237113
>788|H451C|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.31701
>789|H451D|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.213918
>78|S550Y|ARO:3004563|Clostridioides difficile rpoB with mutation conferring resistance to rifampicin|MEG_6095|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.8363%,0.0591572
>790|H451R|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.250859
>791|S456L|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.305842
>793|S450L|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.687285%,0.0987973
>794|H526L|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.20962%,0.0859107
>795|D515G|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.95189%,0.0987973
>796|D515N|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.74914%,0.0378007
>798|Q513L|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.43643%,0.04811
>799|V146F|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.276632
>79|Q1074R|ARO:3004563|Clostridioides difficile rpoB with mutation conferring resistance to rifampicin|MEG_6095|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.40357%,0.208266
>7|G93A|ARO:3004045|Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan|NA|NA|NA|NA|NA|NA|Escherichia|WP_000506490.1|93|fabI_G93A|ISONIAZID/TRICLOSAN|ISONIAZID/TRICLOSAN|Escherichia_isoniazid/triclosan_resistant_FabI|wt_coherence=TRUE,16.5354%,1.72441
>800|A381V|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.302405
>804|Q513P|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.773196%,0.00773196
>805|Q490H|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.323024
>806|E504A|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.46735%,0.0609966
>807|D518H|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.429553%,0.00429553
>808|Q513R|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.35052%,0.0506873
>809|H526P|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.687285%,0.00859107
>80|S550F|ARO:3004563|Clostridioides difficile rpoB with mutation conferring resistance to rifampicin|MEG_6095|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.07942%,0.0680713
>810|Q517H|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.6323%,0.0223368
>811|T508S|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.0378%,0.0841924
>812|L511M|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.0764605
>815|L538P|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.429553%,0.00429553
>816|L545M|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.515464%,0.00515464
>817|L571V|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.318729
>818|R633C|ARO:3003283|Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin|MEG_6090|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.60825%,0.353093
>819|D342N|ARO:3004721|Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide|MEG_6142|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|RPSA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.87949%,0.676533
>81|D492V|ARO:3004563|Clostridioides difficile rpoB with mutation conferring resistance to rifampicin|MEG_6095|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.40357%,0.103728
>820|D343N|ARO:3004721|Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide|MEG_6142|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|RPSA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.87949%,0.665962
>821|A344P|ARO:3004721|Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide|MEG_6142|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|RPSA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.87949%,0.877378
>822|I351F|ARO:3004721|Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide|MEG_6142|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|RPSA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.87949%,0.408034
>823|E325K|ARO:3004721|Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide|MEG_6142|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|RPSA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.87949%,0.693446
>824|G341R|ARO:3004721|Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide|MEG_6142|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|RPSA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.87949%,0.610994
>825|D123A|ARO:3004721|Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide|MEG_6142|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|RPSA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.87949%,0.84778
>826|S324F|ARO:3004721|Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide|MEG_6142|Drugs|Mycobacterium_tuberculosis-specific_Drug|Pyrazinamide-resistant_mutant|RPSA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.87949%,0.591966
>827|K88R|ARO:3003395|Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin|MEG_6144|Drugs|Aminoglycosides|Aminoglycoside-resistant_16S_ribosomal_subunit_protein|RPSL|RequiresSNPConfirmation|Campylobacter|WP_057042458.1|88|rpsL_K88R|AMINOGLYCOSIDE|STREPTOMYCIN|Campylobacter_streptomycin_resistant_RpsL|wt_coherence=TRUE,36.2069%,3.37069
>828|K43R|ARO:3003395|Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin|MEG_6144|Drugs|Aminoglycosides|Aminoglycoside-resistant_16S_ribosomal_subunit_protein|RPSL|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,15.5172%,0.913793
>829|T40I|ARO:3003395|Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin|MEG_6144|Drugs|Aminoglycosides|Aminoglycoside-resistant_16S_ribosomal_subunit_protein|RPSL|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,36.2069%,3.39655
>82|D245Y|ARO:3004681|Clostridioides difficile rpoC with mutation conferring resistance to vancomycin|MEG_6138|Drugs|Glycopeptides|Vancomycin-resistant_mutation|RPOC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.64267%,0.194276
>830|K88Q|ARO:3003395|Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin|MEG_6144|Drugs|Aminoglycosides|Aminoglycoside-resistant_16S_ribosomal_subunit_protein|RPSL|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.89655%,0.612069
>831|G91R|ARO:3004153|Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid|MEG_7250|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|THYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,17.6471%,1.07843
>832|T202A|ARO:3004153|Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid|MEG_7250|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|THYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,18.4314%,1.40784
>833|Y36C|ARO:3004153|Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid|MEG_7250|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|THYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.4706%,1.28627
>834|V77F|ARO:3004153|Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid|MEG_7250|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|THYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.4706%,1.4549
>835|W83C|ARO:3004153|Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid|MEG_7250|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|THYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.4706%,1.14118
>836|S105P|ARO:3004153|Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid|MEG_7250|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|THYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.4706%,1.65882
>837|R126Q|ARO:3004153|Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid|MEG_7250|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|THYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.4706%,1.0902
>838|F152V|ARO:3004153|Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid|MEG_7250|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|THYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.4706%,2.24706
>839|C161T|ARO:3004153|Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid|MEG_7250|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|THYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.4706%,1.10196
>83|D105G|ARO:3003974|Cutibacterium acnes gyrA conferring resistance to fluoroquinolones|MEG_3182|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.453001%,0.00453001
>840|H207R|ARO:3004153|Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid|MEG_7250|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|THYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.4706%,1.5098
>841|I211V|ARO:3004153|Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid|MEG_7250|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|THYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.4706%,1.41961
>842|P224L|ARO:3004153|Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid|MEG_7250|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|THYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.4706%,1.41961
>843|R235P|ARO:3004153|Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid|MEG_7250|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|THYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.4706%,1.69412
>845|H75N|ARO:3004153|Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid|MEG_7250|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|THYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.4706%,1.16863
>846|W101R|ARO:3004153|Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid|MEG_7250|Drugs|Mycobacterium_tuberculosis-specific_Drug|Para-aminosalicylic_acid_resistant_mutant|THYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.4706%,1.37255
>847|F185L|ARO:3003445|Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides|MEG_7258|Drugs|Aminoglycosides|Aminoglycoside-resistant_arabinosyltransferase|TLYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.1538%,1.60385
>848|E238K|ARO:3003445|Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides|MEG_7258|Drugs|Aminoglycosides|Aminoglycoside-resistant_arabinosyltransferase|TLYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.1538%,1.91154
>849|V128E|ARO:3003445|Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides|MEG_7258|Drugs|Aminoglycosides|Aminoglycoside-resistant_arabinosyltransferase|TLYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.1538%,1.05769
>84|S101L|ARO:3003974|Cutibacterium acnes gyrA conferring resistance to fluoroquinolones|MEG_3182|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.01925%,0.0101925
>850|A67E|ARO:3003445|Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides|MEG_7258|Drugs|Aminoglycosides|Aminoglycoside-resistant_arabinosyltransferase|TLYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.1538%,0.873077
>851|L150P|ARO:3003445|Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides|MEG_7258|Drugs|Aminoglycosides|Aminoglycoside-resistant_arabinosyltransferase|TLYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.1538%,0.934615
>852|A91E|ARO:3003445|Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides|MEG_7258|Drugs|Aminoglycosides|Aminoglycoside-resistant_arabinosyltransferase|TLYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.1538%,1.03846
>853|L118P|ARO:3003445|Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides|MEG_7258|Drugs|Aminoglycosides|Aminoglycoside-resistant_arabinosyltransferase|TLYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.1538%,1.26923
>854|P183L|ARO:3003445|Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides|MEG_7258|Drugs|Aminoglycosides|Aminoglycoside-resistant_arabinosyltransferase|TLYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.1538%,1.11538
>855|K69E|ARO:3003445|Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides|MEG_7258|Drugs|Aminoglycosides|Aminoglycoside-resistant_arabinosyltransferase|TLYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.1538%,1.40385
>857|N236K|ARO:3003445|Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides|MEG_7258|Drugs|Aminoglycosides|Aminoglycoside-resistant_arabinosyltransferase|TLYA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,16.1538%,1.32308
>858|Q998R|ARO:3003325|Mycobacterium tuberculosis variant bovis embB with mutation conferring resistance to ethambutol|MEG_2711|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.297248
>859|T610K|ARO:3003325|Mycobacterium tuberculosis variant bovis embB with mutation conferring resistance to ethambutol|MEG_2711|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.284404
>85|V241D|ARO:3003970|D-Ala-D-Ala ligase|MEG_7333|Drugs|Glycopeptides|VanA-type_resistance_protein|VAN|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,12.2449%,0.880466
>860|F1012S|ARO:3003325|Mycobacterium tuberculosis variant bovis embB with mutation conferring resistance to ethambutol|MEG_2711|Drugs|Mycobacterium_tuberculosis-specific_Drug|Ethambutol_resistant_arabinosyltransferase|EMBB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.85321%,0.277982
>861|R202W|ARO:3003779|Mycobacterium tuberculosis variant bovis ndh with mutation conferring resistance to isoniazid|MEG_4131|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|NDH|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.23077%,0.571429
>862|V329A|ARO:3003779|Mycobacterium tuberculosis variant bovis ndh with mutation conferring resistance to isoniazid|MEG_4131|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|NDH|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.95604%,0.0395604
>863|L239P|ARO:3003779|Mycobacterium tuberculosis variant bovis ndh with mutation conferring resistance to isoniazid|MEG_4131|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|NDH|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.23077%,0.773626
>864|D366G|ARO:3003779|Mycobacterium tuberculosis variant bovis ndh with mutation conferring resistance to isoniazid|MEG_4131|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|NDH|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.23077%,0.898901
>865|A91T|ARO:3003298|Mycobacterium leprae gyrA conferring resistance to fluoroquinolones|MEG_3181|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.38437%,0.258662
>866|A115T|ARO:3003778|Mycolicibacterium smegmatis ndh with mutation conferring resistance to isoniazid|MEG_4132|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|NDH|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.35412%,0.908686
>868|Y122N|ARO:3003778|Mycolicibacterium smegmatis ndh with mutation conferring resistance to isoniazid|MEG_4132|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|NDH|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.35412%,0.496659
>869|R145C|ARO:3003778|Mycolicibacterium smegmatis ndh with mutation conferring resistance to isoniazid|MEG_4132|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|NDH|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.35412%,0.714922
>86|D295G|ARO:3003970|D-Ala-D-Ala ligase|MEG_7333|Drugs|Glycopeptides|VanA-type_resistance_protein|VAN|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,12.2449%,1.06706
>870|F170S|ARO:3003778|Mycolicibacterium smegmatis ndh with mutation conferring resistance to isoniazid|MEG_4132|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|NDH|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.35412%,0.826281
>871|A187P|ARO:3003778|Mycolicibacterium smegmatis ndh with mutation conferring resistance to isoniazid|MEG_4132|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|NDH|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.35412%,0.69265
>872|V246A|ARO:3003778|Mycolicibacterium smegmatis ndh with mutation conferring resistance to isoniazid|MEG_4132|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|NDH|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.35412%,0.583519
>873|V272E|ARO:3003778|Mycolicibacterium smegmatis ndh with mutation conferring resistance to isoniazid|MEG_4132|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|NDH|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.35412%,0.634744
>874|V300G|ARO:3003778|Mycolicibacterium smegmatis ndh with mutation conferring resistance to isoniazid|MEG_4132|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|NDH|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.35412%,0.879733
>875|Q335H|ARO:3003778|Mycolicibacterium smegmatis ndh with mutation conferring resistance to isoniazid|MEG_4132|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|NDH|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.35412%,0.732739
>876|Y361H|ARO:3003778|Mycolicibacterium smegmatis ndh with mutation conferring resistance to isoniazid|MEG_4132|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|NDH|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.35412%,0.710468
>877|T29P|ARO:3003778|Mycolicibacterium smegmatis ndh with mutation conferring resistance to isoniazid|MEG_4132|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|NDH|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.35412%,0.641425
>878|H46P|ARO:3003778|Mycolicibacterium smegmatis ndh with mutation conferring resistance to isoniazid|MEG_4132|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|NDH|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.35412%,0.674833
>879|G84D|ARO:3003778|Mycolicibacterium smegmatis ndh with mutation conferring resistance to isoniazid|MEG_4132|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|NDH|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.35412%,0.605791
>87|P313L|ARO:3003970|D-Ala-D-Ala ligase|MEG_7333|Drugs|Glycopeptides|VanA-type_resistance_protein|VAN|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,12.2449%,1.04956
>880|L100P|ARO:3003778|Mycolicibacterium smegmatis ndh with mutation conferring resistance to isoniazid|MEG_4132|Drugs|Mycobacterium_tuberculosis-specific_Drug|Isoniazid-resistant_mutant|NDH|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.35412%,0.603563
>881|M95I|ARO:3004631|Mycoplasma genitalium gyrA mutation confers resistance to fluoroquinolones|MEG_3185|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.241546%,0.00483092
>882|G93C|ARO:3004631|Mycoplasma genitalium gyrA mutation confers resistance to fluoroquinolones|MEG_3185|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.62319%,0.0724638
>883|V103I|ARO:3004630|Mycoplasma genitalium parC mutations confers resistance to Moxifloxacin|MEG_5331|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.43338%,0.301423
>884|D87N|ARO:3004630|Mycoplasma genitalium parC mutations confers resistance to Moxifloxacin|MEG_5331|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.23415%,0.0517464
>885|D87H|ARO:3004630|Mycoplasma genitalium parC mutations confers resistance to Moxifloxacin|MEG_5331|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.55239%,0.0918499
>886|A67S|ARO:3004630|Mycoplasma genitalium parC mutations confers resistance to Moxifloxacin|MEG_5331|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.62225%,0.0401035
>887|P62S|ARO:3004630|Mycoplasma genitalium parC mutations confers resistance to Moxifloxacin|MEG_5331|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.04528%,0.0905563
>888|D87Y|ARO:3004630|Mycoplasma genitalium parC mutations confers resistance to Moxifloxacin|MEG_5331|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.32859%,0.0633894
>889|D87G|ARO:3004630|Mycoplasma genitalium parC mutations confers resistance to Moxifloxacin|MEG_5331|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.905563%,0.0181113
>890|S83N|ARO:3004630|Mycoplasma genitalium parC mutations confers resistance to Moxifloxacin|MEG_5331|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.32859%,0.0362225
>891|A119V|ARO:3004630|Mycoplasma genitalium parC mutations confers resistance to Moxifloxacin|MEG_5331|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.43338%,0.379043
>892|A67T|ARO:3004630|Mycoplasma genitalium parC mutations confers resistance to Moxifloxacin|MEG_5331|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.32859%,0.0245796
>893|G81C|ARO:3004630|Mycoplasma genitalium parC mutations confers resistance to Moxifloxacin|MEG_5331|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.10479%,0.0491591
>894|D82N|ARO:3004630|Mycoplasma genitalium parC mutations confers resistance to Moxifloxacin|MEG_5331|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.84605%,0.0504528
>895|S83R|ARO:3004630|Mycoplasma genitalium parC mutations confers resistance to Moxifloxacin|MEG_5331|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.58732%,0.0698577
>896|S83I|ARO:3004630|Mycoplasma genitalium parC mutations confers resistance to Moxifloxacin|MEG_5331|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.258732%,0.00388098
>897|S91I|ARO:3003310|Mycoplasma hominis parC conferring resistance to fluoroquinolones|MEG_5330|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,0.540541%,0.027027
>898|K149R|ARO:3003310|Mycoplasma hominis parC conferring resistance to fluoroquinolones|MEG_5330|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.54054%,0.326486
>899|R229S|ARO:3004873|Neisseria gonorrhoeae folP with mutation conferring resistance to sulfonamides|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,15.2174%,1.48913
>89|G98R|ARO:3003970|D-Ala-D-Ala ligase|MEG_7333|Drugs|Glycopeptides|VanA-type_resistance_protein|VAN|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,12.2449%,0.71137
>8|G93S|ARO:3004045|Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan|NA|NA|NA|NA|NA|NA|Escherichia|WP_000506490.1|93|fabI_G93S|ISONIAZID/TRICLOSAN|ISONIAZID/TRICLOSAN|Escherichia_isoniazid/triclosan_resistant_FabI|wt_coherence=TRUE,16.5354%,0.685039
>900|D95G|ARO:3003928|Neisseria gonorrhoeae gyrA conferring resistance to fluoroquinolones|MEG_3177|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.43172%,0.0980176
>901|S91F|ARO:3003928|Neisseria gonorrhoeae gyrA conferring resistance to fluoroquinolones|MEG_3177|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.21145%,0.061674
>902|D95N|ARO:3003928|Neisseria gonorrhoeae gyrA conferring resistance to fluoroquinolones|MEG_3177|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.20264%,0.0914097
>903|K450T|ARO:3004859|Neisseria gonorrhoeae gyrB conferring resistance to zoliflodacin|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.71066%,0.517766
>904|K450N|ARO:3004859|Neisseria gonorrhoeae gyrB conferring resistance to zoliflodacin|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.32995%,0.343909
>905|D429N|ARO:3004859|Neisseria gonorrhoeae gyrB conferring resistance to zoliflodacin|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,2.03046%,0.0215736
>906|A121D|ARO:3000464|Neisseria gonorrhoeae porin PIB (por)|MEG_5808|Drugs|Multi-drug_resistance|MDR_mutant_porin_proteins|POR|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,12.3529%,0.797059
>907|G120K|ARO:3000464|Neisseria gonorrhoeae porin PIB (por)|MEG_5808|Drugs|Multi-drug_resistance|MDR_mutant_porin_proteins|POR|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,12.3529%,1.09118
>908|G120D|ARO:3000464|Neisseria gonorrhoeae porin PIB (por)|MEG_5808|Drugs|Multi-drug_resistance|MDR_mutant_porin_proteins|POR|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,12.3529%,1.12353
>909|S87R|ARO:3003929|Neisseria gonorrhoeae parC conferring resistance to fluoroquinolones|MEG_5326|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.55731%,0.0355731
>90|T450I|ARO:3003761|eatAv|MEG_2694|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|EATAV|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.53659%,0.697154
>910|E91G|ARO:3003929|Neisseria gonorrhoeae parC conferring resistance to fluoroquinolones|MEG_5326|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.08432%,0.0685112
>911|P551L|ARO:3004832|Neisseria gonorrhoeae PBP2 conferring resistance to beta-lactam antibiotics|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,7.32984%,0.720768
>912|A516G|ARO:3004832|Neisseria gonorrhoeae PBP2 conferring resistance to beta-lactam antibiotics|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.42408%,0.635253
>913|A311V|ARO:3004832|Neisseria gonorrhoeae PBP2 conferring resistance to beta-lactam antibiotics|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,7.32984%,0.755672
>914|V316P|ARO:3004832|Neisseria gonorrhoeae PBP2 conferring resistance to beta-lactam antibiotics|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,7.32984%,0.591623
>915|T483S|ARO:3004832|Neisseria gonorrhoeae PBP2 conferring resistance to beta-lactam antibiotics|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,8.726%,0.797557
>916|P551S|ARO:3004832|Neisseria gonorrhoeae PBP2 conferring resistance to beta-lactam antibiotics|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,7.32984%,0.39267
>917|A501T|ARO:3004832|Neisseria gonorrhoeae PBP2 conferring resistance to beta-lactam antibiotics|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,7.32984%,0.535777
>918|A501V|ARO:3004832|Neisseria gonorrhoeae PBP2 conferring resistance to beta-lactam antibiotics|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,7.32984%,0.361257
>919|G542S|ARO:3004832|Neisseria gonorrhoeae PBP2 conferring resistance to beta-lactam antibiotics|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,7.32984%,0.612565
>91|H215R|ARO:3003760|Enterococcus faecalis cls with mutation conferring resistance to daptomycin|MEG_1731|Drugs|Lipopeptides|Daptomycin-resistant_mutant|CLS|RequiresSNPConfirmation|Enterococcus_faecalis|WP_002413481.1|215|cls_H215R|LIPOPEPTIDE|DAPTOMYCIN|Enterococcus_faecalis_daptomycin_resistant_Cls|wt_coherence=TRUE,7.82241%,0.274841
>920|F504L|ARO:3004832|Neisseria gonorrhoeae PBP2 conferring resistance to beta-lactam antibiotics|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.1082%,0.120419
>921|A510V|ARO:3004832|Neisseria gonorrhoeae PBP2 conferring resistance to beta-lactam antibiotics|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.58464%,0.078534
>922|A501P|ARO:3004832|Neisseria gonorrhoeae PBP2 conferring resistance to beta-lactam antibiotics|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.24956%,0.743455
>923|A39T|ARO:3004851|Neisseria gonorrhoeae mtrR with mutation conferring resistance|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,20.7921%,1.47525
>924|L421P|ARO:3004833|Neisseria gonorrhoeae PBP1 conferring resistance to beta-lactam|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.31646%,0.378481
>925|E666K|ARO:3004835|Neisseria gonorrhoeae pilQ gene conferring resistance to beta-lactam|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.80913%,0.351314
>926|I312M|ARO:3003937|Neisseria meningititis PBP2 conferring resistance to beta-lactam|MEG_5401|Drugs|betalactams|Penicillin_binding_protein|PBP2|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,7.32984%,0.369983
>927|G482S|ARO:3003937|Neisseria meningititis PBP2 conferring resistance to beta-lactam|MEG_5401|Drugs|betalactams|Penicillin_binding_protein|PBP2|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,7.32984%,0.294939
>928|F504L|ARO:3003937|Neisseria meningititis PBP2 conferring resistance to beta-lactam|MEG_5401|Drugs|betalactams|Penicillin_binding_protein|PBP2|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,7.32984%,0.678883
>929|A510V|ARO:3003937|Neisseria meningititis PBP2 conferring resistance to beta-lactam|MEG_5401|Drugs|betalactams|Penicillin_binding_protein|PBP2|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,7.32984%,0.774869
>92|R267H|ARO:3003760|Enterococcus faecalis cls with mutation conferring resistance to daptomycin|MEG_1731|Drugs|Lipopeptides|Daptomycin-resistant_mutant|CLS|RequiresSNPConfirmation|Enterococcus_faecalis|WP_002413481.1|267|cls_R267H|LIPOPEPTIDE|DAPTOMYCIN|Enterococcus_faecalis_daptomycin_resistant_Cls|wt_coherence=TRUE,8.87949%,0.805497
>930|V316T|ARO:3003937|Neisseria meningititis PBP2 conferring resistance to beta-lactam|MEG_5401|Drugs|betalactams|Penicillin_binding_protein|PBP2|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,7.32984%,0.411867
>931|N512Y|ARO:3003937|Neisseria meningititis PBP2 conferring resistance to beta-lactam|MEG_5401|Drugs|betalactams|Penicillin_binding_protein|PBP2|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,7.32984%,0.556719
>932|G545S|ARO:3003937|Neisseria meningititis PBP2 conferring resistance to beta-lactam|MEG_5401|Drugs|betalactams|Penicillin_binding_protein|PBP2|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,7.32984%,0.687609
>933|A501P|ARO:3003937|Neisseria meningititis PBP2 conferring resistance to beta-lactam|MEG_5401|Drugs|betalactams|Penicillin_binding_protein|PBP2|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.75916%,0.30541
>934|G261S|ARO:3003361|Planobispora rosea EF-Tu mutants conferring resistance to inhibitor GE2270A|MEG_7305|Drugs|Elfamycins|EF-Tu_inhibition|TUFAB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.7969%,0.550129
>935|V295C|ARO:3003361|Planobispora rosea EF-Tu mutants conferring resistance to inhibitor GE2270A|MEG_7305|Drugs|Elfamycins|EF-Tu_inhibition|TUFAB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.7969%,1.07969
>936|G279A|ARO:3003361|Planobispora rosea EF-Tu mutants conferring resistance to inhibitor GE2270A|MEG_7305|Drugs|Elfamycins|EF-Tu_inhibition|TUFAB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.7969%,0.992288
>937|V278A|ARO:3003361|Planobispora rosea EF-Tu mutants conferring resistance to inhibitor GE2270A|MEG_7305|Drugs|Elfamycins|EF-Tu_inhibition|TUFAB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,10.7969%,0.88946
>938|S80L|ARO:3003702|Pseudomonas aeruginosa gyrA and parC conferring resistance to fluoroquinolones|MEG_5325|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.63003%,0.273458
>939|H80R|ARO:3003684|Pseudomonas aeruginosa gyrA conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.91803%,0.395628
>93|R218Q|ARO:3003760|Enterococcus faecalis cls with mutation conferring resistance to daptomycin|MEG_1731|Drugs|Lipopeptides|Daptomycin-resistant_mutant|CLS|RequiresSNPConfirmation|Enterococcus_faecalis|WP_002413481.1|218|cls_R218Q|LIPOPEPTIDE|DAPTOMYCIN|Enterococcus_faecalis_daptomycin_resistant_Cls|wt_coherence=TRUE,1.90275%,0.131078
>941|D87N|ARO:3003684|Pseudomonas aeruginosa gyrA conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,3.49727%,0.063388
>942|R154A|ARO:3003390|Escherichia coli ompF with mutation conferring resistance to beta-lactam antibiotics|MEG_4289|Drugs|betalactams|Mutant_porin_proteins|OMPFB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,11.8644%,1.44633
>943|G141D|ARO:3003390|Escherichia coli ompF with mutation conferring resistance to beta-lactam antibiotics|MEG_4289|Drugs|betalactams|Mutant_porin_proteins|OMPFB|RequiresSNPConfirmation|Escherichia|WP_000977920.1|141|ompF_G141D|FOSFOMYCIN|FOSFOMYCIN|Escherichia_fosfomycin_resistant_OmpF|wt_coherence=TRUE,11.8644%,0.596045
>944|G141E|ARO:3003390|Escherichia coli ompF with mutation conferring resistance to beta-lactam antibiotics|MEG_4289|Drugs|betalactams|Mutant_porin_proteins|OMPFB|RequiresSNPConfirmation|Escherichia|WP_000977920.1|141|ompF_G141E|FOSFOMYCIN|FOSFOMYCIN|Escherichia_fosfomycin_resistant_OmpF|wt_coherence=TRUE,11.8644%,0.841808
>945|R154D|ARO:3003390|Escherichia coli ompF with mutation conferring resistance to beta-lactam antibiotics|MEG_4289|Drugs|betalactams|Mutant_porin_proteins|OMPFB|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,11.8644%,1.27684
>946|Q142X|ARO:3003686|Pseudomonas aeruginosa oprD with mutation conferring resistance to imipenem|MEG_4296|Drugs|betalactams|Mutant_porin_proteins|OPRD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.65517%,0.845977
>947|Q142X|ARO:3003686|Pseudomonas aeruginosa oprD with mutation conferring resistance to imipenem|MEG_4296|Drugs|betalactams|Mutant_porin_proteins|OPRD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.65517%,0.547126
>948|Q142X|ARO:3003686|Pseudomonas aeruginosa oprD with mutation conferring resistance to imipenem|MEG_4296|Drugs|betalactams|Mutant_porin_proteins|OPRD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.65517%,0.632184
>949|Q142X|ARO:3003686|Pseudomonas aeruginosa oprD with mutation conferring resistance to imipenem|MEG_4296|Drugs|betalactams|Mutant_porin_proteins|OPRD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.65517%,0.71954
>94|E554K|ARO:3003805|Enterococcus faecalis gshF with mutation conferring daptomycin resistance|MEG_3175|Drugs|Lipopeptides|Daptomycin-resistant_mutant|GSHF|RequiresSNPConfirmation|Enterococcus_faecalis|WP_002389492.1|554|gshF_E554K|LIPOPEPTIDE|DAPTOMYCIN|Enterococcus_faecalis_daptomycin_resistant_GshF|wt_coherence=TRUE,5.61497%,0.602941
>950|Q142X|ARO:3003686|Pseudomonas aeruginosa oprD with mutation conferring resistance to imipenem|MEG_4296|Drugs|betalactams|Mutant_porin_proteins|OPRD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.65517%,0.731034
>951|Q142X|ARO:3003686|Pseudomonas aeruginosa oprD with mutation conferring resistance to imipenem|MEG_4296|Drugs|betalactams|Mutant_porin_proteins|OPRD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.65517%,0.783908
>952|Q142X|ARO:3003686|Pseudomonas aeruginosa oprD with mutation conferring resistance to imipenem|MEG_4296|Drugs|betalactams|Mutant_porin_proteins|OPRD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.65517%,0.926437
>953|Q142X|ARO:3003686|Pseudomonas aeruginosa oprD with mutation conferring resistance to imipenem|MEG_4296|Drugs|betalactams|Mutant_porin_proteins|OPRD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.65517%,0.671264
>954|Q142X|ARO:3003686|Pseudomonas aeruginosa oprD with mutation conferring resistance to imipenem|MEG_4296|Drugs|betalactams|Mutant_porin_proteins|OPRD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.65517%,0.809195
>955|Q142X|ARO:3003686|Pseudomonas aeruginosa oprD with mutation conferring resistance to imipenem|MEG_4296|Drugs|betalactams|Mutant_porin_proteins|OPRD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.65517%,0.632184
>956|Q142X|ARO:3003686|Pseudomonas aeruginosa oprD with mutation conferring resistance to imipenem|MEG_4296|Drugs|betalactams|Mutant_porin_proteins|OPRD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.65517%,0.795402
>957|Q142X|ARO:3003686|Pseudomonas aeruginosa oprD with mutation conferring resistance to imipenem|MEG_4296|Drugs|betalactams|Mutant_porin_proteins|OPRD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.65517%,0.788506
>958|Q142X|ARO:3003686|Pseudomonas aeruginosa oprD with mutation conferring resistance to imipenem|MEG_4296|Drugs|betalactams|Mutant_porin_proteins|OPRD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.65517%,0.797701
>959|Q142X|ARO:3003686|Pseudomonas aeruginosa oprD with mutation conferring resistance to imipenem|MEG_4296|Drugs|betalactams|Mutant_porin_proteins|OPRD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.65517%,0.88046
>95|T194I|ARO:3003077|Enterococcus faecalis liaF mutant conferring daptomycin resistance|MEG_3588|Drugs|Lipopeptides|Daptomycin-resistant_mutant|LIAFSR|RequiresSNPConfirmation|Enterococcus_faecalis|WP_002381168.1|194|liaF_T194I|LIPOPEPTIDE|DAPTOMYCIN|Enterococcus_faecalis_daptomycin_resistant_LiaF|wt_coherence=TRUE,8.08511%,0.0978723
>960|Q142X|ARO:3003686|Pseudomonas aeruginosa oprD with mutation conferring resistance to imipenem|MEG_4296|Drugs|betalactams|Mutant_porin_proteins|OPRD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.65517%,0.813793
>961|Q142X|ARO:3003686|Pseudomonas aeruginosa oprD with mutation conferring resistance to imipenem|MEG_4296|Drugs|betalactams|Mutant_porin_proteins|OPRD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.65517%,0.990805
>962|Q142X|ARO:3003686|Pseudomonas aeruginosa oprD with mutation conferring resistance to imipenem|MEG_4296|Drugs|betalactams|Mutant_porin_proteins|OPRD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.65517%,0.82069
>963|Q142X|ARO:3003686|Pseudomonas aeruginosa oprD with mutation conferring resistance to imipenem|MEG_4296|Drugs|betalactams|Mutant_porin_proteins|OPRD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.65517%,0.91954
>964|Q142X|ARO:3003686|Pseudomonas aeruginosa oprD with mutation conferring resistance to imipenem|MEG_4296|Drugs|betalactams|Mutant_porin_proteins|OPRD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.65517%,0.694253
>965|Q142X|ARO:3003686|Pseudomonas aeruginosa oprD with mutation conferring resistance to imipenem|MEG_4296|Drugs|betalactams|Mutant_porin_proteins|OPRD|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.65517%,1.02759
>966|M437I|ARO:3003685|Pseudomonas aeruginosa parE conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,1.12721%,0.0128824
>967|A473V|ARO:3003685|Pseudomonas aeruginosa parE conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,6.76329%,0.391304
>968|A110V|ARO:3003895|Pseudomonas mutant PhoP conferring resistance to colistin|MEG_5784|Drugs|Lipopeptides|Colistin-resistant_mutant|PHOP|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.3548%,1.86175
>969|R117L|ARO:3003895|Pseudomonas mutant PhoP conferring resistance to colistin|MEG_5784|Drugs|Lipopeptides|Colistin-resistant_mutant|PHOP|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,19.3548%,1.43318
>970|K123Q|ARO:3003896|Pseudomonas mutant PhoQ conferring resistance to colistin|MEG_5785|Drugs|Lipopeptides|Colistin-resistant_mutant|PHOQ|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.54545%,0.975
>971|V260G|ARO:3003896|Pseudomonas mutant PhoQ conferring resistance to colistin|MEG_5785|Drugs|Lipopeptides|Colistin-resistant_mutant|PHOQ|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,9.54545%,0.909091
>972|G70D|ARO:3004956|Neisseria gonorrhoeae rpld|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,21.2121%,1.38384
>973|V57L|ARO:3003930|rpsJ|MEG_6143|Drugs|Tetracyclines|Tetracycline_resistance_ribosomal_protection_proteins|RPSJ|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,44.2105%,3.88421
>974|V57M|ARO:3003930|rpsJ|MEG_6143|Drugs|Tetracyclines|Tetracycline_resistance_ribosomal_protection_proteins|RPSJ|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,44.2105%,3.36842
>976|S97P|ARO:3003926|Salmonella enterica gyrA conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|Salmonella|WP_001281271.1|97|gyrA_S97P|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_GyrA|wt_coherence=TRUE,2.41379%,0.0287356
>977|D87N|ARO:3003926|Salmonella enterica gyrA conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|Salmonella|WP_001281271.1|87|gyrA_D87N|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_GyrA|wt_coherence=TRUE,2.06897%,0.0275862
>978|D87G|ARO:3004334|Salmonella enterica gyrA with mutation conferring resistance to triclosan|NA|NA|NA|NA|NA|NA|Salmonella|WP_001281271.1|87|gyrA_D87G|QUINOLONE/TRICLOSAN|QUINOLONE/TRICLOSAN|Salmonella_quinolone/triclosan_resistant_GyrA|wt_coherence=TRUE,0.229885%,0.00229885
>97|A180T|ARO:3003791|Enterococcus faecalis liaS mutant conferring daptomycin resistance|MEG_3587|Drugs|Lipopeptides|Daptomycin-resistant_mutant|LIAFSR|RequiresSNPConfirmation|Enterococcus_faecalis|WP_002365182.1|180|liaS_A180T|LIPOPEPTIDE|DAPTOMYCIN|Enterococcus_faecalis_daptomycin_resistant_LiaS|wt_coherence=TRUE,11.6992%,0.924791
>982|Y59H|ARO:3003379|Salmonella enterica ramR mutants|MEG_6046|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|RAMR|RequiresSNPConfirmation|Salmonella|WP_000113609.1|59|ramR_Y59H|MULTIDRUG|AMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE|Salmonella_ampicillin/chloramphenicol/quinolone/rifampin/tetracycline_resistant_RamR|wt_coherence=TRUE,22.7027%,1.83784
>983|R46P|ARO:3003379|Salmonella enterica ramR mutants|MEG_6046|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|RAMR|RequiresSNPConfirmation|Salmonella|WP_000113609.1|46|ramR_R46P|MULTIDRUG|AMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE|Salmonella_ampicillin/chloramphenicol/quinolone/rifampin/tetracycline_resistant_RamR|wt_coherence=TRUE,22.7027%,1.7027
>984|M84I|ARO:3003379|Salmonella enterica ramR mutants|MEG_6046|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|RAMR|RequiresSNPConfirmation|Salmonella|WP_000113609.1|84|ramR_M84I|MULTIDRUG|AMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE|Salmonella_ampicillin/chloramphenicol/quinolone/rifampin/tetracycline_resistant_RamR|wt_coherence=TRUE,22.7027%,2.36757
>985|T50P|ARO:3003379|Salmonella enterica ramR mutants|MEG_6046|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|RAMR|RequiresSNPConfirmation|Salmonella|WP_000113609.1|50|ramR_T50P|MULTIDRUG|AMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE|Salmonella_ampicillin/chloramphenicol/quinolone/rifampin/tetracycline_resistant_RamR|wt_coherence=TRUE,22.7027%,1.63784
>986|E160D|ARO:3003379|Salmonella enterica ramR mutants|MEG_6046|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|RAMR|RequiresSNPConfirmation|Salmonella|WP_000113609.1|160|ramR_E160D|MULTIDRUG|AMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE|Salmonella_ampicillin/chloramphenicol/quinolone/rifampin/tetracycline_resistant_RamR|wt_coherence=TRUE,22.7027%,1.56216
>989|G121D|ARO:3003382|Salmonella enterica soxR with mutation conferring antibiotic resistance|MEG_6548|Multi-compound|Drug_and_biocide_resistance|Drug_and_biocide_ABC_efflux_regulator|SOXR|RequiresSNPConfirmation|Salmonella|WP_000412686.1|121|soxR_G121D|MULTIDRUG|AMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE|Salmonella_ampicillin/chloramphenicol/quinolone/rifampin/tetracycline_resistant_SoxR|wt_coherence=TRUE,29.1667%,3.52778
>98|I440S|ARO:3003797|Enterococcus faecalis YybT with mutation conferring daptomycin resistance|MEG_7843|Drugs|Lipopeptides|Daptomycin-resistant_mutant|YYBT|RequiresSNPConfirmation|Enterococcus_faecalis|WP_002356022.1|440|yybT_I440S|LIPOPEPTIDE|DAPTOMYCIN|Enterococcus_faecalis_daptomycin_resistant_YybT|wt_coherence=TRUE,6.46154%,0.341538
>990|E466D|ARO:3003307|Salmonella serovars gyrB conferring resistance to fluoroquinolones|MEG_3238|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRB|RequiresSNPConfirmation|Salmonella|WP_000072047.1|466|gyrB_E466D|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_GyrB|wt_coherence=TRUE,5.27638%,0.513819
>991|V461G|ARO:3003317|Salmonella serovars parE conferring resistance to fluoroquinolones|NA|NA|NA|NA|NA|NA|Salmonella|WP_000195318.1|461|parE_V461G|QUINOLONE|QUINOLONE|Salmonella_quinolone_resistant_ParE|wt_coherence=TRUE,6.75241%,0.686495
>992|E52K|ARO:3003383|Salmonella serovars soxS with mutation conferring antibiotic resistance|MEG_6552|Multi-compound|Drug_and_biocide_and_metal_resistance|Drug_and_biocide_and_metal_resistance_regulator|SOXS|RequiresSNPConfirmation|Salmonella|WP_000019483.1|52|soxS_E52K|MULTIDRUG|AMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE|Salmonella_ampicillin/chloramphenicol/quinolone/rifampin/tetracycline_resistant_SoxS|wt_coherence=TRUE,42.4242%,3.47475
>993|N57K|ARO:3003940|Shigella flexneri gyrA conferring resistance to fluoroquinolones|MEG_3178|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,4.84429%,0.629758
>994|H80P|ARO:3003940|Shigella flexneri gyrA conferring resistance to fluoroquinolones|MEG_3178|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|GYRA|RequiresSNPConfirmation|NA|NA|NA|NA|NA|NA|NA|wt_coherence=TRUE,5.65167%,0.863899
>995|S129P|ARO:3003941|Shigella flexneri parC conferring resistance to fluoroquinolones|MEG_5332|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|Escherichia|WP_001281881.1|129|parC_S129P|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParC|wt_coherence=TRUE,5.64516%,0.399194
>996|D111H|ARO:3003941|Shigella flexneri parC conferring resistance to fluoroquinolones|MEG_5332|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|Escherichia|WP_001281881.1|111|parC_D111H|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParC|wt_coherence=TRUE,6.3172%,0.625
>997|A85T|ARO:3003941|Shigella flexneri parC conferring resistance to fluoroquinolones|MEG_5332|Drugs|Fluoroquinolones|Fluoroquinolone-resistant_DNA_topoisomerases|PARC|RequiresSNPConfirmation|Escherichia|WP_001281881.1|85|parC_A85T|QUINOLONE|QUINOLONE|Escherichia_quinolone_resistant_ParC|wt_coherence=TRUE,4.43548%,0.0685484
>998|L52F|ARO:3003074|Staphylococcus aureus cls conferring resistance to daptomycin|MEG_1730|Drugs|Lipopeptides|Daptomycin-resistant_mutant|CLS|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000571549.1|52|cls_L52F|LIPOPEPTIDE|DAPTOMYCIN|Staphylococcus_aureus_daptomycin_resistant_Cls|wt_coherence=TRUE,8.64198%,0.829218
>999|T33N|ARO:3003074|Staphylococcus aureus cls conferring resistance to daptomycin|MEG_1730|Drugs|Lipopeptides|Daptomycin-resistant_mutant|CLS|RequiresSNPConfirmation|Staphylococcus_aureus|WP_000571549.1|33|cls_T33N|LIPOPEPTIDE|DAPTOMYCIN|Staphylococcus_aureus_daptomycin_resistant_Cls|wt_coherence=TRUE,8.64198%,0.705761
>99|R218Q|ARO:3003092|Enterococcus faecium cls conferring resistance to daptomycin|MEG_1732|Drugs|Lipopeptides|Daptomycin-resistant_mutant|CLS|RequiresSNPConfirmation|Enterococcus_faecium|WP_002289473.1|218|cls_R218Q|LIPOPEPTIDE|DAPTOMYCIN|Enterococcus_faecium_daptomycin_resistant_Cls|wt_coherence=TRUE,1.89474%,0.185263
>9|G93V|ARO:3004045|Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan|NA|NA|NA|NA|NA|NA|Escherichia|WP_000506490.1|93|fabI_G93V|ISONIAZID/TRICLOSAN|ISONIAZID/TRICLOSAN|Escherichia_isoniazid/triclosan_resistant_FabI|wt_coherence=TRUE,16.5354%,1.33465
